| Q121950416 | Die Krankheiten des Auges. Krankheiten der Sclera, Iris, Chorioidea und Linse II. Band |
| Q121950626 | Die Krankheiten des Auges: für praktische Ärzte. I. Band |
| Q121950414 | Die Krankheiten des Auges: für praktische Ärzte. I. Band |
| Q121950627 | Die Krankheiten des Auges: für praktische Ärzte. II. Band |
| Q121950628 | Die Krankheiten des Auges: für praktische Ärzte. III. Band |
| Q121950528 | Die Pflege der Augen im gesunden und kranken Zustande: nebst einem Anhange über Augengläser |
| Q121981139 | Dissertatio inauguralis medica de Keratoiditide scrophulosa |
| Q121990285 | Dissertatio inauguralis medica sistens synopsin nosologicam dysopsiarum juxta Swediauri iatrikén disposita: quam consensu et auctoritate perillustris, magnifici ac celeberrimi domini praesidis ac directoris ... |
| Q121991071 | Dissertatio inauguralis medico-ophthalmiatrica sistens observationes circa tartari stibiati in opthalmis rheumaticis virtutem: quam consensu et auctoritate perillustris, magnifici ac celeberrimi domini ... |
| Q122145108 | Dissertatio inauguralis medico-ophthalmiatrica, sistens historias synopticas ophthalmiarum quatuor, phaenomenis et decursu singularium, in clinico ophthalmiatrico Pragensi tractatarum |
| Q121982483 | Dissertatio inauguralis medico-practica sistens historias synopticas keratoiritidum rheumatico-syphiliticarum in clinico ophthalmiatrico Pragensi anni scholastici 1838 tractatarum adnexa epicrisi ... |
| Q122145206 | Dissertatio inauguralis ophthalmojatrica de blepharoblennorrhoea chronica |
| Q122145179 | Historia synoptica blepharoophthalmo-blennorrhoeae acutae in clinico ophthalmiatrico Pragensi tractatae adnexa epicrisi |
| Q121976766 | Klinischer Unterricht in der Augenheilkunde |
| Q121944739 | O některých vzácných nádorech a cizopasnících oka: glioma, pseudoglioma, cryptoglioma, cylindroglioma, cysticercus subretinalis triplex |
| Q121996562 | Oftalmorevmatologie |
| Q121973015 | Operační výkony v oftalmologii |
| Q122120807 | Optická koherenční tomografie |
| Q122008587 | Optická koherenční tomografie: klinický atlas sítnicových patologií |
| Q122019586 | Optics and Optometry Forum 2018: proceedings of students' conference |
| Q121992905 | Oční lékařství pro studenty oboru zubní lékařství |
| Q122113854 | Oční projevy systémových onemocnění |
| Q122019973 | Praktická oftalmologie |
| Q122040918 | Praktický průvodce očními chorobami |
| Q122141334 | Tabulky k vyšetření barvocitu: (navíc 3 dětské tabulky s alternativními symboly): vynalezli a vytříbili Jakob Stilling, Ernst Hertel, Karl Velhagen |
| Q122007552 | Uzdravte si oči: staré čínské metody pro dobrý zrak |
| Q122081007 | Willsův oční manuál: diagnostika a léčba očních chorob v praxi |
| Q121949579 | Šance pro oči: deset kroků k nápravě zraku vlastními silami |
| Q122091040 | Špatně vidím (nevidím), můžete mi pomoci? |
| Q64060981 | "Smart Eye Camera": An innovative technique to evaluate tear film breakup time in a murine dry eye disease model |
| Q96611820 | "Stripe sign"- MRI characteristic of extraocular muscles in tendon sparing thyroid eye disease |
| Q67738688 | 2nd symposium of the International Society on Metabolic Eye disease |
| Q91291525 | A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease |
| Q96818232 | A Comparison of Efficacy and Safety of Two Lipid-Based Lubricant Eye Drops for the Management of Evaporative Dry Eye Disease |
| Q102386914 | A Comprehensive Review of the Clinical Trials Conducted for Dry Eye Disease and the Impact of the Vehicle Comparators in These Trials |
| Q59104204 | A Comprehensive Review on Dry Eye Disease: Diagnosis, Medical Management, Recent Developments, and Future Challenges |
| Q52929405 | A Deep Learning Algorithm for Prediction of Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration from Color Fundus Photography. |
| Q52818918 | A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14. |
| Q37732321 | A Metabolome-Wide Study of Dry Eye Disease Reveals Serum Androgens as Biomarkers |
| Q96113657 | A Multi-Center Study of the Prevalence of Dry Eye Disease in Chinese Refractive Surgery Candidates |
| Q92386747 | A New Era in the Treatment of Thyroid Eye Disease |
| Q92554417 | A New Ophthalmic Pharmaceutical Formulation, Topical Sulglycotide, Enhances the Ocular Mucin Secretion in Desiccation Stress-Mediated Dry Eye Disease |
| Q93084486 | A New Rabbit Model of Chronic Dry Eye Disease Induced by Complete Surgical Dacryoadenectomy |
| Q52687189 | A Novel Combination Therapy for Patients With Dry Eye Disease: A Pilot Study. |
| Q101573732 | A Novel Epidemiological Approach to Geographically Mapping Population Dry Eye Disease in the United States Through Google Trends |
| Q92994581 | A Novel Method of CT Exophthalmometry in Patients With Thyroid Eye Disease |
| Q92970826 | A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease |
| Q64072411 | A Phase I/II Placebo-Controlled Randomized Pilot Clinical Trial of Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients With Dry Eye Disease |
| Q57484944 | A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease |
| Q91534566 | A Pilot Study of the Short Term Effectiveness and Safety of Amniotic Fluid in Severe Dry Eye Disease |
| Q38547456 | A Pragmatic Approach to the Management of Dry Eye Disease: Evidence into Practice. |
| Q104756902 | A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare® System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease |
| Q37048445 | A REVIEW OF EYE DISEASE IN CENTRAL CHINA. |
| Q89741210 | A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies |
| Q104585524 | A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease |
| Q101403388 | A Retrospective Data Review Confirms That Topical Preservative-Free Hydrocortisone Improves Inflammation in Dry Eye Disease |
| Q58611873 | A Review of the Emerging Role of Silk for the Treatment of the Eye |
| Q104142604 | A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments |
| Q96687302 | A Set of Global Metabolomic Biomarker Candidates to Predict the Risk of Dry Eye Disease |
| Q89507630 | A Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD |
| Q73160859 | A case of bilateral inferior rectus restriction after previous unilateral inferior rectus recession for thyroid eye disease |
| Q86814203 | A case of extraocular muscle enlargement causing diplopia: thinking beyond thyroid eye disease |
| Q47304566 | A case of eye disease (Lippitudo) on the Roman frontier in Britain |
| Q69092850 | A case of eye disease due to dietary vitamin A deficiency in Glasgow |
| Q89841209 | A case of isolated amyloidosis in extraocular muscle mimicking thyroid eye disease |
| Q91026330 | A cerium oxide loaded glycol chitosan nano-system for the treatment of dry eye disease |
| Q41234521 | A classification model for predicting eye disease in newly diagnosed people with type 2 diabetes. |
| Q35300774 | A clinic based survey of blindness and eye disease in Cambodia |
| Q73396645 | A comment on grand rounds #55. A case of bilateral inferior rectus restriction after previous unilateral inferior rectus recession for thyroid eye disease |
| Q41442733 | A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment |
| Q74631033 | A comparative study of mydriatic and cycloplegic agents; in human subjects without eye disease |
| Q42941533 | A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial |
| Q71493705 | A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. The Herpetic Eye Disease Study Group |
| Q73440303 | A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The Epithelial Keratitis Trial. The Herpetic Eye Disease Study Group |
| Q40554840 | A distinct cytokines profile in tear film of dry eye disease (DED) patients with HIV infection. |
| Q37204567 | A field test of Web-based screening for dry eye disease to enhance awareness of eye problems among general Internet users: a latent strategy to promote health |
| Q90342179 | A generative adversarial network approach to predicting postoperative appearance after orbital decompression surgery for thyroid eye disease |
| Q54286700 | A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy. |
| Q40731686 | A model for a blinding eye disease of the aged |
| Q24561532 | A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity |
| Q84237624 | A new appreciation for dry eye disease |
| Q92603669 | A new approach of ocular nebulization with vitamin B12 versus oxytocin for the treatment of dry eye disease: an in vivo confocal microscopy study |
| Q69568398 | A new drug-induced eye disease: "amiodaron-thesaurismosis" |
| Q34048366 | A new look at dry eye disease and its treatment |
| Q43510709 | A new look at experimental herpes simplex eye disease: preliminary results of clinical disease in the NIH mouse after zosteriform spread |
| Q38049530 | A new mouse model of dry eye disease: oxidative stress affects functional decline in the lacrimal gland |
| Q36887538 | A nonrandomized, open-label study to evaluate the effect of nasal stimulation on tear production in subjects with dry eye disease |
| Q73685980 | A novel inflammatory eye disease induced by lymphocytes from knockout mice sensitized against the deleted ocular antigen |
| Q87363057 | A novel nanoscale-dispersed eye ointment for the treatment of dry eye disease |
| Q64226436 | A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease |
| Q39756430 | A population-based assessment of presbyopia in the state of Andhra Pradesh, south India: the Andhra Pradesh Eye Disease Study |
| Q101131942 | A practical framework for telemedicine in dry eye disease |
| Q72767175 | A preliminary investigation and analysis of the genetic eye disease |
| Q44918696 | A questionnaire-based survey of dry eye disease among leather tannery workers in Kanpur, India: a case-control study |
| Q40095379 | A randomised trial of non-mydriatic ultra-wide field retinal imaging versus usual care to screen for diabetic eye disease: rationale and protocol for the Clearsight trial. |
| Q46272660 | A retrospective study of eye disease among first grade children in Los Angeles |
| Q100571474 | A retrospective study of pediatric thyroid eye disease: the Asian experience |
| Q55042632 | A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases. |
| Q57156050 | A review of the multifunctionality of angiopoietin-like 4 in eye disease |
| Q57157493 | A review of the multifunctionality of angiopoietin-like 4 in eye disease |
| Q82196377 | A serious eye disease; glaucoma |
| Q74657707 | A sneak peek: a case of early thyroid eye disease |
| Q79432519 | A study of plasmin in eye disease |
| Q69836674 | A study of the prevalence of eye disease in the elderly in an English community |
| Q91973798 | A survey of current practices by the British Oculoplastic Surgery Society (BOPSS) and recommendations for delivering a sustainable multidisciplinary approach to thyroid eye disease in the United Kingdom |
| Q28655780 | A survey on computer aided diagnosis for ocular diseases |
| Q73571649 | A view from afar. Vanderbilt University uses a telemedicine program to help diagnose a devastating eye disease before it's too late |
| Q76029905 | ACTH and cortisone therapy in eye disease |
| Q96143382 | ADVM-022 Intravitreal Gene Therapy for DME |
| Q35309267 | AIDS related eye disease in Burundi, Africa |
| Q94003539 | AN AMERICAN HANDBOOK ON EYE DISEASE |
| Q94114887 | Abdominal Sepsis as a Cause of Eye Disease |
| Q104282657 | Abnormal Spontaneous Brain Activities of Limbic-Cortical Circuits in Patients With Dry Eye Disease |
| Q36445561 | Accelerated Restoration of Ocular Surface Health in Dry Eye Disease by Self-Retained Cryopreserved Amniotic Membrane |
| Q93125981 | Achyranthis radix Extract Improves Urban Particulate Matter-Induced Dry Eye Disease |
| Q92860785 | Acute corneal perforation 1 week following uncomplicated cataract surgery: the implication of undiagnosed dry eye disease and topical NSAIDs |
| Q39362474 | Acute eye disease secondary to contact-lens wear |
| Q43617080 | Acute ischemic eye disease from the neurovascular aspect |
| Q26827429 | Acute thyroid eye disease (TED): principles of medical and surgical management |
| Q77060539 | Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group |
| Q64383217 | Adenovirus type 8 infections in the United States. IV. Observations on the pathogenesis of lesions in severe eye disease |
| Q92682385 | Adherence to Topical Medication in Patients with Inflammatory Eye Disease |
| Q91884829 | Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2 |
| Q42912958 | Adherence to recommendations of the age-related eye disease study in patients with age-related macular degeneration |
| Q94458732 | Adherence to the Mediterranean diet and progression to late age-related macular degeneration in the Age-Related Eye Disease Studies 1 and 2 |
| Q73006396 | Adipogenesis in thyroid eye disease |
| Q37190609 | Advances in Gene Therapy for Diseases of the Eye. |
| Q92442286 | Advances in dry eye disease treatment |
| Q97591634 | Advances in steroid sparing medical management of active thyroid eye disease |
| Q37012076 | Advances in the management of thyroid eye disease |
| Q36377672 | Advocacy for eye care |
| Q91575792 | Age-Related Changes in the Clinical Phenotype of Compressive Optic Neuropathy in Thyroid Eye Disease |
| Q81477403 | Age-Related Eye Disease Study severity scale and simplified severity scale for age-related macular degeneration |
| Q91284910 | Age-Related Eye Disease and Cognitive Function: The Search for Mediators |
| Q47151976 | Age-Related Eye Disease and Participation in Cognitive Activities |
| Q91703386 | Age-Related Macular Degeneration and Mortality in the Age-Related Eye Disease Study (AREDS): The Effect of Sex and Time |
| Q35773063 | Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease |
| Q26823002 | Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions |
| Q50598577 | Age-related eye disease and cognitive function. |
| Q38617884 | Age-related eye disease and gender |
| Q45038338 | Age-related eye disease and mobility limitations in older adults |
| Q40611217 | Age-related eye disease and survival. The Beaver Dam Eye Study |
| Q50660016 | Age-related eye disease in the elderly members of rural African community. |
| Q44049783 | Age-related eye disease study caveats. |
| Q50472458 | Age-related eye disease, quality of life, and functional activity. |
| Q91914620 | Aged mice exhibit severe exacerbations of dry eye disease with an amplified memory Th17 cell response |
| Q98216421 | Ageing and the natural history of dry eye disease: A prospective registry-based cross-sectional study |
| Q34273593 | Aging and dry eye disease |
| Q80110350 | Agreement of physician treatment practices with the international task force guidelines for diagnosis and treatment of dry eye disease |
| Q64246027 | Air Pollutants are associated with Dry Eye Disease in Urban Ophthalmic Outpatients: a Prevalence Study in China |
| Q44936014 | Aland eye disease (Forsius-Eriksson-Miyake syndrome) with probability established in a Danish family |
| Q33658758 | Aland eye disease: linkage data |
| Q93658628 | Aland eye disease: no albino misrouting |
| Q37312045 | Aland island eye disease: clinical and electrophysiological studies of a Welsh family |
| Q47561954 | Algorithm for dry eye disease diagnosis in individuals infected with human T-cell lymphotropic virus type 1. |
| Q102336030 | Algorithmic approach to diagnosis and management of post-refractive surgery dry eye disease |
| Q89811200 | Allergic eye disease |
| Q73828447 | Allergic eye disease associated with mastocytosis |
| Q93056977 | Allergic eye disease in children and adolescents seeking eye care in India: Electronic medical records driven big data analytics report II |
| Q43095204 | Allergic eye disease mechanisms |
| Q97072567 | Alpha-lipoic acid: A possible pharmacological agent for treating dry eye disease and retinopathy in diabetes |
| Q35589468 | Alteration of galectin-3 in tears of patients with dry eye disease |
| Q96603196 | Alterations in corneal biomechanics underlie early stages of autoimmune-mediated dry eye disease |
| Q61196350 | Alterations of Tear Neuromediators in Dry Eye Disease |
| Q45930063 | Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2. |
| Q98618714 | An Adoptive Threshold-Based Multi-Level Deep Convolutional Neural Network for Glaucoma Eye Disease Detection and Classification |
| Q104493032 | An Association Rule Analysis of Combined Acupoints for the Treatment of Patients with Dry Eye Disease |
| Q26774854 | An Overview of Ophthalmologic Survey Methodology in the 2008-2015 Korean National Health and Nutrition Examination Surveys |
| Q98948485 | An algorithm for Botulinum toxin A injection for upper eyelid retraction associated with thyroid eye disease: long-term results |
| Q28235016 | An amino acid exchange in exon I of the human lecithin: cholesterol acyltransferase (LCAT) gene is associated with fish eye disease |
| Q90604030 | An amphipathic cell penetrating peptide aids cell penetration of cyclosporin A and increases its therapeutic effect in an in vivo mouse model for dry eye disease |
| Q91308254 | An artificial tear containing flaxseed oil for treating dry eye disease: A randomized controlled trial |
| Q89617094 | An atypical case of unilateral vision loss in thyroid eye disease |
| Q58928078 | An efficient deep-learning tool for detecting eye disease |
| Q44363606 | An improved model of recurrent herpetic eye disease in mice |
| Q52900733 | An independent evaluation of the Age-Related Eye Disease Study (AREDS) cataract grading system. |
| Q72807390 | An introduction to eye disease |
| Q48343172 | An objective approach to dry eye disease severity. |
| Q36305798 | An overview of thyroid eye disease |
| Q38207723 | An update on dry eye disease molecular treatment: advances in drug pipelines |
| Q102073327 | Anaesthesia for ophthalmic procedures in patients with thyroid eye disease |
| Q40338169 | Analysis of Lid Contour in Thyroid Eye Disease With Upper and Lower Eyelid Retraction Using Multiple Radial Midpupil Lid Distances |
| Q90371872 | Analysis of Periorbital Soft Tissue in Thyroid Eye Disease |
| Q43760278 | Analysis of eye disease and adaptation of visual aids in low vision patients: review of 1,000 cases |
| Q59400140 | Analysis of tear fluid proteins: use of multiplex assays in profiling biomarkers of dry eye disease |
| Q96819906 | Analysis of tear inflammatory molecules and clinical correlations in evaporative dry eye disease caused by meibomian gland dysfunction |
| Q88995520 | Anatomic Considerations in Thyroid Eye Disease |
| Q48387598 | Andhra Pradesh Eye Disease Study - Visual Function Questionnaire: further improvements in psychometric properties using Rasch analysis. |
| Q37093590 | Angiogenesis in eye disease: immunity gained or immunity lost? |
| Q86492432 | Angiopoietin-like 4 as an Emerging Therapeutic Target for Diabetic Eye Disease |
| Q27329569 | Angiostrongylus vasorum in the eye: new case reports and a review of the literature |
| Q39933144 | Angle closure in the Andhra Pradesh Eye Disease Study |
| Q33624270 | Anisometropia in Hispanic and african american infants and young children the multi-ethnic pediatric eye disease study |
| Q43488810 | Anterior segment involvement in HIV-related eye disease after the commencement of highly active antiretroviral therapy (HAART) |
| Q91946548 | Anti-N-methyl-D-aspartate Receptor Encephalitis in a Patient with Thyroid Eye Disease |
| Q26767400 | Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases |
| Q75762051 | Antibiotics in external eye disease |
| Q60207677 | Antilens antibodies in cataract and inflammatory eye disease: an evaluation of a new technique |
| Q72068439 | Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group |
| Q77807707 | Antioxidant vitamins and age-related eye disease |
| Q87393673 | Apoptosis of conjunctival epithelial cells before and after the application of autologous serum eye drops in severe dry eye disease |
| Q93343185 | Application of In Vivo Confocal Microscopy in Dry Eye Disease |
| Q69399364 | Application of subjective and objective measurement of dark adaptation to ocular pathology using the same equipment |
| Q90754701 | Applications of Optical Coherence Tomography Angiography in Diabetic Eye Disease |
| Q27024925 | Applying principles of health system strengthening to eye care |
| Q84608418 | Approve bevacizumab for use in eye disease in cash strapped times |
| Q96055830 | Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance |
| Q89539996 | Aqueous deficiency is a contributor to evaporation-related dry eye disease |
| Q47925680 | Are patients attending the smoking cessation clinic aware of the association between eye disease and smoking? |
| Q36964382 | Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy? |
| Q37062319 | Are we pharmacovigilant enough in ophthalmic practice? |
| Q83875102 | Art and Eye Disease |
| Q51060402 | Arteriovenous crossing patterns in branch retinal vein occlusion. The Eye Disease Case-Control Study Group. |
| Q81104578 | Arthritis and inflammatory eye disease |
| Q90263150 | Artificial Intelligence in Diabetic Eye Disease Screening |
| Q58553410 | Artificial intelligence and deep learning in ophthalmology |
| Q71635294 | Assessing the prevalence of eye disease in the community |
| Q92735939 | Assessment of Orbital Computed Tomography (CT) Imaging Biomarkers in Patients with Thyroid Eye Disease |
| Q64117967 | Assessment of lacrimal glands in thyroid eye disease with diffusion-weighted magnetic resonance imaging |
| Q104486058 | Assessment of patient burden from dry eye disease using a combination of five visual analogue scales and a radar graph: a pilot study of the PENTASCORE |
| Q50968097 | Assessment of the Tear Meniscus by Strip Meniscometry and Keratograph in Patients With Dry Eye Disease According to the Presence of Meibomian Gland Dysfunction. |
| Q39884322 | Associated factors for age-related maculopathy in the adult population in southern India: the Andhra Pradesh Eye Disease Study |
| Q92189867 | Association Between Dry Eye Disease and Migraine Headaches in a Large Population-Based Study |
| Q40193449 | Association Between Menstrual Irregularity and Dry Eye Disease: A Population-Based Study |
| Q87929267 | Association Between Menstrual Irregularity and Dry Eye Disease: A Population-Based Study |
| Q91918843 | Association Between Migraine Headaches and Dry Eye Disease in Patients Studied in General Practices in Germany |
| Q38995428 | Association Between Migraine and Dry Eye Disease: A Nationwide Population-Based Study |
| Q93052779 | Association Between Single Nucleotide Polymorphisms in the Vitamin D Receptor and Incidence of Dry Eye Disease in Chinese Han Population |
| Q90918388 | Association Between Sleep Quality, Mood Status, and Ocular Surface Characteristics in Patients With Dry Eye Disease |
| Q56243498 | Association Between the Cilioretinal Artery and Choroidal Neovascularization in Age-Related Macular Degeneration: A Secondary Analysis From the Age-Related Eye Disease Study |
| Q64054722 | Association between Dry Eye Disease and Psychological Stress among Paramedical Workers in Korea |
| Q58555493 | Association between Dry Eye Disease, Air Pollution and Weather Changes in Taiwan |
| Q61804333 | Association between Three Heavy Metals and Dry Eye Disease in Korean Adults: Results of the Korean National Health and Nutrition Examination Survey |
| Q100499406 | Association between asthma with dry eye disease: A protocol for systematic review and meta-analysis |
| Q38174021 | Association between atopy and herpetic eye disease: results from the pacific ocular inflammation study |
| Q39997747 | Association between depression and dry eye disease in an elderly population |
| Q57045583 | Association between diabetic eye disease and other complications of diabetes: implications for care. A systematic review |
| Q24628833 | Association between dietary fat intake and age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS): an ancillary study of the Women's Health Initiative |
| Q34647050 | Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the Age-Related Eye Disease Study |
| Q60046536 | Association between dry eye disease and asthma: a nationwide population-based study |
| Q50201362 | Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis. |
| Q33440549 | Association between video display terminal use and dry eye disease in school children |
| Q90311498 | Association between vitamin D and dry eye disease: A systematic review and meta-analysis of observational studies |
| Q51134189 | Association for research in vision and ophthalmology - 2009 annual meeting. Reducing disparities in eye disease and treatment: part 1. |
| Q51134192 | Association for research in vision and ophthalmology - 2009 annual meeting. Reducing disparities in eye disease and treatment: part 2. |
| Q92524759 | Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39 |
| Q94939257 | Association of Dry Eye Disease with Dyslipidemia and Statin Use |
| Q90884717 | Association of Fellow Eye With Study Eye Disease Trajectories and Need for Fellow Eye Treatment in Collaborative Initial Glaucoma Treatment Study (CIGTS) Participants |
| Q92449326 | Association of Killer Cell Immunoglobulin-like Receptor Genotypes and Haplotypes in Dry Eye Disease Patients Treated with Restasis and Systane |
| Q91082903 | Association of Risk of Obstructive Sleep Apnea With Thyroid Eye Disease: Compressive Optic Neuropathy |
| Q100696321 | Association of Severity of Dry Eye Disease with Work Productivity and Activity Impairment in the Dry Eye Assessment & Management Study |
| Q96947312 | Association of Systemic Comorbidities with Dry Eye Disease |
| Q98388198 | Association of dry eye disease and sun exposure in geographically diverse adult (≥40 years) populations of India: The SEED (sun exposure, environment and dry eye disease) study - Second report of the ICMR-EYE SEE study group |
| Q57091538 | Association of dyslipidemia and oral statin use, and dry eye disease symptoms in the Blue Mountains Eye Study |
| Q81469856 | Association of inflammatory eye disease with granuloma annulare? |
| Q39628362 | Association of killer cell immunoglobulin-like receptor and human leukocyte antigen-C genotype with dry eye disease in a Chinese Han population |
| Q98782268 | Association of meibomian gland morphology with symptoms and signs of dry eye disease in the Dry Eye Assessment and Management (DREAM) study |
| Q64122183 | Association of treatment-achieved HbA with incidence of coronary artery disease and severe eye disease in diabetes patients |
| Q63344335 | Associations Between Intermediate Age-Related Macular Degeneration and Lutein and Zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS) |
| Q89875479 | Associations Between Systemic Omega-3 Fatty Acid Levels With Moderate-to-Severe Dry Eye Disease Signs and Symptoms at Baseline in the Dry Eye Assessment and Management Study |
| Q34760523 | Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the Carotenoids in the Age-Related Eye Disease Study, an Ancillary Study of the Women's Health Initiative |
| Q26781979 | Associations between signs and symptoms of dry eye disease: a systematic review |
| Q35242945 | Associations between subjective happiness and dry eye disease: a new perspective from the Osaka study |
| Q34655512 | Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 |
| Q69612702 | Astigmatism occurring in association with pediatric eye disease |
| Q93385360 | Asymmetric lacrimal gland enlargement: an indicator for detection of pathological entities other than thyroid eye disease |
| Q93665652 | Atlas of Eye Disease |
| Q36631179 | Atopic disease and herpes simplex eye disease: a population-based case-control study |
| Q69076354 | Atromid-S in eye disease |
| Q90082786 | Atrophy in Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 15 |
| Q76146563 | Aureomycin--a modern therapy in eye disease |
| Q55633003 | Author Correction: Changes in Distribution of Dry Eye Disease by the New 2016 Diagnostic Criteria from the Asia Dry Eye Society. |
| Q53019791 | Autoimmune lymphocytic hypophysitis in association with autoimmune eye disease and sequential treatment with infliximab and rituximab. |
| Q69842124 | Autoimmune mechanisms in inflammatory eye disease |
| Q66890209 | Autoimmunity in chronic inflammatory eye disease (author's transl) |
| Q96340090 | Autologous serum eye drops improve tear production, both lachrymal flow and stability tests and conjunctival impression cytology with transfer in dry eye disease |
| Q92301021 | Autologous serum eye drops versus artificial tear drops for dry eye disease: a systematic review and meta-analysis of randomized controlled trials |
| Q104745662 | Automatic Detection of Genetics and Genomics of Eye Disease Using Deep Assimilation Learning Algorithm |
| Q90735660 | Autonomous early detection of eye disease in childhood photographs |
| Q47110611 | Awareness and eye health-seeking practices for cataract among urban slum population of Delhi: The North India eye disease awareness study |
| Q43749674 | Awareness of diabetic eye disease among general practitioners and diabetic patients in Yangon, Myanmar |
| Q35995565 | Axial Globe Position Measurement: A Prospective Multicenter Study by the International Thyroid Eye Disease Society. |
| Q38068619 | B-cell targeted therapy with rituximab for thyroid eye disease: closer to the clinic. |
| Q92190009 | Baltimore Reading and Eye Disease Study (BREDS): compliance and satisfaction with glasses usage |
| Q40213274 | Baseline risk factors for incidence of blindness in a South Indian population: the chennai eye disease incidence study |
| Q92077466 | Berunda Polypeptides: Biheaded Rapamycin Carriers for Subcutaneous Treatment of Autoimmune Dry Eye Disease |
| Q33970876 | Bevacizumab in inflammatory eye disease |
| Q104500257 | Bilateral inferior oblique enlargement in thyroid eye disease |
| Q35978942 | Bilateral metastatic melanoma to the extraocular-muscles simulating thyroid eye disease |
| Q70841437 | Bilateral orbital metastases from breast carcinoma masquerading as thyroid eye disease |
| Q35174246 | Bilateral versus unilateral thyroid eye disease |
| Q70299042 | Bile acids and plasma high density lipoproteins: biliary lipid metabolism in fish eye disease |
| Q28261108 | Biochemical Basis for Dominant Inheritance, Variable Penetrance, and Maternal Effects in RBP4 Congenital Eye Disease |
| Q64285170 | Bioinformatic Analysis Identifies Potentially Key Differentially Expressed Genes and Pathways in Orbital Adipose Tissues of Patients with Thyroid Eye Disease |
| Q80415346 | Blindness and eye disease in Cambodia |
| Q33648061 | Blindness and eye disease in Kenya: ocular status survey results from the Kenya Rural Blindness Prevention Project |
| Q59797116 | Blindness and eye disease in a Tibetan region of China: findings from a Rapid Assessment of Avoidable Blindness survey |
| Q30753191 | Blindness in patients with diabetes who have been screened for eye disease |
| Q73227071 | Blindness in the Bantu; a survey of external eye disease and malnutrition in the North Eastern Transvaal |
| Q57593831 | Blink Test enhances ability to screen for dry eye disease |
| Q36776787 | Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease |
| Q90164048 | Blood-Based Treatments for Severe Dry Eye Disease: The Need of a Consensus |
| Q90497735 | Bony Orbital Volume Expansion in Thyroid Eye Disease |
| Q42793888 | Botulinum neurotoxin type A versus punctal plug insertion in the management of dry eye disease |
| Q35305157 | Botulinum toxin A treatment of overactive corrugator supercilii in thyroid eye disease |
| Q84489402 | Botulinum toxin type a and its uses in dry eye disease |
| Q44981848 | Brief communication on the occurrence of thelaciae pathogenes of an enzootic eye disease in cattle in the GDR |
| Q39843458 | Brightness, contrast, and color balance of digital versus film retinal images in the age-related eye disease study 2. |
| Q43673935 | Burden and predictors of undetected eye disease in Mexican-Americans: the Los Angeles Latino Eye Study |
| Q91314485 | Burden of dry eye disease in Germany: a retrospective observational study using German claims data |
| Q90777380 | Burden of eye disease and demand for care in the Bangladesh Rohingya displaced population and host community: A cohort study |
| Q38671715 | Burden of vision loss associated with eye disease in China 1990-2020: findings from the Global Burden of Disease Study 2015. |
| Q55343915 | CHILD CARE IN GENERAL PRACTICE. EYE DISEASE IN CHILDREN. |
| Q43032448 | Calorie restriction: A new therapeutic intervention for age-related dry eye disease in rats |
| Q92879111 | Can dietary approaches to the treatment of dry eye disease be improved? |
| Q50200238 | Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms? |
| Q84131925 | Canakinumab in a patient with juvenile Behcet's syndrome with refractory eye disease |
| Q72301938 | Canine ocular mucins in health and dry eye disease |
| Q61953755 | Cardiovascular therapies and their role in diabetic eye disease |
| Q71364226 | Carotid-cavernous fistula mimicking Graves' eye disease |
| Q40735994 | Case-Control Study of Herpes Simplex Eye Disease: Bronx Epidemiology of Human Immunodeficiency Virus Eye Studies. |
| Q101053961 | Cataract Surgery in Dry Eye Disease: Visual Outcomes and Complications |
| Q51896616 | Cataract classification using serial examinations in the age-related eye disease study: age-related eye disease study report no. 24. |
| Q96220413 | Cataract surgery and dry eye disease: A review |
| Q60486312 | Cationorm® (cationic emulsion eye drops) in dry eye disease: a guide to its use |
| Q91649160 | Central Retinal Vein Occlusion with Chorioretinal Folds Secondary to Active Thyroid Eye Disease |
| Q35762167 | Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study: a propensity score approach. AREDS report No. 21 |
| Q103031027 | Challenges in diagnosing coexisting ocular myasthenia gravis and thyroid eye disease |
| Q33502975 | Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. |
| Q100943269 | Changes in Corneal Subbasal Nerves after Punctal Occlusion in Dry Eye Disease |
| Q48138863 | Changes in Distribution of Dry Eye Disease by the New 2016 Diagnostic Criteria from the Asia Dry Eye Society. |
| Q95298739 | Changes in Field of Binocular Single Vision and Ocular Deviation Angle After Balanced Orbital Decompression in Thyroid Eye Disease |
| Q91690870 | Changes in Human Tear Proteome Following Topical Treatment of Dry Eye Disease: Cyclosporine A Versus Diquafosol Tetrasodium |
| Q100407004 | Changes in horizontal strabismus after inferior rectus muscle recession with or without nasal transposition in thyroid eye disease: A retrospective, observational study |
| Q36626466 | Changes in incidence of diabetes mellitus-related eye disease among US elderly persons, 1994-2005. |
| Q35554026 | Changes in lens opacities on the age-related eye disease study grading scale predict progression to cataract surgery and vision loss: age-related eye disease study report no. 34 |
| Q48259178 | Changing trend in referral to secondary care specialist thyroid eye disease clinic following the Amsterdam declaration |
| Q64976153 | Characteristics of inflammatory eye disease associated with hidradenitis suppurativa. |
| Q38370253 | Characteristics of symptoms experienced by persons with dry eye disease while driving in China |
| Q91629104 | Characterization and Management of Inflammatory Eye Disease in Patients with Hidradenitis Suppurativa |
| Q104746887 | Characterization of Ebola Virus-Associated Eye Disease |
| Q90358056 | Characterization of dry eye disease in a mouse model by optical coherence tomography and fluorescein staining |
| Q50454716 | Characterization of dry eye disease in diabetic patients versus nondiabetic patients. |
| Q93344260 | Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation: Results from two pivotal clinical trials |
| Q49928500 | Characterizing Intraorbital Optic Nerve Changes on Diffusion Tensor Imaging in Thyroid Eye Disease Before Dysthyroid Optic Neuropathy. |
| Q92054678 | Chorioretinal Folds in Thyroid Eye Disease |
| Q49352759 | Choroidal Nevi in the Singapore Epidemiology of Eye Disease Study. |
| Q37067291 | Chronic dry eye disease is principally mediated by effector memory Th17 cells |
| Q85681279 | Chronic eye disease and the WHO Universal Eye Health Global Action Plan 2014-2019 |
| Q56864480 | Ciclosporin use in dry eye disease patients |
| Q36596473 | Cigarette smoking and thyroid eye disease: a systematic review |
| Q64986317 | Circular RNAs: Novel Promising Biomarkers in Ocular Diseases. |
| Q67318659 | Citrus eye disease |
| Q69121780 | Classification of herpetic eye disease |
| Q91015278 | Classifying signs and symptoms of dry eye disease according to underlying mechanism via the Delphi method: the DIDACTIC study |
| Q84376462 | Climate change, fluorescent lighting, and eye disease: a little too light on the science |
| Q98613385 | Climatic and Environmental Correlates of Dry Eye Disease Severity: A Report From the Dry Eye Assessment and Management (DREAM) Study |
| Q92047448 | Clinical Accuracy of an Advanced Corneal Topographer with Tear-Film Analysis in Functional and Structural Evaluation of Dry Eye Disease |
| Q35803329 | Clinical Effect of Antioxidant Glasses Containing Extracts of Medicinal Plants in Patients with Dry Eye Disease: A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial |
| Q61054786 | Clinical Outcomes of Fixed Versus As-Needed Use of Artificial Tears in Dry Eye Disease: A 6-Week, Observer-Masked Phase 4 Clinical Trial |
| Q93094688 | Clinical Outcomes of Lifitegrast 5% Ophthalmic Solution in the Treatment of Dry Eye Disease |
| Q93946441 | Clinical Pathology of Eye Disease |
| Q87965873 | Clinical Relevance and Application of the Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration |
| Q67854591 | Clinical and electroretinographic comparison between Åland Island eye disease and a newly found related disease with X-chromosomal inheritance |
| Q38316762 | Clinical challenges of thyroid eye disease in HIV-positive patients on highly active antiretroviral therapy |
| Q74484952 | Clinical course of macular holes: the Eye Disease Case-Control Study |
| Q59793763 | Clinical efficacy of transcutaneous triamcinolone acetonide injection for upper eyelid retraction and swelling in patients with thyroid eye disease |
| Q37050310 | Clinical evaluation of the efficacy of PEG/PG lubricant eye drops with gelling agent (HP-Guar) for the relief of the signs and symptoms of dry eye disease: a review |
| Q93746771 | Clinical experiments in cellular immunity in eye disease |
| Q63387333 | Clinical pathophysiology of thyroid eye disease: The Cone Model |
| Q79404172 | Clinical perspectives of thyroid eye disease |
| Q97692359 | Clinical profile of thyroid eye disease and factors predictive of disease severity |
| Q34827226 | Clinical research in pediatric ophthalmology: the Pediatric Eye Disease Investigator Group |
| Q83809653 | Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management |
| Q100629344 | Cluster-randomised trial of community-based screening for eye disease in adults in Nepal: the Village-Integrated Eye Worker Trial II (VIEW II) trial protocol |
| Q85313669 | Co-crystals to see improved therapeutic action for eye disease |
| Q43150109 | Co-existence of classic familial lecithin-cholesterol acyl transferase deficiency and fish eye disease in the same family. |
| Q34652041 | Cognitive impairment in the Age-Related Eye Disease Study: AREDS report no. 16. |
| Q90978240 | Color Doppler imaging in thyroid eye disease and its correlation to disease activity |
| Q91125225 | Color Doppler imaging of orbital vasculature before and after orbital decompression in thyroid eye disease |
| Q36821665 | Color vision deficiency in preschool children: the multi-ethnic pediatric eye disease study |
| Q74293956 | Colour Doppler imaging of superior ophthalmic vein in thyroid-associated eye disease |
| Q82457493 | Combined endoscopic medial and external lateral orbital decompression for progressive thyroid eye disease |
| Q49360082 | Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial. |
| Q74216894 | Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease |
| Q42424359 | Comment on "Perspective: A Critical Look at the Ancillary Age-Related Eye Disease Study 2: Nutrition and Cognitive Function Results in Older Individuals with Age-Related Macular Degeneration". |
| Q42563364 | Comment on 'Acute thyroid eye disease (TED): principles of medical and surgical management'. |
| Q49680187 | Comment on: 'Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine'. |
| Q92169096 | Comment on: Pathological consequences of Anti-Citrullinated Protein Antibodies in Tear Fluid and therapeutic potential of Pooled Human Immune Globulin-Eye Drops in Dry Eye Disease: Too much of a good thing, how chronic neutrophilic inflammation can |
| Q91036963 | Commentary on: Simultaneous Aesthetic Eyelid Surgery and Orbital Decompression for Rehabilitation of Thyroid Eye Disease: The One-Stage Approach |
| Q97692347 | Commentary: Multidisciplinary team approach to tackle thyroid eye disease |
| Q97692357 | Commentary: Risk factors predicting visual morbidity in thyroid eye disease |
| Q97692343 | Commentary: Thyroid eye disease in India: A wake-up call? |
| Q50691974 | Community screening for eye disease by laypersons: the Hoffberger program. |
| Q57479433 | Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study |
| Q44866954 | Comorbidities of dry eye disease: a nationwide population-based study |
| Q60958788 | Comparative Efficacy of Medical Treatments for Thyroid Eye Disease: A Network Meta-Analysis |
| Q93005957 | Comparative Evaluation of 5 Validated Symptom Questionnaires as Screening Instruments for Dry Eye Disease |
| Q53833506 | Comparative analysis on the dynamic of lacrimal gland damage and regeneration after Interleukin-1α or duct ligation induced dry eye disease in mice. |
| Q68661763 | Comparative evaluation of methods for laboratory diagnosis of herpetic eye disease |
| Q57806393 | Comparative performance of lid wiper epitheliopathy and corneal staining in detecting dry eye disease |
| Q39848782 | Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage |
| Q92202219 | Comparing Dry Eye Disease After Small Incision Lenticule Extraction and Laser Subepithelial Keratomileusis |
| Q91378157 | Comparison of choroidal thickness in patients with active and stable thyroid eye disease |
| Q89505798 | Comparison of corneal thickness in patients with dry eye disease using the Pentacam rotating Scheimpflug camera and anterior segment optical coherence tomography |
| Q80888186 | Comparison of ease of swallowing of dietary supplement products for age-related eye disease |
| Q36464782 | Comparison of nonmydriatic digital retinal imaging versus dilated ophthalmic examination for nondiabetic eye disease in persons with diabetes |
| Q85895361 | Comparison of retention rates and complications of 2 different types of silicon lacrimal punctal plugs in the treatment of dry eye disease |
| Q39686657 | Comparison of the effectiveness of detecting diabetic eye disease: diabetic retinal photography versus ophthalmic consultation |
| Q46421571 | Complex visual hallucinations and attentional performance in eye disease and dementia: a test of the Perception and Attention Deficit model |
| Q71234016 | Complex visual hallucinations in partial blindness due to eye disease |
| Q92339453 | Comprehensive Clinical, Diagnostic, and Advanced Imaging Characterization of the Ocular Surface in Spontaneous Aqueous Deficient Dry Eye Disease in Dogs |
| Q26752848 | Comprehensive Review of the Literature on Existing Punctal Plugs for the Management of Dry Eye Disease |
| Q37563132 | Comprehensive review of ocular angiostrongyliasis with special reference to optic neuritis. |
| Q68849884 | Compressive optic neuropathy in dysthyroid eye disease |
| Q46802840 | Concern about the Pediatric Eye Disease Investigator Group 2-year follow-up study |
| Q89117005 | Concerns over Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease |
| Q39609945 | Conducting community-based, culturally specific, eye disease screening clinics for urban African Americans with diabetes. |
| Q79949923 | Congenitally enlarged extraocular muscles: can congenital thyroid eye disease exist in a euthyroid infant? |
| Q58122088 | Conjunctival Inflammatory Gene Expression Profiling in Dry Eye Disease: Correlations With HLA-DRA and HLA-DRB1 |
| Q51043921 | Conjunctival impression cytology evaluation of patients with dry eye disease using scleral contact lenses. |
| Q101220836 | Considerations for Use of Immune Checkpoint Inhibitors in Cancer Therapy for Patients with Co-Existing Thyroid Eye Disease |
| Q70466921 | Considerations in the Management of Dysthyroid Eye Disease |
| Q93343221 | Contact Lens-Associated Dry Eye Disease: Recent Advances Worldwide and in Japan |
| Q37087681 | Contact lenses and associated anterior segment disorders: dry eye disease, blepharitis, and allergy |
| Q53242467 | Content Design and System Implementation of a Teleophthalmology System for Eye Disease Diagnosis and Treatment and Its Preliminary Practice in Guangdong, China. |
| Q100764226 | Contour Variability in Thyroid Eye Disease with Compressive Optic Neuropathy Treated with Radiation Therapy |
| Q92515429 | Contralateral Mueller's muscle-conjunctiva resection: a therapeutic option in thyroid eye disease patients with unilateral eyelid retraction |
| Q31116059 | Contrast sensitivity perimetry data from adults free of eye disease |
| Q57593835 | Core Outcome Sets for Clinical Trials in Dry Eye Disease |
| Q35833720 | Corneal Epithelial Immune Dendritic Cell Alterations in Subtypes of Dry Eye Disease: A Pilot In Vivo Confocal Microscopic Study |
| Q72360688 | Corneal Opacity Associated with Eye Disease in Hatchery-Reared Lake Trout |
| Q87891924 | Corneal biomechanical properties in thyroid eye disease |
| Q27469149 | Corneal collagen crosslinking in keratoconus and other eye disease |
| Q36269034 | Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine |
| Q78582835 | Corneal opacifications in a low high density lipoprotein syndrome: suspicion of fish eye disease: a case report |
| Q36898549 | Corneal permeability changes in dry eye disease: an observational study |
| Q79719085 | Corneal striae in thyroid eye disease |
| Q36081576 | Correction of Excyclotropia by Surgery on the Inferior Rectus Muscle in Patients with Thyroid Eye Disease: A Retrospective, Observational Study |
| Q35303535 | Correction of lower eyelid retraction in thyroid eye disease: a randomised controlled trial of retractor tenotomy with adjuvant antimetabolite versus scleral graft |
| Q45891151 | Correction: Evaluation of Clustering and Genotype Distribution for Replication in Genome Wide Association Studies: The Age-Related Eye Disease Study |
| Q96113115 | Correlation Analysis between Ocular Surface Parameters with Subjective Symptom Severity in Dry Eye Disease |
| Q80342820 | Correlation between clinical diagnosis and PCR analysis of serum, aqueous, and vitreous samples in patients with inflammatory eye disease |
| Q50449041 | Correlation between tear film osmolarity, dry eye disease, and rheumatoid arthritis. |
| Q102336502 | Correlation of Automated Computed Tomography Volumetric Analysis Metrics With Motility Disturbances in Thyroid Eye Disease |
| Q96175212 | Correlation of corneal immune cell changes with clinical severity in dry eye disease: An in vivo confocal microscopy study |
| Q46469927 | Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD). |
| Q43482891 | Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications |
| Q57176695 | Correlations between the Visual Apparatus and Dental Occlusion: A Literature Review |
| Q91067522 | Corrigendum to "Drugs - Do we need them? Applications of non-pharmaceutical therapy in anterior eye disease: A review" [Contact Lens Anterior Eye 40 (2017) 360-366] |
| Q100437418 | Corrigendum to "Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients" |
| Q104574558 | Corrigendum: The Efficacy and Safety of Qiming Granule for Dry Eye Disease: A Systematic Review and Meta-Analysis |
| Q75784513 | Cortisone in eye disease; three case reports |
| Q92066837 | Cosmetic blepharoplasty and dry eye disease: a review of the incidence, clinical manifestations, mechanisms and prevention |
| Q37339390 | Cost effectiveness analysis of screening for sight threatening diabetic eye disease |
| Q77067274 | Cost savings associated with detection and treatment of diabetic eye disease |
| Q41152486 | Cost-Effectiveness of Ikervis® In Severe Dry Eye Disease In The Uk [Update]. |
| Q91951744 | Course of upper eyelid retraction in thyroid eye disease |
| Q77906746 | Cracking the crock: how to deal with factitious eye disease |
| Q26800562 | Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search |
| Q99583099 | Crosslinked hyaluronic acid with liposomes and crocin for management symptoms of dry eye disease caused by moderate meibomian gland dysfunction |
| Q91199705 | Current Practice Patterns and Opinions on the Management of Recent-Onset or Chronic Herpes Zoster Ophthalmicus of Zoster Eye Disease Study Investigators |
| Q80883371 | Current clinical practice of consultant ophthalmologists in treating herpetic eye disease in the United Kingdom |
| Q73755330 | Current concepts concerning orbital radiotherapy in patients with thyroid eye disease |
| Q72721369 | Current options in management: closed microsurgery for severe diabetic eye disease |
| Q33558489 | Current recommendations for the treatment of diabetic eye disease |
| Q64900138 | Customary practices in the monitoring of dry eye disease in Sjogren's syndrome. |
| Q72573676 | Cyclosporin in infiltrative eye disease |
| Q92416549 | Cyclosporine 0.09% solution (Cequa) for dry eye Disease |
| Q91323220 | Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model |
| Q95941389 | Cyclosporine Anionic and Cationic Ophthalmic Emulsions in Dry Eye Disease: A Literature Review |
| Q67842465 | Cyclosporine: a therapy in inflammatory eye disease |
| Q91269650 | Cytokine expression in tears of patients with glaucoma or dry eye disease: A prospective, observational cohort study |
| Q92139096 | Cytokine production in thyroid eye disease: in vitro effects of dexamethasone and IL-6 blockade with tocilizumab |
| Q77583155 | Cytokine therapy in eye disease |
| Q47983697 | Cytokines in thyroid eye disease: potential for anticytokine therapy |
| Q37472797 | Dataset of tear film cytokine levels in dry eye disease (DED) patients with and without HIV infection |
| Q80340781 | Death from eye disease and occurrences of death in ophthalmological practice |
| Q72927570 | Decision-making in the therapy of external eye disease: noninfected corneal ulcers |
| Q48296396 | Decompression for thyroid eye disease: An evolving trend of multidisciplinary approach |
| Q98773073 | Deficiency in Acyl-CoA:Wax Alcohol Acyltransferase 2 causes evaporative dry eye disease by abolishing biosynthesis of wax esters |
| Q92465209 | Defining the needs and preferences of patients with dry eye disease |
| Q93343154 | Definition and Diagnostic Criteria of Dry Eye Disease: Historical Overview and Future Directions |
| Q35198055 | Deletion mapping of Aland Island eye disease to Xp21 between DXS67 (B24) and Duchenne muscular dystrophy |
| Q98947963 | Demodex and eye disease: a review |
| Q98727402 | Demographic and clinical profile of 1000 patients with thyroid eye disease presenting to a Tertiary Eye Care Institute in India |
| Q50536717 | Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena). |
| Q50558766 | Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena). |
| Q98463869 | Dengue-associated Eye Disease |
| Q38926020 | Depression and anxiety in dry eye disease: a systematic review and meta-analysis |
| Q93133289 | Depression and dry eye disease: a need for an interdisciplinary approach? |
| Q40910039 | Depression, Stress, Quality of Life, and Dry Eye Disease in Korean Women: A Population-Based Study |
| Q36259467 | Depressive Symptoms in Patients With Dry Eye Disease: A Case-Control Study Using the Beck Depression Inventory |
| Q91067314 | Depressive symptoms, resilience, and personality traits in dry eye disease |
| Q104680072 | Dermatologists' Knowledge and Attitudes Toward Dry Eye Disease, Refractive Surgery, and Contact Lenses When Prescribing Isotretinoin in Saudi Arabia |
| Q34103843 | Description and evaluation of the first national patient and public involvement day for thyroid eye disease in the United Kingdom |
| Q33502970 | Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial |
| Q40429922 | Design and baseline characteristics of a population-based study of eye disease in southern Chinese people: the Dongguan Eye Study |
| Q46070689 | Design and organization of the herpetic eye disease study (HEDS) |
| Q33848201 | Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials |
| Q42965542 | Detecting the Progression of Eye Disease: CUSUM Charts for Assessing the Visual Field and Retinal Nerve Fiber Layer Thickness. |
| Q47141449 | Determination of Risk Factors and Treatment of Dry Eye Disease in Type 1 Diabetes Before Corneal Complications at Sindh Institute of Ophthalmology And Visual Sciences |
| Q57063015 | Development and Validation of the Singapore Thyroid Eye Disease Quality of Life Questionnaire |
| Q39316857 | Development and progression of diabetic eye disease in Newcastle (1977-1984): rates and risk factors |
| Q77320743 | Development of an animal model of autoimmune thyroid eye disease |
| Q30413598 | Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique |
| Q26746232 | Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease |
| Q33566484 | Diabetes and thyroid-related eye disease |
| Q77072861 | Diabetes and thyroid-related eye disease |
| Q33574984 | Diabetes- and thyroid-related eye disease |
| Q92024017 | Diabetes-induced eye disease among First Nations people in Ontario: a longitudinal, population-based cohort study |
| Q95835990 | Diabetic Eye Disease: Advancements in Technology, Detection, and Access to Care |
| Q28083984 | Diabetic eye disease |
| Q71516991 | Diabetic eye disease |
| Q73570687 | Diabetic eye disease |
| Q51350672 | Diabetic eye disease among adults in Fiji with previously undiagnosed diabetes. |
| Q33614015 | Diabetic eye disease among adults in Fiji with self-reported diabetes |
| Q91605867 | Diabetic eye disease and screening attendance by ethnicity in New Zealand: A systematic review |
| Q68550182 | Diabetic eye disease detection by primary-care physicians |
| Q44877579 | Diabetic eye disease in Central Africa |
| Q33231783 | Diabetic eye disease. |
| Q32151974 | Diabetic eye disease: a natural history study |
| Q36799836 | Diabetic eye disease: a primary care perspective. |
| Q30948269 | Diabetic eye disease: how can it be prevented? |
| Q70455979 | Diagnosis and treatment of eye disease caused by organophosphorus agricultural chemicals |
| Q70376883 | Diagnosis of diabetic eye disease |
| Q70519093 | Diagnosis of diabetic eye disease |
| Q27024827 | Diagnosis of dry eye disease and emerging technologies |
| Q40769232 | Diagnosis of metabolic eye disease by chemical analysis of serum, leukocytes and skin fibroblast tissue culture |
| Q88188449 | Diagnosis, treatment, and monitoring of dry eye disease |
| Q100945976 | Diagnostic ability of maximum blink interval together with Japanese version of Ocular Surface Disease Index score for dry eye disease |
| Q91355057 | Diagnostic profile of tear osmolarity and inter-ocular variability for dry eye disease |
| Q34910419 | Diagnostic techniques for inflammatory eye disease: past, present and future: a review. |
| Q67471273 | Diagnostic tests for dry eye disease in normals and dry eye patients with and without Sjögren's syndrome |
| Q90928695 | Dietary DHA amplifies LXA4 circuits in tissues and lymph node PMN and is protective in immune-driven dry eye disease |
| Q55044809 | Dietary carbohydrate and the progression of age-related macular degeneration: a prospective study from the Age-Related Eye Disease Study. |
| Q83310631 | Dietary carbohydrate intake and glycemic index in relation to cortical and nuclear lens opacities in the Age-Related Eye Disease Study |
| Q34323879 | Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group |
| Q56534843 | Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group |
| Q34978847 | Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study |
| Q64247384 | Dietary intervention in patients with age-related macular degeneration: protocol for a randomised controlled trial |
| Q98782091 | Dietary nutrient intake and progression to late age-related macular degeneration in the Age-Related Eye Disease Studies 1 and 2 |
| Q41154020 | Dietary sources of lutein in adults suffering eye disease (AMD/cataracts). |
| Q98511207 | Different adverse effects of air pollutants on dry eye disease: Ozone, PM2.5, and PM10 |
| Q68527871 | Different substrate specificities of plasma lecithin: cholesterol acyl transferase in fish eye disease and Tangier disease |
| Q74030858 | Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease |
| Q39724665 | Differential modulation of allergic eye disease by chronic and acute ascaris infection |
| Q33565409 | Differentiating Urgent and Emergent Causes of Acute Red Eye for the Emergency Physician |
| Q36016279 | Differentiating drusen: Drusen and drusen-like appearances associated with ageing, age-related macular degeneration, inherited eye disease and other pathological processes. |
| Q68745213 | Diplopia in thyroid eye disease |
| Q37536295 | Discordant Dry Eye Disease (An American Ophthalmological Society Thesis). |
| Q100543156 | Disease-Specific Expression of Conjunctiva Associated Lymphoid Tissue (CALT) in Mouse Models of Dry Eye Disease and Ocular Allergy |
| Q83849458 | Diseases and treatment of the eye: diabetic eye disease |
| Q83849462 | Diseases and treatment of the eye: diabetic eye disease prevalence data |
| Q100682389 | Disruption of blood-aqueous barrier in dry eye disease |
| Q30858868 | Does direct ophthalmoscopy improve retinal screening for diabetic eye disease by retinal photography? |
| Q24630563 | Does eating particular diets alter the risk of age-related macular degeneration in users of the Age-Related Eye Disease Study supplements? |
| Q91328549 | Dose-dependent benzalkonium chloride toxicity imparts ocular surface epithelial changes with features of dry eye disease |
| Q41997258 | Drugs - Do we need them? Applications of non-pharmaceutical therapy in anterior eye disease: A review |
| Q61759579 | Dry Eye Disease |
| Q35944414 | Dry Eye Disease After Refractive Surgery |
| Q36407619 | Dry Eye Disease Incidence Associated with Chronic Graft-Host Disease: Nonconcurrent Cohort Study (An American Ophthalmological Society Thesis) |
| Q40064942 | Dry Eye Disease Is Already Present in Hematological Patients Before Hematopoietic Stem Cell Transplantation |
| Q91791499 | Dry Eye Disease Is More Prevalent in Children with Diabetes than in Those without Diabetes |
| Q36009304 | Dry Eye Disease Patients with Xerostomia Report Higher Symptom Load and Have Poorer Meibum Expressibility. |
| Q90302860 | Dry Eye Disease Practice in Ghana: Diagnostic Perspectives, Treatment Modalities, and Challenges |
| Q97416742 | Dry Eye Disease after Cataract Surgery: Study of its Determinants and Risk Factors |
| Q92310310 | Dry Eye Disease and Refractive Corrections |
| Q94471303 | Dry Eye Disease and Tear Cytokine Levels-A Meta-Analysis |
| Q89466688 | Dry Eye Disease and the Oculofacial Pain Syndrome |
| Q57258837 | Dry Eye Disease in Chronic Graft-Versus-Host Disease: Results From a Spanish Retrospective Cohort Study |
| Q35975632 | Dry Eye Disease in Patients with Functioning Filtering Blebs after Trabeculectomy |
| Q48030152 | Dry Eye Disease in Patients with Newly Diagnosed Depressive Disorder |
| Q90415394 | Dry Eye Disease in Routine Rheumatology Practice |
| Q101038199 | Dry Eye Disease in University-based Clinics in Canada: A Retrospective Chart Review |
| Q92824372 | Dry Eye Disease: A Review of Epidemiology in Taiwan, and its Clinical Treatment and Merits |
| Q40249769 | Dry Eye Disease: Concordance Between the Diagnostic Tests in African Eyes |
| Q100937917 | Dry Eye Disease: Early Recognition with Guidance on Management and Treatment for Primary Care Family Physicians |
| Q90079719 | Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy |
| Q34346990 | Dry Eye Disease: Impact on Quality of Life and Vision |
| Q46681607 | Dry Eye Disease: Let's Start Thinking Outside of the Artificial Tear Box. |
| Q38853787 | Dry Eye Disease: Present Challenges in the Management and Future Trends |
| Q87938191 | Dry Eye Disease: Prevalence, Assessment, and Management |
| Q95477103 | Dry Eye Disease: Prevalence, Assessment, and Management |
| Q61628159 | Dry Eye Disease: Time to Introduce Ocular Surface Stress Tests? |
| Q34264457 | Dry eye disease after LASIK. |
| Q35473036 | Dry eye disease after refractive surgery: comparative outcomes of small incision lenticule extraction versus LASIK. |
| Q58698839 | Dry eye disease also might influence psychological status and quality of life in patients with primary Sjögren’s syndrome |
| Q38997991 | Dry eye disease and allergic conditions: A Korean nationwide population-based study |
| Q35796783 | Dry eye disease and depression-anxiety-stress: A hospital-based case control study in Turkey |
| Q80479434 | Dry eye disease and its implications on visual function |
| Q36799601 | Dry eye disease and microbial keratitis: is there a connection? |
| Q46317252 | Dry eye disease and oxidative stress. |
| Q45191438 | Dry eye disease and work productivity loss in visual display users: the Osaka study |
| Q37756166 | Dry eye disease as an inflammatory disorder |
| Q38119440 | Dry eye disease caused by viral infection: review. |
| Q64099037 | Dry eye disease immune responses and topical therapy |
| Q43929308 | Dry eye disease in French elderly subjects: the Alienor Study |
| Q96685607 | Dry eye disease in India |
| Q39616989 | Dry eye disease in an adult population in South-West Nigeria |
| Q98578887 | Dry eye disease in children and adolescents in India |
| Q81691160 | Dry eye disease in patients after cataract surgery |
| Q43735526 | Dry eye disease in patients treated with antidepressants |
| Q48474529 | Dry eye disease in patients with depressive and anxiety disorders in Shanghai. |
| Q37637612 | Dry eye disease in patients with metabolic syndrome |
| Q50180142 | Dry eye disease in strabismus patients: Does eye deviation harm ocular surface? |
| Q47249194 | Dry eye disease in the elderly in a French population-based study (the Montrachet study: Maculopathy, Optic Nerve, nuTRition, neurovAsCular and HEarT diseases): Prevalence and associated factors |
| Q35655252 | Dry eye disease in type 2 diabetes mellitus; comparison of the tear osmolarity test with other common diagnostic tests: a diagnostic accuracy study using STARD standard |
| Q48070039 | Dry eye disease is associated with deterioration of mental health in male Japanese university staff |
| Q61802909 | Dry eye disease ranking among common reasons for seeking eye care in a large US claims database |
| Q90403115 | Dry eye disease revisited: What have we missed? |
| Q104103233 | Dry eye disease symptoms and quality of life in perimenopausal and postmenopausal women |
| Q38120327 | Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies. |
| Q99611385 | Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification |
| Q92719948 | Dry eye disease – diagnosis and treatment |
| Q43448087 | Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study |
| Q91942200 | Dry eye disease: A longitudinal study among pregnant women in Enugu, south east, Nigeria |
| Q34273384 | Dry eye disease: A review of diagnostic approaches and treatments |
| Q36916372 | Dry eye disease: an immune-mediated ocular surface disorder |
| Q37152826 | Dry eye disease: pathophysiology, classification, and diagnosis. |
| Q46565707 | Dry eye disease: prevalence, distribution and determinants in a hospital-based population |
| Q34391914 | Dry eye disease: the scale of the problem |
| Q58588885 | Dry eye disease: when to treat and when to refer |
| Q86655834 | Dynamic change of optical quality in patients with dry eye disease |
| Q46812932 | Dysthyroid eye disease masquerading as glaucoma |
| Q72836309 | Dysthyroid eye disease presenting as Brown's syndrome |
| Q67908704 | Dysthyroid eye disease with radiological features of orbital tumour |
| Q42708225 | Dysthyroid eye disease: medical investigations |
| Q46652479 | EXTERNAL EYE DISEASE: A COLOUR ATLAS. |
| Q33192381 | EYE DISEASE FROM NATURAL AND MAN-MADE RADIATION |
| Q52475252 | EYE DISEASE OF LAJOS KOSSUTH |
| Q39898886 | EYE DISEASE RESULTING FROM MALNUTRITION. |
| Q72997967 | Ear, nose, and throat pathology in relation to eye disease |
| Q95936182 | Early experience with teprotumumab for chronic thyroid eye disease |
| Q92319438 | Early low-dose rituximab for active thyroid eye disease: An effective and well-tolerated treatment |
| Q92834076 | Early macular and peripapillary vasculature dropout in active thyroid eye disease |
| Q88086011 | Early results on the use of chitosan-N-acetylcysteine (Lacrimera®) in the management of dry eye disease of varied etiology |
| Q72124221 | Early symptoms of eye disease |
| Q92895520 | Early treatment of diabetic eye disease in New Zealand |
| Q90920203 | Early use of steroid-sparing agents in the inactivation of moderate-to-severe active thyroid eye disease: a step-down approach |
| Q26751127 | Eclectic Ocular Comorbidities and Systemic Diseases with Eye Involvement: A Review |
| Q38839563 | Economic Burden of Eye Disease in Diabetic Patients: Literature Review |
| Q91827218 | Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States |
| Q78779729 | Economic analysis in eye disease |
| Q26770830 | Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review |
| Q89740382 | Economic impact of dry eye disease in Spain: A multicentre retrospective insurance claims database analysis |
| Q99237751 | Effect of Dry Eye Disease on the Kinetics of Lacrimal Gland Dendritic Cells as Visualized by Intravital Multi-Photon Microscopy |
| Q58805766 | Effect of Hyaluronic Acid/Trehalose in Two Different Formulations on Signs and Symptoms in Patients with Moderate to Severe Dry Eye Disease |
| Q89350118 | Effect of Repeated Freeze-Thaw on Serum Biomarkers Associated with Eye Disease |
| Q98461430 | Effect of acupuncture versus artificial tears for dry eye disease: A protocol for systematic review and meta-analysis |
| Q30457640 | Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial |
| Q97593573 | Effect of natural extract eye drops in dry eye disease rats |
| Q82366081 | Effect of systane and optive on aqueous tear evaporation in patients with dry eye disease |
| Q33686685 | Effect of thermal pulsation treatment on tear film parameters in dry eye disease patients |
| Q42732950 | Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunction |
| Q37280480 | Effectiveness of sodium hyaluronate eye gel in patients with dry eye disease: a multi-centre, open label, uncontrolled study. |
| Q47715552 | Effects of Lycium barbarum (goji berry) on dry eye disease in rats |
| Q100416784 | Effects of Oral Vitamin B1 and Mecobalamin on Dry Eye Disease |
| Q91550759 | Effects of Polyunsaturated Fatty Acids on Nonspecific Typical Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials |
| Q93064116 | Effects of Preservative-free 3% Diquafosol in Patients with Pre-existing Dry Eye Disease after Cataract Surgery: A Randomized Clinical Trial |
| Q91232535 | Effects of an Aging Population and Racial Demographics on Eye Disease Prevalence: Projections for Georgia Through 2050 |
| Q90529029 | Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines |
| Q91794674 | Effects of intranasal administration of violet oil in dry eye disease |
| Q89466684 | Effects of the External Environment on Dry Eye Disease |
| Q104478243 | Efficacy and Safety of Houttuynia Eye Drops Atomization Treatment for Meibomian Gland Dysfunction-Related Dry Eye Disease: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial |
| Q89164875 | Efficacy and Safety of Immunosuppressive Agents for Thyroid Eye Disease |
| Q99565095 | Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial |
| Q91093050 | Efficacy and Safety of Topical 3% Diquafosol Ophthalmic Solution for the Treatment of Multifactorial Dry Eye Disease: Meta-Analysis of Randomized Clinical Trials |
| Q91710605 | Efficacy and Safety of Topical Chloroquine in Mild to Moderate Dry Eye Disease |
| Q96818222 | Efficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial |
| Q92367899 | Efficacy and safety of 0.05% cyclosporine ophthalmic emulsion in treatment of Chinese patients with moderate to severe dry eye disease: A 12-week, multicenter, randomized, double-masked, placebo-controlled phase III clinical study |
| Q88073084 | Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies |
| Q53620228 | Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial. |
| Q47632045 | Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: a randomized controlled study |
| Q88933158 | Efficacy and safety of acupuncture at a single BL1 acupoint in the treatment of moderate to severe dry eye disease: Protocol for a randomized, controlled trial |
| Q40765221 | Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group |
| Q60302033 | Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study |
| Q90424378 | Efficacy and safety of pulsed intravenous methylprednisolone in early active thyroid eye disease |
| Q35507058 | Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial |
| Q91495791 | Efficacy and safety of using topical cyclosporine A for treatment of moderate to severe dry eye disease |
| Q101368803 | Efficacy of 0.1% crosslinked hyaluronic acid, coenzyme Q10 and vitamin E in the management of dry eye disease in menopause patients receiving antidepressants |
| Q83829771 | Efficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye disease |
| Q36280601 | Efficacy of Carboxymethylcellulose and Hyaluronate in Dry Eye Disease: A Systematic Review and Meta-Analysis |
| Q91288807 | Efficacy of Omega-3 Fatty Acid Supplementation for Treatment of Dry Eye Disease: A Meta-Analysis of Randomized Clinical Trials |
| Q36137428 | Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial |
| Q88050501 | Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease |
| Q82285281 | Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease |
| Q37903534 | Efficacy of the intraoperative relaxed muscle positioning technique in thyroid eye disease and analysis of cases requiring reoperation |
| Q96165065 | Efficacy of topical bevacizumab 0.05% eye drops in dry eye disease: A double-masked, randomized trial |
| Q36044544 | Efficacy of topical blockade of interleukin-1 in experimental dry eye disease |
| Q92192934 | Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: A systematic literature review |
| Q45401248 | Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study |
| Q72008553 | Elastic modulus of orbicularis oculi muscle in normal humans, humans with Graves' eye disease, and cynomolgus monkeys |
| Q71290036 | Electron microscopic structure of serum lipoproteins from patients with fish eye disease |
| Q44182453 | Electrophysiological and morphological alterations in peripheral nerves by the pig paramyxovirus of blue eye disease in neonatal pigs |
| Q70674643 | Electrophysiological testing in diabetic eye disease |
| Q69468182 | Electroretinography and electro-oculography to localize abnormalities in early-stage inflammatory eye disease |
| Q104517279 | Elephantiasis in a patient with thyroid eye disease |
| Q95925328 | Elevated Immunoglobulin G4 Levels in Patients with Thyroid Eye Disease and Their Clinical Implications |
| Q91892487 | Emerging targets of inflammation and tear secretion in dry eye disease |
| Q89069656 | Emerging trends in childhood blindness and ocular morbidity in India: the Pavagada Pediatric Eye Disease Study 2 |
| Q74229492 | Emotional factors in eye disease |
| Q27030818 | Encephalocraniocutaneous lipomatosis: a case report and review of the literature |
| Q92511865 | Endoscopic Orbital Decompression by Oculoplastic Surgeons for Proptosis in Thyroid Eye Disease |
| Q74025485 | Endoscopic orbital decompression for dysthyroid eye disease |
| Q92104746 | Endoscopic orbital decompression for proptosis in non-thyroid eye disease |
| Q45730081 | Enhanced clearance of herpes simplex virus type 1 and reduced herpetic eye disease in STAT6 knockout mice is associated with increased IL-2. |
| Q98954302 | Enhanced closed eye neutrophil degranulation in dry eye disease |
| Q96588237 | Enrollment in the Zoster Eye Disease Study |
| Q91486828 | Epidemiologic Research in Dry Eye Disease and the Utility of Mobile Health Technology |
| Q40072100 | Epidemiology of a Rare Event: The Singapore Epidemiology of Eye Disease Study |
| Q77714861 | Epidemiology of blindness and eye disease |
| Q30239114 | Epidemiology of dry eye disease in Africa: The sparse information, gaps and opportunities |
| Q69397736 | Epidemiology of eye disease in the elderly |
| Q40035026 | Epidemiology of symptoms of dry eye disease (DED) in Jordan: A cross-sectional non-clinical population-based study |
| Q58612884 | Epidermal Fatty Acid-Binding Protein: A Novel Marker in the Diagnosis of Dry Eye Disease in Sjögren Syndrome |
| Q84615528 | Epitopes, immunoglobulin classes and immunoglobulin G subclasses of calsequestrin antibodies in patients with thyroid eye disease |
| Q60302035 | Erratum: A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum] |
| Q61810142 | Erratum: A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum] |
| Q68486438 | Erythrocyte abnormalities in a hypoalphalipoproteinemia syndrome resembling fish eye disease |
| Q33782709 | Establishing and monitoring a control programme to reduce the impact of eye disease in sub-Saharan Africa |
| Q90856039 | Establishing the usefulness of the GO-QOL in a UK hospital-treated population with thyroid eye disease in the CIRTED trial |
| Q91354085 | Estimated Prevalence and Incidence of Dry Eye Disease Based on Coding Analysis of a Large, All-age United States Health Care System |
| Q36502928 | Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature |
| Q26827086 | Etiopathogenesis and therapy of epithelial ingrowth after Descemet's stripping automated endothelial keratoplasty |
| Q34353014 | European survey on the opinion and use of micronutrition in age-related macular degeneration: 10 years on from the Age-Related Eye Disease Study |
| Q92507140 | Evaluating Patient Experiences in Dry Eye Disease Through Social Media Listening Research |
| Q39345782 | Evaluating ocular blood flow |
| Q39576517 | Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10. |
| Q91035648 | Evaluating the diagnostic utility of evaporative dry eye disease markers |
| Q36167545 | Evaluation and Referral of Diabetic Eye Disease in the Endocrinology and Primary Care Office Settings |
| Q87796295 | Evaluation of Corneal Biomechanical Properties in Patients With Thyroid Eye Disease Using An Ocular Response Analyzer |
| Q53841146 | Evaluation of Corneal Biomechanical Properties in Patients With Thyroid Eye Disease Using Ocular Response Analyzer. |
| Q92750634 | Evaluation of Dry Eye Disease in Children With Systemic Lupus Erythematosus and Healthy Controls |
| Q42716529 | Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11. |
| Q61800264 | Evaluation of Objective Signs and Subjective Symptoms of Dry Eye Disease in Patients with Inflammatory Bowel Disease |
| Q106098607 | Evaluation of R:GEN as Intervention in Subjects With Early Stages of AMD for Safety and Exploratory Efficacy Outcomes |
| Q90627764 | Evaluation of Tear Protein Markers in Dry Eye Disease with Different LT-alpha Expression Levels |
| Q78580446 | Evaluation of a screening procedure in the detection of eye disease |
| Q90678680 | Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study |
| Q37444735 | Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose |
| Q33388223 | Evaluation of clustering and genotype distribution for replication in genome wide association studies: the age-related eye disease study |
| Q73445934 | Evaluation of conjunctival morphology in thyroid associated eye disease by use of impression cytology |
| Q92653082 | Evaluation of dry eye disease in newly diagnosed anxiety and depression patients using anterior segment optical coherence tomography |
| Q92456395 | Evaluation of incomplete blinking as a measurement of dry eye disease |
| Q96953435 | Evaluation of objective visual quality in dry eye disease and corneal nerve changes |
| Q37166967 | Evaluation of optimized digital fundus reflex photographs for lens opacities in the age-related eye disease study 2: AREDS2 report 7 |
| Q37359850 | Evaluation of patients with dry eye disease for conjunctival Chlamydia trachomatis and Ureaplasma urealyticum |
| Q52239444 | Evaluation of screening schemes for eye disease in a primary care setting. |
| Q91653112 | Evaluation of strip meniscometry, tear meniscus height and depth in the diagnosis of dry eye disease in asian Indian eyes |
| Q85222339 | Evaluation of tear malate dehydrogenase 2 in mild dry eye disease |
| Q92901359 | Evaluation of the Ocular Surface Disease Index Questionnaire as a Discriminative Test for Clinical Findings in Dry Eye Disease Patients |
| Q92118248 | Evaluation of the Safety and Efficacy of Intense Pulsed Light Treatment with Meibomian Gland Expression of the Upper Eyelids for Dry Eye Disease |
| Q34148253 | Evaluation of the age-related eye disease study clinical lens grading system AREDS report No. 31. |
| Q48078283 | Evaluation of thyroid eye disease: quality-of-life questionnaire (TED-QOL) in Korean patients. |
| Q46831270 | Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease |
| Q85340568 | Evaporative dry eye disease: promising new approaches for diagnosis and treatment |
| Q34626661 | Evidence for integrating eye health into primary health care in Africa: a health systems strengthening approach |
| Q41505971 | Evidence for the presence in human plasma of lecithin: cholesterol acyltransferase activity (beta-LCAT) specifically esterifying free cholesterol of combined pre-beta- and beta-lipoproteins. Studies of fish eye disease patients and control subjects |
| Q34952967 | Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? |
| Q73778058 | Evolution of some ophthalmological problems in the last twenty years |
| Q58616248 | Evolution of thyroid eye disease decompression-dysthyroid optic neuropathy |
| Q71938477 | Exact origin of the word glaucoma and type of eye disease where it falls |
| Q39721743 | Exclusion of dysthyroid eye disease as a cause of unilateral proptosis |
| Q70635779 | Exfoliative syndrome in Tunisia (apropos of 119 cases) |
| Q33765236 | Exome sequencing in developmental eye disease leads to identification of causal variants in GJA8, CRYGC, PAX6 and CYP1B1. |
| Q69610142 | Exophthalmometer readings in patients with Graves' eye disease |
| Q49391282 | Exotropia and hypotropia as the initial presentation sign of thyroid eye disease in an 18-year-old man. |
| Q44677280 | Experience in improvement of eye disease prevention in children |
| Q46875985 | Experience of ambulatory anesthesia in Charles Nicolle hospital |
| Q41591101 | Experience with the efficient management of the paperwork in an eye disease clinic |
| Q57242051 | Experimental Design Issue for Assessment of Carotenoids Lutein and Zeaxanthin in Age-Related Eye Disease Study 2 Formulation for Age-Related Macular Degeneration |
| Q87378224 | Experimental design issue for assessment of carotenoids lutein and zeaxanthin in age-related eye disease study 2 formulation for age-related macular degeneration--reply |
| Q35805082 | Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED). |
| Q90035249 | Explanatory Model of Dry Eye Disease Using Health and Nutrition Examinations: Machine Learning and Network-Based Factor Analysis From a National Survey |
| Q57593838 | Exploring the Asian ethnic predisposition to dry eye disease in a pediatric population |
| Q73396202 | Exposure to diagnostic x-rays and incident age-related eye disease |
| Q91091271 | Expression of Nod-like Receptors and Clinical Correlations in Patients With Dry Eye Disease |
| Q34758079 | Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye disease |
| Q93724406 | External Eye Disease: A Colour Atlas |
| Q57476503 | Extract and Aucubin Prevent Desiccating Stress-Induced Corneal Epithelial Cell Injury and Improve Tear Secretion in a Mouse Model of Dry Eye Disease |
| Q55206226 | Extraintestinal Manifestations of Inflammatory Bowel Disease. |
| Q72459769 | Extraocular muscle problems in thyroid eye disease |
| Q37187115 | Eye Care Disparities and Health-Related Consequences in Elderly Patients with Age-Related Eye Disease |
| Q93838792 | Eye Disease and Refraction |
| Q93964984 | Eye Disease in Children |
| Q93966039 | Eye Disease in Children |
| Q35566244 | Eye Disease in Latinos |
| Q53153535 | Eye Disease in Patients with Diabetes Screened with Telemedicine. |
| Q47356824 | Eye Disease in the Tropics |
| Q28066059 | Eye Globe Abnormalities on MR and CT in Adults: An Anatomical Approach |
| Q73808359 | Eye complications caused by vitamin A deficiency in Tunisia |
| Q70463997 | Eye disease among American Indians of the Southwest. I. Overall analysis |
| Q68672692 | Eye disease among American Indians of the Southwest. II. Trachoma |
| Q40634386 | Eye disease among ambulatory Jewish senior citizens in California |
| Q38510312 | Eye disease among the impressionists: Monet, Cassatt, Degas, and Pissarro |
| Q46642934 | Eye disease and blindness in relation to vitamin A deficiency in Northern Nigeria. |
| Q33300273 | Eye disease and care at hospital clinics in Cook Islands, Fiji, Samoa and Tonga |
| Q34674438 | Eye disease and care in Latin America and the Caribbean |
| Q39664463 | Eye disease and color defects |
| Q71080132 | Eye disease and the ageing population |
| Q37232353 | Eye disease and the older diabetic |
| Q24685785 | Eye disease associated with handling pet tarantulas: three case reports |
| Q41878874 | Eye disease at a community health centre |
| Q42238547 | Eye disease caused by ethambutol |
| Q71568825 | Eye disease caused by the juice of a "kitrana" plant |
| Q46974477 | Eye disease control in Morocco |
| Q79239086 | Eye disease following BCG vaccination. Studies of the significance of tuberculosis in the etiology of certain eye diseases, with particular reference to ocular complications after BCG vaccination |
| Q72913510 | Eye disease in IBR |
| Q46124603 | Eye disease in Latinos: insights from the Los Angeles Latino Eye Study |
| Q46573364 | Eye disease in Wesley Guild Hospital, Ilesa, Nigeria. |
| Q39010348 | Eye disease in a geriatric nursing home population |
| Q33809049 | Eye disease in a patient with rheumatoid arthritis. |
| Q36795025 | Eye disease in an onchocerciasis-endemic area of the forest-savanna mosaic region of Nigeria |
| Q70769718 | Eye disease in cases of chronic atrophic polychondritis (author's transl) |
| Q71851355 | Eye disease in infants and pre-schoolers. 1 |
| Q45304181 | Eye disease in mite infestation of facial skin |
| Q41257318 | Eye disease in sickling disorders |
| Q46671900 | Eye disease in the Bushmen. |
| Q39211328 | Eye disease in the Eskimo and in the Australian Aboriginal: a brief comparison |
| Q70470168 | Eye disease in the Navajo indians |
| Q33462223 | Eye disease in the West Bank and Gaza strip |
| Q45333539 | Eye disease in veterans with diabetes |
| Q52490809 | Eye disease induced by organic phosphorous insecticides |
| Q44293041 | Eye disease induced by organic phosphorous insecticides--adult case |
| Q44153586 | Eye disease induced by traditional eye practices. |
| Q42461505 | Eye disease of the elderly. |
| Q84214253 | Eye disease related to onchocerciasis: a clinical study in the Aratha-ú, Yanomami Tribe, Roraima State, Brazil |
| Q82159475 | Eye disease resulting from increased use of fluorescent lighting as a climate change mitigation strategy |
| Q44537110 | Eye disease: a threat to happy old age |
| Q46588329 | Eye involvement in AIDS: the first 12 Tunisian cases |
| Q46811540 | Eye involvements in protein malnutrition in infants |
| Q69388778 | Eyelid retraction in Graves' eye disease |
| Q91218892 | FDG-PET Scanning Shows Distributed Changes in Cortical Activity Associated with Visual Hallucinations in Eye Disease |
| Q40723058 | FTY720 ameliorates Dry Eye Disease in NOD mice: Involvement of leukocytes inhibition and goblet cells regeneration in ocular surface tissue |
| Q64109544 | Factors Associated with Knowledge, Attitude and Practices of Common Eye Diseases in General Population: A Multicenter Cross-Sectional Study from Pakistan |
| Q81645061 | Factors associated with decompression and strabismus surgery in thyroid eye disease |
| Q60301127 | Factors influencing subjective symptoms in dry eye disease |
| Q90597579 | Factors influencing the long-term results of autologous microvascular submandibular gland transplantation for severe dry eye disease |
| Q73576647 | Fading of the light. The eye disease AMD is currently incurable, but you can take steps to manage it |
| Q96774181 | False Myths versus Medical Facts: Ten Common Misconceptions Related to Dry Eye Disease |
| Q67027479 | False diagnosis of orbital apex tumor by CAT scan in thyroid eye disease |
| Q68128521 | Familial high-density-lipoprotein deficiency causing corneal opacities (fish eye disease) in a family of Dutch descent |
| Q93647267 | FasL antibodies may compromise ocular immunity rather than cause eye disease |
| Q74044567 | Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease |
| Q39632082 | Fear of blindness and perceptions about blind people. The Andhra Pradesh Eye Disease Study. |
| Q46987567 | Fear of visual loss in patients with diabetes: results of the prevalence of diabetic eye disease in Tayside, Scotland (P-DETS) study |
| Q39703127 | Feasibility of tele-ophthalmology for screening for eye disease in remote communities. |
| Q42641166 | Female reproductive factors and eye disease in a rural South Indian population: the Aravind Comprehensive Eye Survey |
| Q91124775 | Festschrift on Diabetic Eye Disease in Honor of Prof. José Cunha-Vaz |
| Q92025157 | Fibrosis in dysthyroid eye disease |
| Q34331124 | Finding and interpreting genetic variations that are important to ophthalmologists |
| Q84342017 | First signs of glaucoma injury occur in the brain. What has generally been considered an eye disease is actually related to conditions such as Alzheimer's and Parkinson's diseases |
| Q71460884 | Fish eye disease |
| Q71595838 | Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia |
| Q28828283 | Fit for the Eye: Aptamers in Ocular Disorders |
| Q35302993 | Flashing lights in thyroid eye disease: a new symptom described and (possibly) explained |
| Q33244911 | Fluorophotometry as a diagnostic tool for the evaluation of dry eye disease |
| Q39648290 | For the patient. Eye screening can prevent eye disease. Personalized follow-up increases return rate at urban eye disease screening clinics for African Americans with diabetes: results of a randomized trial |
| Q89474553 | Fourth International Thyroid Eye Disease Symposium: Introduction |
| Q78767807 | Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease |
| Q34162982 | Frequency doubling perimetry and the detection of eye disease in the community |
| Q46892476 | Frequency of ophthalmic assessments among elderly whites and African Americans with eye disease and impact on visual function |
| Q64245946 | From Development to Application: Bridging the Translational Gap of Artificial Intelligence-based Diagnostics for Childhood Cataract |
| Q68045720 | From the Centers for Disease Control. Sensitivity of death certificate data for monitoring diabetes mortality--Diabetic Eye Disease Follow-Up Study, 1985-1990 |
| Q92216097 | Functional ibuprofen-loaded cationic nanoemulsion: Development and optimization for dry eye disease treatment |
| Q84059102 | Fungal eye disease at a tertiary care center: the utility of routine inpatient consultation |
| Q57983635 | Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease |
| Q64114483 | GRIK5 Genetically Regulated Expression Associated with Eye and Vascular Phenomes: Discovery through Iteration among Biobanks, Electronic Health Records, and Zebrafish |
| Q104755975 | Ganglioside GT1b increases hyaluronic acid synthase 2 via PI3K activation with TLR2 dependence in orbital fibroblasts from thyroid eye disease patients |
| Q98180886 | Gender Specific Differences in Signs and Symptoms of Dry Eye Disease |
| Q35230711 | Gender and blindness: eye disease and the use of eye care services. |
| Q50331845 | Gender differences in adolescent dry eye disease: a health problem in girls. |
| Q101408884 | Gender differences in clinical presentation and prognosis of thyroid eye disease |
| Q97567741 | Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update |
| Q81335480 | Gene symbol: LCAT. Disease: Fish eye disease |
| Q30397703 | Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review) |
| Q55523294 | Genetic Eye Disease: Retinitis Pigmentosa and Other Inherited Eye Diseases. |
| Q47793048 | Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration: Independent Statistical Evaluations of Data from the Age-Related Eye Disease Study |
| Q55345197 | Genetic Syndromes Associated with Congenital Cardiac Defects and Ophthalmologic Changes - Systematization for Diagnosis in the Clinical Practice. |
| Q36766616 | Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease Study |
| Q35036606 | Genetic differences in drug metabolism associated with ocular toxicity |
| Q37537304 | Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS). |
| Q68002938 | Genetic eye disease diagnosed in Staffordshire bull terriers |
| Q33596132 | Genetic mapping of a cone and rod dysfunction (Aland Island eye disease) to the proximal short arm of the human X chromosome. |
| Q46957887 | Genetic testing for inherited eye disease: who benefits? |
| Q99209911 | Genistein-Calcitriol Mitigates Hyperosmotic Stress-Induced TonEBP, CFTR Dysfunction, VDR Degradation and Inflammation in Dry Eye Disease |
| Q34434235 | Genome-wide association analyses of genetic, phenotypic, and environmental risks in the age-related eye disease study. |
| Q104504179 | Geographic access disparities to clinical trials in diabetic eye disease in the United States |
| Q30537710 | Georg Friedrich Händel's eye disease |
| Q90905466 | Glaucoma-associated long-term mortality in a rural cohort from India: the Andhra Pradesh Eye Disease Study |
| Q64059409 | Global computational mutagenesis of domain structures associated with inherited eye disease |
| Q74638503 | Glycosaminoglycans in thyroid eye disease |
| Q33481147 | Goethe's eye disease |
| Q76307056 | Good control drastically cuts eye disease rates |
| Q61799655 | Gout as a Risk Factor for Dry Eye Disease: A Population-Based Cohort Study |
| Q79610311 | Graded full-thickness anterior blepharotomy for correction of upper eyelid retraction not associated with thyroid eye disease |
| Q94506060 | Graded transantral orbital decompression outcomes in stable thyroid eye disease: a series of 47 orbits |
| Q89310896 | Grading Severity and Activity in Thyroid Eye Disease |
| Q26801585 | Granulomatose avec polyangéite du sujet âgé: à propos de deux cas et revue de la littérature |
| Q36890134 | Grave's Eye disease developing following radioiodine treatment for toxic nodular goitre. |
| Q34164739 | Graves' eye disease: orbital compliance and other physical measurements. |
| Q88932978 | Greater Proptosis Is Not Associated With Improved Compressive Optic Neuropathy in Thyroid Eye Disease |
| Q47786545 | Greek mythology: the eye, ophthalmology, eye disease, and blindness |
| Q71507836 | Group eye disease due to coal tar pitch |
| Q71022146 | Guanethidine drops in thyroid eye disease |
| Q70329248 | Guidelines for diabetic eye disease control--Kentucky |
| Q93029402 | HIF1α-mediated TRAIL Expression Regulates Lacrimal Gland Inflammation in Dry Eye Disease |
| Q44173082 | HIV-related eye disease in patients presenting to a tertiary care government hospital in Turkey |
| Q36324893 | HLA and eye disease: a synopsis. |
| Q70811624 | Hashimoto's thyroiditis associated with dysthyroid eye disease, pretibial myxoedema and thyroid acropachy |
| Q79965960 | Hazardous drinking among adults with diabetes and related eye disease or visual problems: a population-based cross-sectional survey |
| Q73968561 | Healing of eye disease by cure of oral foci |
| Q34454857 | Helicobacter pylori infection and eye diseases: a systematic review. |
| Q73087787 | Hereditary hemorrhagic telangiectasis as an eye disease |
| Q57456134 | Herpes Zoster Eye Disease: New Ways to Combat an Old Foe? |
| Q38114778 | Herpes simplex and herpes zoster eye disease: presentation and management at a city hospital for the underserved in the United States |
| Q46043424 | Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis |
| Q46662608 | Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis |
| Q90572978 | Herpetic Eye Disease Study: A Controlled Trial of Topical Corticosteroids for Herpes Simplex Stromal Keratitis |
| Q40242973 | Herpetic Eye Disease in Rabbits After Inoculation of Autonomic Ganglia |
| Q70152117 | Herpetic eye disease |
| Q43963398 | Herpetic eye disease caused by herpes simplex virus |
| Q46768504 | Herpetic eye disease in diabetic patients |
| Q70835650 | Herpetic eye disease study. You can help |
| Q59360219 | Herpetic eye disease study: lessons learned |
| Q35734258 | Herpetic eye disease: immunopathogenesis and therapeutic measures |
| Q37143860 | Herpetic simplex eye disease in the pediatric population |
| Q71743980 | High prevalence of eye disease in a Haitian locale |
| Q97549473 | High-Dose Oral Methylprednisolone for the Management of Severe Active Thyroid Eye Disease During the Coronavirus Disease 2019 Pandemic |
| Q41009873 | History of the diagnosis of the ancient Egyptian eye disease "trachoma" |
| Q34627770 | Horizontal eye position in thyroid eye disease: a retrospective comparison with normal individuals and changes after orbital decompression surgery |
| Q91232335 | Hormone replacement therapy for dry eye disease patients: systematic review and meta-analysis |
| Q46229960 | Hospital-based eye disease in rural Matabeleland |
| Q33646650 | How do general practitioners manage eye disease in the community? |
| Q40094448 | How much eye care services do Asian populations need? Projection from the Singapore Epidemiology of Eye Disease (SEED) study |
| Q28070119 | Human Microbiota and Ophthalmic Disease |
| Q46466320 | Hyaluronic acid gel injection for upper eyelid retraction in thyroid eye disease: functional and dynamic high-resolution ultrasound evaluation |
| Q78660268 | Hydrocortisone and ACTH in eye disease |
| Q39042956 | Hypertensive eye disease: a review. |
| Q35542692 | Hyperthyroid vs hypothyroid eye disease: the same severity and activity |
| Q69047587 | Hypoalphalipoproteinemia resembling fish eye disease |
| Q84467424 | I've been seeing tiny, random black specks in front of my eyes. Could this be some kind of eye disease, like macular degeneration? |
| Q787518 | ICD-10 Chapter VII: Diseases of the eye, adnexa |
| Q69973585 | IInd joint meeting of the International Society for Genetic Eye Disease and the International Society for Paediatric Ophthalmology. Ghent, Belgium, 11-13 May 1984 |
| Q47881895 | Iatrogenic dry eye disease: an eledoisin/carnitine and osmolyte drops study |
| Q72416302 | Iatrogenic eye disease |
| Q37492486 | Identifying masked superior oblique involvement in thyroid eye disease to avoid postoperative A-pattern exotropia and intorsion |
| Q86112421 | IgG4 Staining in Thyroid Eye Disease |
| Q50101452 | IgG4-related orbital disease masquerading as thyroid eye disease, vice versa, or both? |
| Q91259615 | Illicit drugs: Effects on eye |
| Q81891397 | Iluvien: a new sustained delivery technology for posterior eye disease |
| Q93011410 | Imaging Biomarkers for Dry Eye Disease |
| Q89112967 | Imaging Investigation of Thyroid Eye Disease |
| Q73289879 | Imaging Somatostatin Receptor Activity in Patients with Active Thyroid Eye Disease Using Tc-99m Depreotide |
| Q57819621 | Imaging biomarkers in thyroid eye disease and their clinical associations |
| Q72069819 | Immunoglobulin A (IgA) deficiency and eye disease |
| Q52871558 | Immunoglobulin G4-positive staining of orbital lesions in thyroid eye disease: Report of two cases. |
| Q72016767 | Immunological investigations in vernal eye disease |
| Q33789467 | Immunopathogenesis of thyroid eye disease: emerging paradigms |
| Q44655324 | Immunosuppressant drugs in the treatment of allergic eye disease: do they have potential usage? |
| Q34199530 | Immunosuppressive therapy in patients with thyroid eye disease: an overview of current concepts |
| Q92249890 | Immunotherapies for thyroid eye disease |
| Q96636453 | Impact of Attrition, Intercellular Shear in Dry Eye Disease: When Cells are Challenged and Neurons are Triggered |
| Q90223560 | Impact of Dry Eye Disease on Vision Quality: An Optical Quality Analysis System Study |
| Q39171599 | Impact of Dry Eye Disease on Work Productivity, and Patients' Satisfaction With Over-the-Counter Dry Eye Treatments |
| Q37751734 | Impact of dry eye disease and treatment on quality of life |
| Q53221113 | Impact of impaired vision and eye disease on quality of life in Andhra Pradesh. |
| Q88268544 | Impact of lifestyle intervention on dry eye disease in office workers: a randomized controlled trial |
| Q26764956 | Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure |
| Q64134659 | Impacts of air pollution on dry eye disease among residents in Hangzhou, China: A case-crossover study |
| Q89308900 | Importance of eye disease in headache |
| Q50442111 | Importance of tear film instability in dry eye disease in office workers using visual display terminals: the Osaka study. |
| Q48926000 | Improvement in amblyopic eye function and contralateral eye disease: evidence of residual plasticity. |
| Q36393194 | Improvement in the signs and symptoms of dry eye disease with dobesilate eye drops |
| Q42566773 | Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxib |
| Q100566479 | Improving parents' knowledge of early signs of paediatric eye disease: A double-blind randomised controlled trial |
| Q41628644 | In Vivo Confocal Microscopy Evaluation of Ocular Surface with Graft-Versus-Host Disease-Related Dry Eye Disease |
| Q36126638 | In Vivo Confocal Microscopy in Dry Eye Disease Associated With Chronic Graft-Versus-Host Disease |
| Q48818970 | In search of sight. Physicians in Chicago use fetal cells to combat a degenerative eye disease afflicting millions. |
| Q47200608 | In vitro normalization of cholesteryl ester content and particle size of fish eye disease high density lipoproteins |
| Q27026571 | In vivo confocal microscopy in dry eye disease and related conditions |
| Q91021279 | In vivo confocal microscopy morphometric analysis of corneal subbasal nerve plexus in dry eye disease using newly developed fully automated system |
| Q38690954 | Incidence and risk factors of symptomatic dry eye disease in Asian Malays from the Singapore Malay Eye Study. |
| Q92396742 | Incidence of Macular Atrophy after Untreated Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 40 |
| Q35318774 | Incidence of blindness due to diabetic eye disease in Fife 1990-9. |
| Q91434907 | Incidence of diabetic eye disease among migrants: A cohort study of 100,000 adults with diabetes in Denmark |
| Q54512727 | Incidence of eye disease in cases of connective tissue disease |
| Q46577992 | Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications |
| Q91893032 | Incidence, demographics, types and risk factors of dry eye disease in India: Electronic medical records driven big data analytics report I |
| Q35012576 | Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007: the effect of oral antiviral prophylaxis |
| Q100378689 | Increased Systemic Immune-Inflammation Index Levels in Patients with Dry Eye Disease |
| Q47793835 | Increased risk of co-morbid eye disease in patients with chronic renal failure: a population-based study. |
| Q92374733 | Individualized Chinese medicine for the treatment of diabetic patients with dry eye disease: A single-case randomized controlled protocol |
| Q74591969 | Indocyanine green angiography in inflammatory eye disease |
| Q89339083 | Induction and Characterization of the Allergic Eye Disease Mouse Model |
| Q46120127 | Inflammation in Dry Eye Disease: How Do We Break the Cycle? |
| Q100515416 | Inflammatory basis for dry eye disease flares |
| Q39110040 | Inflammatory eye disease: Pre-treatment assessment of patients prior to commencing immunosuppressive and biologic therapy: Recommendations from an expert committee |
| Q87850868 | Influence of Nasal Tear Osmolarity on Ocular Symptoms Related to Dry Eye Disease |
| Q92374212 | Influence of Perfluorohexyloctane Eye Drops on Tear Film Thickness in Patients with Mild to Moderate Dry Eye Disease: A Randomized Controlled Clinical Trial |
| Q84784174 | Influence of modest changes in whole-body hydration on tear fluid osmolarity: important considerations for dry eye disease detection |
| Q35812987 | Influence of sex hormones and genetic predisposition in Sjögren's syndrome: a new clue to the immunopathogenesis of dry eye disease |
| Q90299403 | Influence of surgical approach for decompression on lower eyelid position in thyroid eye disease |
| Q70008807 | Inherited eye disease in dogs |
| Q93679675 | Inherited eye disease in dogs |
| Q36254103 | Inherited eye disease: cause and late effect. |
| Q108591389 | Inhibition of Aberrant α(1,2)-Fucosylation at Ocular Surface Ameliorates Dry Eye Disease |
| Q102384486 | Inhibition of Fibrotic Contraction by Sirolimus (Rapamycin) in an Ex Vivo Model of Thyroid Eye Disease |
| Q69257772 | Inhibitory effect of normal high density lipoproteins on lecithin:cholesterol acyltransferase activity in fish eye disease plasma |
| Q80430546 | Institutional Treatment of Eye Disease in Children |
| Q92666754 | Intense Pulsed Light Therapy with Meibomian Gland Expression for Dry Eye Disease |
| Q92507830 | Intense pulse light therapy treatment for refractory dry eye disease due to meibomian gland dysfunction |
| Q91758734 | Intense pulsed light for improving dry eye disease in rosacea |
| Q91958474 | Intense pulsed light therapy: A promising complementary treatment for dry eye disease |
| Q34458485 | Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study |
| Q86953403 | Interaction between topographic/tomographic parameters and dry eye disease in keratoconus patients |
| Q35001933 | Interferon-γ-secreting NK cells promote induction of dry eye disease |
| Q74120740 | Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion |
| Q48573682 | International publication trends in dry eye disease research: A bibliometric analysis. |
| Q90894014 | Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy |
| Q34294722 | Intracranial melanocytic meningeal tumours and melanosis oculi: case report and literature review. |
| Q87048776 | Intraocular pressure change with eye positions before and after orbital decompression for thyroid eye disease |
| Q44673683 | Intravenous pulse methylprednisolone therapy in eye disease: effect on glucose tolerance |
| Q68882356 | Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease |
| Q95840976 | Intravital Multiphoton Microscopy of the Ocular Surface: Alterations in Conventional Dendritic Cell Morphology and Kinetics in Dry Eye Disease |
| Q53435683 | Introductory comments for session V "neovasculogenesis" presented at the fifth symposium, the International Society on Metabolic Eye Disease October 24-26, 1982 |
| Q98904200 | Investigation of Meibomian Gland Function and Dry Eye Disease in Patients with Graves' Ophthalmopathy |
| Q33299675 | Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery |
| Q39076661 | Investigation of epidemic eye disease in Fiji. |
| Q33573617 | Involvement of Nrf2 in Ocular Diseases |
| Q35672575 | Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease |
| Q42704142 | Iridoschisis and keratoconus in a patient with severe allergic eye disease and compulsive eye rubbing: a case report |
| Q37308738 | Irritable bowel syndrome might be associated with dry eye disease |
| Q33614579 | Is aspirin associated with diabetic retinopathy? The Singapore Epidemiology of Eye Disease (SEED) study |
| Q91498604 | Is gabapentin effective in dry eye disease and neuropathic ocular pain? |
| Q92330147 | Is gabapentin effective in dry eye disease and neuropathic ocular pain? |
| Q37393926 | Is household air pollution a risk factor for eye disease? |
| Q36093403 | Is prophylactic laser peripheral iridotomy for primary angle closure suspects a risk factor for cataract progression? The Chennai Eye Disease Incidence Study |
| Q44228262 | Is the Credé eye disease prevention with silver nitrate still necessary. Position of the German-Austrian Society of Neonatology and Pediatric Intensive Care |
| Q24201374 | Ivermectin for onchocercal eye disease (river blindness) |
| Q33940718 | Ivermectin for onchocercal eye disease (river blindness). |
| Q43993542 | Japan Ministry of Health study on prevalence of dry eye disease among Japanese high school students |
| Q31957860 | Keio Mutation Database for eye disease genes (KMeyeDB). |
| Q53534950 | Keratitis in Dry Eye Disease and Topical Ciclosporin A. |
| Q69365434 | Keratoplasty in acute eye disease |
| Q42246017 | Ketocarotenoid circulation, but not retinal carotenoid accumulation, is linked to eye disease status in a wild songbird |
| Q80797441 | Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease |
| Q89928664 | Kinetics of Corneal Antigen Presenting Cells in Experimental Dry Eye Disease |
| Q91246202 | Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy |
| Q36848950 | Knowledge of diabetic eye disease and vision care guidelines among Hispanic individuals in Baltimore with and without diabetes |
| Q35305578 | Knowledge, attitudes, and self care practices associated with age related eye disease in Australia |
| Q64966819 | Knowledge, beliefs and practices regarding sickle cell eye disease of patients at the sickle cell unit, Jamaica. |
| Q94187059 | LIFITEGRAST 5% FOR DRY EYE DISEASE: COMBINED EFFICACY AND SAFETY FROM FIVE RANDOMIZED CONTROLLED TRIALS |
| Q70948432 | Laboratory Screening for Metabolic Eye Disease: A Review |
| Q38117227 | Laboratory support in the diagnosis of uveitis |
| Q47253380 | Lack of Longitudinal Association between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD EYE Study. |
| Q36952140 | Lack of concordance between fixation preference and HOTV optotype visual acuity in preschool children: the Baltimore Pediatric Eye Disease Study |
| Q91237244 | Lack of social support and social trust as potential risk factors for dry eye disease: JPHC-NEXT study |
| Q97559020 | Lacrimal Gland Myoepithelial Cells Are Altered in a Mouse Model of Dry Eye Disease |
| Q71075007 | Laser treatment for eye disease |
| Q26995365 | Laser, intravitreal drug application, and surgery to treat diabetic eye disease |
| Q79954849 | Late presentation of severe thyroid eye disease |
| Q37992602 | Latent dry eye disease state variable |
| Q69757869 | Leads from the MMWR. Guidelines for diabetic eye disease control--Kentucky |
| Q48932669 | Legacy of the age-related eye disease [corrected] study. |
| Q72069901 | Lens opacities in the dog as models for human eye disease |
| Q104695746 | Letter to the Editor: "Dry Eye Disease after Cataract Surgery: Study of its Determinants and Risk Factors" |
| Q38162547 | Leukotriene receptor antagonists in allergic eye disease: a systematic review and meta-analysis |
| Q83377607 | Levator excursion and its relationship to lid lag in thyroid eye disease |
| Q82591832 | Levator excursion as a predictor of both eyelid lag and lagophthalmos in thyroid eye disease |
| Q69610145 | Lid protractor force generation in Graves' eye disease |
| Q49103626 | Life, eye disease and work of Joseph Plateau. |
| Q38925614 | Lifestyle Determinants on Prevention and Improvement of Dry Eye Disease from the Perspective of Iranian Traditional Medicine |
| Q87809124 | Lifitegrast (Xiidra) for Dry Eye Disease |
| Q95517158 | Lifitegrast (Xiidra) for dry eye disease |
| Q91446846 | Lifitegrast Ophthalmic Solution 5% (Xiidra) for Dry Eye Disease |
| Q91017783 | Lifitegrast Ophthalmic Solution 5.0% for Treatment of Dry Eye Disease: Overview of Clinical Trial Program |
| Q34493904 | Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study |
| Q45037685 | Lifitegrast clinical efficacy for treatment of signs and symptoms of dry eye disease across three randomized controlled trials |
| Q46401944 | Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3). |
| Q38608475 | Lifitegrast for the treatment of dry eye disease in adults |
| Q42708147 | Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study |
| Q33739879 | Lifitegrast ophthalmic solution in the treatment of signs and symptoms of dry eye disease: design, development, and place in therapy |
| Q26774853 | Lifitegrast, a Novel Integrin Antagonist for Treatment of Dry Eye Disease |
| Q93137705 | Lifitegrast: a novel drug for patients with dry eye disease |
| Q78033080 | Limbal stem cell transplantation in chronic inflammatory eye disease |
| Q96115376 | Lipid Annotation by Combination of UHPLC-HRMS (MS), Molecular Networking, and Retention Time Prediction: Application to a Lipidomic Study of In Vitro Models of Dry Eye Disease |
| Q91607843 | Lipid polarity gradient formed by ω-hydroxy lipids in tear film prevents dry eye disease |
| Q27687657 | Liposomes and nanotechnology in drug development: focus on ocular targets |
| Q37106301 | Liquid nitrogen cryotherapy for surface eye disease (an AOS thesis) |
| Q45178229 | Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice |
| Q33784381 | Local periocular vaccination protects against eye disease more effectively than systemic vaccination following primary ocular herpes simplex virus infection in rabbits |
| Q34892662 | Local therapies for inflammatory eye disease in translation: past, present and future |
| Q76013674 | Local use of cortisone acetate in eye disease |
| Q35195904 | Localization of the Aland Island eye disease locus to the pericentromeric region of the X chromosome by linkage analysis. |
| Q91814205 | Location and pattern of non-invasive keratographic tear film break-up according to dry eye disease subtypes |
| Q90606216 | Locking Y Lateral Canthopexy as a Treatment for Dry Eye Disease Caused by Eyelid Malposition |
| Q47739852 | Long-Term Topical Diquafosol Tetrasodium Treatment of Dry Eye Disease Caused by Chronic Graft-Versus-Host Disease: A Retrospective Study |
| Q96812719 | Long-acting mucoadhesive thermogels for improving topical treatments of dry eye disease |
| Q36494967 | Long-term Natural History of Dry Eye Disease from the Patient's Perspective |
| Q104675004 | Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT] |
| Q68049972 | Long-term efficacy of orbital decompression for compressive optic neuropathy of Graves' eye disease |
| Q43882744 | Long-term follow-up of patients with thyroid eye disease treated with endoscopic orbital decompression |
| Q37471561 | Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up |
| Q70841383 | Long-term visual outcome following orbital decompression for dysthyroid eye disease |
| Q69713801 | Long-term visual results of vitreous surgery in diabetic eye disease |
| Q39132796 | Longitudinal Andhra Pradesh Eye Disease Study: rationale, study design and research methodology |
| Q84857357 | Looking at ocriplasmin as a new option in eye disease |
| Q92679240 | Looking to the future of zebrafish as a model to understand the genetic basis of eye disease |
| Q94549615 | Loteprednol Etabonate for the Treatment of Dry Eye Disease: A Literature Review |
| Q100995602 | Loteprednol combined with sodium hyaluronate in the treatment of dry eye disease and its effect on TNF-α and CXCL10 in tears |
| Q78746588 | Lowering lipids in eye disease |
| Q96292610 | Lung and eye disease develop concurrently in supplemental oxygen-exposed neonatal mice |
| Q28290149 | Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration |
| Q26773085 | Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease |
| Q91665714 | MSC Transplantation Improves Lacrimal Gland Regeneration after Surgically Induced Dry Eye Disease in Mice |
| Q43881495 | Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the women's health initiative |
| Q44743294 | Macular pigment measurement by heterochromatic flicker photometry in older subjects: the carotenoids and age-related eye disease study. |
| Q26853288 | Magnetic resonance imaging for the ophthalmologist: a primer |
| Q61054792 | Making Sense of the Evidence From the Age-Related Eye Disease Study 2 Randomized Clinical Trial |
| Q43784580 | Making sense of the evidence from the age-related eye disease study 2 randomized clinical trial-reply |
| Q38259825 | Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study |
| Q80347919 | Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007) |
| Q42039917 | Management of diabetic eye disease: an overview |
| Q92222609 | Management of dry eye disease to optimize cataract surgery outcomes: Two tables for a daily clinical practice |
| Q68463256 | Management of dysthyroid eye disease |
| Q70867805 | Management of eye disease in the insulin-dependent diabetic patient |
| Q90590751 | Management of graves myopathy: Understanding and managing vertical strabismus from thyroid eye disease |
| Q89986580 | Management of moderate-to-severe dry eye disease using chitosan-N-acetylcysteine (Lacrimera®) eye drops: a retrospective case series |
| Q42281196 | Management of patients with herpes simplex virus eye disease having cataract surgery in the United Kingdom |
| Q38906232 | Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit |
| Q89536542 | Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies |
| Q71041031 | Managing HIV. Part 5: Treating secondary outcomes. 5.11 HIV and eye disease |
| Q34066986 | Managing eye disease in primary care. Part 1. How to screen for occult disease |
| Q34066991 | Managing eye disease in primary care. Part 2. How to recognize and treat common eye problems |
| Q34066996 | Managing eye disease in primary care. Part 3. When to refer for ophthalmologic care |
| Q70394156 | Managing strabismus in endocrine eye disease |
| Q104748055 | Manuscript title: Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial |
| Q79220938 | Many elderly patients with chronic eye disease don't get recommended exams |
| Q104679832 | Mask-associated dry eye disease (MADE) and dry eye due to prolonged screen time: Are we heading towards a new dry eye epidemic during the COVID-19 Era? |
| Q71429249 | Mass screening of glaucoma and other eye disease using the Arden grating test |
| Q59695970 | Maternal Inheritance of a Recessive RBP4 Defect in Canine Congenital Eye Disease. |
| Q58599953 | Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease |
| Q47374338 | Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay |
| Q58759867 | Maximum blink interval is associated with tear film breakup time: A new simple, screening test for dry eye disease |
| Q87964638 | Measurement of Medial Wall Bowing and Clinical Associations in Thyroid Eye Disease |
| Q36951805 | Measuring the personal burden of eye disease and vision impairment |
| Q99717908 | Medical and Surgical Treatment of Thyroid Eye Disease |
| Q97692289 | Medical management of thyroid eye disease - A paradigm shift |
| Q95648146 | Medical treatment in thyroid eye disease in 2020 |
| Q51125698 | Meibomian gland dropout in patients with dry eye disease in China. |
| Q89817740 | Meibomian gland dropout is associated with immunodeficiency at HIV diagnosis: Implications for dry eye disease |
| Q104739094 | Metabolomics approach to biomarkers of dry eye disease using 1H-NMR in rats |
| Q40163208 | Methodological problems in eye disease epidemiology |
| Q80347912 | Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007) |
| Q36996217 | Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2) |
| Q38710435 | Methotrexate as a Corticosteroid-Sparing Agent for Thyroid Eye Disease |
| Q90959618 | Methotrexate as an Adjuvant in Severe Thyroid Eye Disease: Does It Really Work as a Steroid-Sparing Agent? |
| Q79131157 | Methotrexate in inflammatory eye disease |
| Q92196259 | Microbial Keratitis in Thyroid Eye Disease: Clinical Features, Microbiological Profile, and Treatment Outcome |
| Q41844410 | Minimally invasive surgery for thyroid eye disease |
| Q99556752 | Minor salivary gland transplantation for severe dry eye disease due to cicatrising conjunctivitis: multicentre long-term outcomes of a modified technique |
| Q70697983 | Mobile eye units in the fight against eye disease in East Africa |
| Q41143444 | Modified Full Thickness Graded Blepharotomy for Upper Eyelid Retraction Associated With Thyroid Eye Disease in East Asians |
| Q38034859 | Molecular and cellular biomarkers in dry eye disease and ocular allergy. |
| Q90985706 | Molecular evidence for the role of inflammation in dry eye disease |
| Q84485416 | Morphology of conjunctival changes in thyroid eye disease |
| Q46740979 | Multi-rule quality control for the age-related eye disease study |
| Q54596780 | Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. |
| Q36701941 | Multivitamin-multimineral supplements and eye disease: age-related macular degeneration and cataract |
| Q86689148 | Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease |
| Q69935826 | Mörike's eye disease |
| Q83067946 | NEI releases complete data from Age-Related Eye Disease Study |
| Q79327011 | NEW eye disease in infancy |
| Q26765952 | NRP1 function and targeting in neurovascular development and eye disease |
| Q61971184 | Nanomedicine for the Brain and the Eye: Disease Management in Poorly Accessible Compartments of the Body |
| Q38098509 | Nanotechnology approaches for ocular drug delivery |
| Q54117205 | Narrow Spectrum Kinase Inhibitors Demonstrate Promise for the Treatment of Dry Eye Disease and Other Ocular Inflammatory Disorders. |
| Q34655531 | National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10 |
| Q91127226 | Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17 |
| Q22305674 | Natural compounds: evidence for a protective role in eye disease |
| Q34164826 | Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28. |
| Q92971159 | Natural history of dry eye disease: Perspectives from inter-ethnic comparison studies |
| Q98732415 | Natural history of inflammatory and non-inflammatory dry eye in thyroid eye disease |
| Q87892084 | Neonatal Graves' Eye Disease |
| Q68338844 | Neovascular glaucoma following vitrectomy for diabetic eye disease |
| Q40201924 | Neuraminidase activity of blue eye disease porcine rubulavirus: Specificity, affinity and inhibition studies. |
| Q27000669 | Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features |
| Q89164613 | Neurofibromatosis Type 2-Related Eye Disease Correlated With Genetic Severity Type |
| Q91026766 | Neurokinin-1 Receptor Antagonism Ameliorates Dry Eye Disease by Inhibiting Antigen-Presenting Cell Maturation and T Helper 17 Cell Activation |
| Q92959380 | Neutrophil Extracellular Traps: Current Perspectives in the Eye |
| Q64889532 | Neutrophils cause obstruction of eyelid sebaceous glands in inflammatory eye disease in mice. |
| Q89991851 | New Nonsurgical Option Approved for Thyroid Eye Disease |
| Q47095036 | New Paradigms for the Study of Ocular Alphaherpesvirus Infections: Insights into the Use of Non-Traditional Host Model Systems. |
| Q90417535 | New Therapeutic Strategy and Innovative Lubricating Ophthalmic Solution in Minimizing Dry Eye Disease Associated with Cataract Surgery: A Randomized, Prospective Study |
| Q90863824 | New approaches for diagnosis of dry eye disease |
| Q33580099 | New discoveries in diabetes- and thyroid-related eye disease |
| Q33774520 | New testing options for diagnosing and grading dry eye disease |
| Q92262928 | No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report |
| Q93336348 | No Relation Between the Severity of Corneal Nerve, Epithelial, and Keratocyte Cell Morphology With Measures of Dry Eye Disease in Type 1 Diabetes |
| Q46881746 | No changes in serum concentrations of interleukin 10 (IL-10) and interferon gamma (IF-gamma) before and after treatment of the thyroid eye disease (TED). |
| Q97412647 | Nocturnal Lagophthalmos and Sleep Quality in Patients with Dry Eye Disease |
| Q98470265 | Non-EPI-DWI for Detection, Disease Monitoring, and Clinical Decision-Making in Thyroid Eye Disease |
| Q55641400 | Non-Primate Lentiviral Vectors and Their Applications in Gene Therapy for Ocular Disorders. |
| Q45948933 | Non-surgical treatment for eyelid retraction in thyroid eye disease (TED). |
| Q26999057 | Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives |
| Q68375260 | Normalization of high density lipoprotein in fish eye disease plasma by purified normal human lecithin: cholesterol acyltransferase |
| Q91990226 | Normalized ocular surface temperature models for tear film characteristics and dry eye disease evaluation |
| Q88552079 | Normative Retinal Thicknesses in Common Animal Models of Eye Disease Using Spectral Domain Optical Coherence Tomography |
| Q26752617 | Novel Insights into the Role of Long Noncoding RNA in Ocular Diseases |
| Q49976599 | Novel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment. |
| Q27015832 | Nutrients for the aging eye |
| Q81505672 | Nutrition may be factor in developing eye disease |
| Q67246930 | Nystagmographical studies in Aland eye disease |
| Q69130765 | Nystagmographical studies in Aland eye disease |
| Q83784167 | OCT assessment of tear meniscus after punctal occlusion in dry eye disease |
| Q61657646 | OP60 Optimising Risk-Based Screening: The Case Of Diabetic Eye Disease |
| Q90834548 | Objective assessment of optical quality in dry eye disease using a double-pass imaging system |
| Q73661214 | Objective evaluation of improvement in optic neuropathy following radiation therapy for thyroid eye disease |
| Q73685710 | Objective evaluation of improvement in optic neuropathy following radiation therapy for thyroid eye disease, by S. Rush, J. M. Winterkorn, and R. Zak. Int J. Radiat Oncol Biol. Phys 47:191-4, 2000 |
| Q46124921 | Occult thyroid eye disease in patients presenting with dry eye symptoms |
| Q53531099 | Occult thyroid eye disease in patients with unexplained ocular misalignment identified by standardized orbital echography. |
| Q38676937 | Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration |
| Q24291027 | Ocular Findings in Infants With Microcephaly Associated With Presumed Zika Virus Congenital Infection in Salvador, Brazil |
| Q64229513 | Ocular Manifestations in Hemodialysis Patients: Importance of Ophthalmic Examination in Prevention of Ocular Sequels |
| Q90931447 | Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease |
| Q91081659 | Ocular Pharmacological Profile of Hydrocortisone in Dry Eye Disease |
| Q34073158 | Ocular allergic disorders and dry eye disease: associations, diagnostic dilemmas, and management |
| Q45793104 | Ocular amylosis |
| Q36842136 | Ocular associations of diabetes other than diabetic retinopathy |
| Q82047063 | Ocular complications in peritoneal haemodialysis |
| Q59121199 | Ocular complications of inflammatory bowel disease |
| Q92589512 | Ocular ductions after rectus muscle recession and resection in thyroid eye disease |
| Q59340087 | Ocular features in mucopolysaccharidosis: diagnosis and treatment |
| Q42535223 | Ocular ischaemic syndrome in thyroid eye disease, confirmed using magnetic resonance angiography |
| Q34357240 | Ocular ischemic syndrome - a systematic review. |
| Q71456515 | Ocular manifestations of Behçet's syndrome: 42 cases |
| Q91293194 | Ocular manifestations of crohn's disease |
| Q46123736 | Ocular manifestations of diabetes: 285 cases |
| Q77538875 | Ocular manifestations of xeroderma pigmentosum (report of 5 cases) |
| Q27027227 | Ocular medicines in children: the regulatory situation related to clinical research |
| Q92040385 | Ocular mucins in dry eye disease |
| Q73887246 | Ocular pain: a casualty study. The spectrum and prevalence of pain in acute eye disease |
| Q84329588 | Ocular surface characteristics and impression cytology in patients with active versus inactive Thyroid Eye Disease |
| Q71244779 | Ocular surface drying and tear film osmolarity in thyroid eye disease |
| Q36474926 | Ocular surface extracellular DNA and nuclease activity imbalance: a new paradigm for inflammation in dry eye disease |
| Q35907009 | Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease |
| Q49163694 | Ocular surface inflammation in dry eye disease: What we know and what we do not. |
| Q50451132 | Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease - a randomised comparative study. |
| Q27026994 | Ocular toxocariasis: report of two cases and review of the literature |
| Q27686780 | Ocular transient receptor potential channel function in health and disease |
| Q79826611 | Ocular trauma in a rural population of southern India: the Andhra Pradesh Eye Disease Study |
| Q39553063 | Ocular trauma in an urban population in southern India: the Andhra Pradesh Eye Disease Study |
| Q92047766 | Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease |
| Q93335948 | Omega-3 fatty acid supplements do not improve symptoms of dry eye disease |
| Q79692135 | Omega-3 intake linked with lowered risk of age-related macular degeneration. Foods high in omega-3 could reduce the risk of this debilitating eye disease by 38 percent |
| Q42506915 | Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study. |
| Q50558127 | On call. I'm 53 years old, and I only need glasses for reading. Recently though I've seen tiny black specs that move around in random directions. My eyes are not red, watery, or painful, but I'm worried that I may have the start of an eye disease |
| Q58711460 | On the Use of Santonine in Eye Disease |
| Q57479273 | Once-Daily Cyclosporine-A-MiDROPS for Treatment of Dry Eye Disease |
| Q44365456 | Onchocercal eye disease and the impact of Mectizan treatment |
| Q99760741 | Onchocercal eye disease and the impact of Mectizan treatment |
| Q52497703 | Onchocerciasis, river blindness. An important tropical eye disease |
| Q85030923 | Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect? |
| Q39545622 | Open-angle glaucoma in an urban population in southern India: the Andhra Pradesh eye disease study |
| Q79689063 | Ophtalmologic manifestations of the xeroderma pigmentosum |
| Q26785495 | Ophthalmic Alterations in the Sturge-Weber Syndrome, Klippel-Trenaunay Syndrome, and the Phakomatosis Pigmentovascularis: An Independent Group of Conditions? |
| Q73436869 | Ophthalmic cyclosporine (Restasis) for dry eye disease |
| Q38211007 | Ophthalmic masquerades of the atherosclerotic carotids |
| Q46151597 | Ophthalmologic causes of unfitness for military service in Tunisia (apropos of 1165 cases) |
| Q67816229 | Ophthalmologists participating in TDH eye disease program |
| Q44238392 | Ophthalmopharmacology and chemotherapy in the clinical aspects of eye disease |
| Q36963786 | Optic Neuropathy in Thyroid Eye Disease: A Case Series |
| Q80538694 | Optic disc hemorrhages detected in a large-scale eye disease screening project |
| Q41435610 | Optic nerve dysfunction in thyroid eye disease: CT |
| Q71134281 | Optic nerve dysfunction in thyroid eye disease: a clinician's perspective |
| Q104075021 | Optic neuropathy and diplopia from thyroid eye disease: update on pathophysiology and treatment |
| Q38207225 | Optic neuropathy in thyroid eye disease: results of the balanced decompression technique |
| Q72526106 | Optometric care and undetected eye disease: a case of Berkson's bias? |
| Q90992772 | Oral Hyaluronic Acid Supplementation for the Treatment of Dry Eye Disease: A Pilot Study |
| Q74098387 | Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group |
| Q35304958 | Oral contraception and eye disease: findings in two large cohort studies |
| Q83567069 | Oral leukotriene antagonists in thyroid eye disease: myth or reality? |
| Q41189937 | Orbital Angiogenesis and Lymphangiogenesis in Thyroid Eye Disease: An Analysis of Vascular Growth Factors with Clinical Correlation. |
| Q92367454 | Orbital Bone Decompression for Non-Thyroid Eye Disease Proptosis |
| Q96223473 | Orbital Decompression for Exorbitism and Exophthalmos in a Patient With Thyroid Eye Disease |
| Q98287377 | Orbital Fat Herniation Through the Superior Orbital Fissure in Thyroid Eye Disease |
| Q68419530 | Orbital decompression for optic neuropathy secondary to thyroid eye disease |
| Q41042475 | Orbital decompression for the management of thyroid eye disease: An analysis of outcomes and complications |
| Q74211227 | Orbital decompression for thyroid eye disease: a comparison of external and endoscopic techniques |
| Q49829361 | Orbital decompression for thyroid eye disease: methods, outcomes, and complications. |
| Q57487226 | Orbital decompression in the system of treatment for complicated thyroid eye disease: case report and literature review |
| Q61806231 | Orbital decompression in the system of treatment for complicated thyroid eye disease: case report and literature review [corrigendum] |
| Q36375474 | Orbital decompression surgery for thyroid eye disease: implications for anaesthesia |
| Q38246849 | Orbital fat decompression for thyroid eye disease: retrospective case review and criteria for optimal case selection |
| Q92392823 | Orbital fat expansion in thyroid eye disease is related to age |
| Q37296579 | Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype |
| Q53243373 | Orbital lipectomy (fat decompression) for thyroid eye disease: an operation for everyone? |
| Q24201984 | Orbital radiotherapy for adult thyroid eye disease |
| Q24241938 | Orbital radiotherapy for adult thyroid eye disease |
| Q92584568 | Orbital radiotherapy for thyroid eye disease: case report with a review of the literature |
| Q50156883 | Orbital radiotherapy plus three-wall orbital decompression in a patient with rare ocular manifestations of thyroid eye disease: case report. |
| Q92244188 | Osmokinetics: A new dynamic concept in dry eye disease |
| Q48125115 | Outcomes from community-based diabetic eye disease screening: a 3-year review |
| Q35347819 | Outcomes in Cochrane systematic reviews addressing four common eye conditions: an evaluation of completeness and comparability. |
| Q34616918 | Outcomes, impact on management, and costs of fungal eye disease consults in a tertiary care setting. |
| Q73042411 | Overcorrection after adjustable suture suspension- recession of the inferior rectus muscle in non-thyroid eye disease |
| Q70386238 | Overseas blindness agency malnutrition to prevent children's eye disease |
| Q24608339 | P2Y2 receptor agonists for the treatment of dry eye disease: a review |
| Q36122993 | PDE4 inhibition suppresses IL-17-associated immunity in dry eye disease |
| Q38820149 | Palate Lung Nasal Clone (PLUNC), a Novel Protein of the Tear Film: Three-Dimensional Structure, Immune Activation, and Involvement in Dry Eye Disease (DED). |
| Q30753230 | Panretinal photocoagulation during cataract extraction in eyes with active proliferative diabetic eye disease |
| Q93651404 | Papers presented at the IInd joint meeting of the International Society for Genetic Eye Disease and the International Society for Paediatric Ophthalmology. Ghent, Belgium, 11-13 May 1984 |
| Q38633022 | Pathogenesis of thyroid eye disease: review and update on molecular mechanisms. |
| Q90671707 | Pathological consequences of anti-citrullinated protein antibodies in tear fluid and therapeutic potential of pooled human immune globulin-eye drops in dry eye disease |
| Q37734996 | Pathophysiology of intraocular pressure increase and glaucoma prevalence in thyroid eye disease: a mini-review |
| Q64135295 | Patient adherence to guidelines for diabetes eye care: results from the diabetic eye disease follow-up study |
| Q77515746 | Patient attitudes and awareness of diabetic eye disease |
| Q97868809 | Patient perceptions of autologous serum eye drops for severe dry eye disease |
| Q35010238 | Patient reported differences in dry eye disease between men and women: impact, management, and patient satisfaction |
| Q91823183 | Patient-Reported Burden of Dry Eye Disease in the United States: Results of an Online Cross-Sectional Survey |
| Q91653099 | Patient-reported outcomes of autologous serum tears for the treatment of dry eye disease in a large cohort |
| Q36242214 | Patients With Dry Eye Disease and Low Subbasal Nerve Density Are at High Risk for Accelerated Corneal Endothelial Cell Loss |
| Q39776915 | Patients' attitudes towards mydriasis for diabetic eye disease screening |
| Q38664411 | Patients' expectations for the functional and psychosocial outcomes of orbital decompression surgery for thyroid eye disease: a qualitative study |
| Q35021717 | Pax6 downregulation mediates abnormal lineage commitment of the ocular surface epithelium in aqueous-deficient dry eye disease |
| Q89474563 | Pediatric Thyroid Eye Disease: Clinical Characteristics and Orbital Decompression Outcomes |
| Q37798677 | Pediatric eye disease in Tanzania |
| Q45870542 | Perceptions and understanding of genetics and genetic eye disease and attitudes to genetic testing and gene therapy in a primary eye care setting. |
| Q40953862 | Perceptions of dry eye disease management in current clinical practice |
| Q72625858 | Perceptual problems in thyroid eye disease |
| Q38770198 | Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Researc |
| Q44273235 | Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use? |
| Q58590492 | Persistence of Efficacy of 0.1% Cyclosporin A Cationic Emulsion in Subjects with Severe Keratitis Due to Dry Eye Disease: A Nonrandomized, Open-Label Extension of the SANSIKA Study |
| Q45735509 | Persistence of Escherichia coli, Salmonella choleraesuis, Aujeszky's Disease virus and Blue Eye Disease virus in ensilages based on the solid fraction of pig faeces |
| Q39648277 | Personalized follow-up increases return rate at urban eye disease screening clinics for African Americans with diabetes: results of a randomized trial |
| Q34511778 | Personalized ophthalmology. |
| Q36890365 | Perspective: A Critical Look at the Ancillary Age-Related Eye Disease Study 2: Nutrition and Cognitive Function Results in Older Individuals with Age-Related Macular Degeneration |
| Q34443357 | Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years |
| Q89112953 | Phenotypes of Thyroid Eye Disease |
| Q33651594 | Phlyctenular eye disease in association with Hymenolepis nana in Egypt |
| Q73544395 | Phlyctenular eye disease: a reappraisal |
| Q97680768 | Photophobia: shared pathophysiology underlying dry eye disease, migraine and traumatic brain injury leading to central neuroplasticity of the trigeminothalamic pathway |
| Q47917147 | Photothermal Ring Integrated Intraocular Lens for High-Efficient Eye Disease Treatment |
| Q35660417 | Physical activity restriction in age-related eye disease: a cross-sectional study exploring fear of falling as a potential mediator |
| Q90346137 | Physical inactivity, prolonged sedentary behaviors, and use of visual display terminals as potential risk factors for dry eye disease: JPHC-NEXT study |
| Q91788688 | Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease |
| Q102071230 | Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States |
| Q61661601 | Pig Paramyxovirus of the Blue Eye Disease Binding to a 116 kDa Glycoprotein Expressed in Pig Neuronal Membranes |
| Q38295543 | Pig paramyxovirus of the blue eye disease binding to a 116 kDa glycoprotein expressed in pig neuronal membranes |
| Q94590279 | Pigment Epithelium-derived factor secreted by corneal epithelial cells regulates dendritic cell maturation in dry eye disease |
| Q104792192 | Pigment epithelium-derived factor (PEDF) plays anti-inflammatory roles in the pathogenesis of dry eye disease |
| Q67238375 | Pingelap eye disease |
| Q98892414 | Pneumocephalus after Orbital Decompression Surgery for Thyroid Eye Disease |
| Q52595658 | Policy implications of regional variations in eye disease detection and treatment on Prince Edward Island: a repeated cross-sectional analysis, 2010-2012. |
| Q91299825 | Polydatin Inhibits NLRP3 Inflammasome in Dry Eye Disease by Attenuating Oxidative Stress and Inhibiting the NF-κB Pathway |
| Q89528568 | Polygonum cuspidatum stem extract (PSE) ameliorates dry eye disease by inhibiting inflammation and apoptosis |
| Q72231538 | Poor methodology teaches us nothing about undetected eye disease |
| Q40124955 | Population-based assessment of prevalence and risk factors for pterygium in the South Indian state of Andhra Pradesh: the Andhra Pradesh Eye Disease Study |
| Q92269156 | Population-based study on the epidemiology of dry eye disease and its association with presbyopia and other risk factors |
| Q69804394 | Positional effects on exophthalmometer readings in Graves' eye disease |
| Q42370585 | Possible association between subtypes of dry eye disease and seasonal variation |
| Q35994403 | Possible association of killer cell immunoglobulin-like receptor genotypes and haplotypes with dry eye disease in a Han Chinese population |
| Q102336051 | Post laser-assisted in-situ keratomileusis dry eye disease and temporary punctal plugs |
| Q39714089 | Post-refractive surgery complications and eye disease, active component, U.S. Armed Forces, 2005-2014. |
| Q33785443 | Posterior segment eye disease in sub-Saharan Africa: review of recent population-based studies |
| Q36613476 | Postural visual obscurations in patients with inactive thyroid eye disease; a variant of 'hydraulic' disease |
| Q39928991 | Potential Importance of Ozone in the Association Between Outdoor Air Pollution and Dry Eye Disease in South Korea |
| Q93343265 | Potential Role of Oxidative Stress in Ocular Surface Inflammation and Dry Eye Disease |
| Q34655518 | Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. |
| Q101131624 | Power spectral density and coherence analysis of eye disease with and without visual hallucination |
| Q78626945 | Practical consideration of eye disease |
| Q91905513 | Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease |
| Q28071712 | Precise long non-coding RNA modulation in visual maintenance and impairment |
| Q100639633 | Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease |
| Q92462971 | Precursors and Development of Geographic Atrophy with Autofluorescence Imaging: Age-Related Eye Disease Study 2 Report Number 18 |
| Q61796034 | Predictive factors of prognosis after radiation and steroid pulse therapy in thyroid eye disease |
| Q40178940 | Predictors for incidence of primary open-angle glaucoma in a South Indian population: the Chennai eye disease incidence study |
| Q79340995 | Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative |
| Q73615250 | Predictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study Group |
| Q35843244 | Predictors of the Dose-Effect Relationship regarding Unilateral Inferior Rectus Muscle Recession in Patients with Thyroid Eye Disease |
| Q91036186 | Predominant Contribution of Superior Rectus-Levator Complex Enlargement to Optic Neuropathy and Inferior Visual Field Defects in Thyroid Eye Disease |
| Q86003423 | Preface. Molecular Biology of Eye Disease |
| Q47348314 | Prehistoric eye disease (trachoma?) in Australian aborigines |
| Q36603961 | Preliminary report of improved sleep quality in patients with dry eye disease after initiation of topical therapy |
| Q38610019 | Prevalence and Associations of Retinal Emboli With Ethnicity, Stroke, and Renal Disease in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Disease Study |
| Q64244731 | Prevalence and Determinants of Dry Eye Disease among 40 Years and Older Population of Riyadh (Except Capital), Saudi Arabia |
| Q92604717 | Prevalence and associated risk factors of dry eye disease in 16 northern West bank towns in Palestine: a cross-sectional study |
| Q55122175 | Prevalence and clinical characteristics of dry eye disease in community-based type 2 diabetic patients: the Beixinjing eye study. |
| Q91232264 | Prevalence and impact of eye disease in an urban homeless and marginally housed population |
| Q39921557 | Prevalence and risk factors for primary glaucomas in adult urban and rural populations in the Andhra Pradesh Eye Disease Study |
| Q37257701 | Prevalence and risk factors for refractive errors in the South Indian adult population: The Andhra Pradesh Eye disease study. |
| Q37361004 | Prevalence and risk factors for thyroid eye disease among Korean dysthyroid patients |
| Q51112488 | Prevalence and risk factors of dry eye disease among a hospital-based population in southeast China. |
| Q84884980 | Prevalence and risk factors of dry eye disease in Japan: Koumi study |
| Q49584452 | Prevalence and risk factors of dry eye disease in North India: Ocular surface disease index-based cross-sectional hospital study. |
| Q44915029 | Prevalence and risk factors of dry eye disease in a British female cohort |
| Q92573987 | Prevalence and risk factors of symptomatic dry eye disease in Lebanon |
| Q40770658 | Prevalence of Childhood Blindness and Ocular Morbidity in a Rural Pediatric Population in Southern India: The Pavagada Pediatric Eye Disease Study-1. |
| Q38680274 | Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older |
| Q103812309 | Prevalence of Dry Eye Disease in Africa: A Systematic Review and Meta-analysis |
| Q89867666 | Prevalence of Signs and Symptoms of Dry Eye Disease 5 to 15 After Refractive Surgery |
| Q97638400 | Prevalence of Thyroid Eye Disease in Graves' Disease: A Meta-Analysis and Systematic Review |
| Q61782693 | Prevalence of and risk factors for symptomatic dry eye disease in Singapore |
| Q34474778 | Prevalence of astigmatism in 6- to 72-month-old African American and Hispanic children: the Multi-ethnic Pediatric Eye Disease Study |
| Q55309922 | Prevalence of blindness and eye disease: discussion paper. |
| Q35136887 | Prevalence of cataract in an older population in India: the India study of age-related eye disease |
| Q87429340 | Prevalence of conjunctival shrinkage and its association with dry eye disease: results from a population-based study in Spain |
| Q36951970 | Prevalence of decreased visual acuity among preschool-aged children in an American urban population: the Baltimore Pediatric Eye Disease Study, methods, and results |
| Q83642892 | Prevalence of diabetes-related eye disease in North Carolina: findings from the North Carolina Behavioral Risk Factor Surveillance System |
| Q43673937 | Prevalence of diabetic eye disease in Tayside, Scotland (P-DETS) study: methodology |
| Q39515405 | Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study |
| Q44369243 | Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme |
| Q45897367 | Prevalence of dry eye disease among Japanese visual display terminal users |
| Q33720070 | Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies |
| Q47213683 | Prevalence of dry eye disease and its association with dyslipidemia |
| Q44959502 | Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study |
| Q92068163 | Prevalence of dry eye disease in Ontario, Canada: A population-based survey |
| Q39982462 | Prevalence of dry eye disease in an elderly Korean population. |
| Q99411668 | Prevalence of dry eye disease in the elderly: A protocol of systematic review and meta-analysis |
| Q43521698 | Prevalence of eye disease and number of ophthalmologists |
| Q35813439 | Prevalence of eye disease in Brazilian patients with psoriatic arthritis |
| Q43606556 | Prevalence of eye disease in early childhood and associated factors: findings from the millennium cohort study |
| Q98889009 | Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease: a systematic review of the literature |
| Q86435041 | Prevalence of refractive errors in a multiethnic Asian population: the Singapore epidemiology of eye disease study |
| Q51800704 | Prevalence of trachoma and diabetes-related eye disease among a cohort of adult Aboriginal patients screened over the period 1999-2004 in remote South Australia. |
| Q77299205 | Prevalence of treated dry eye disease in a managed care population |
| Q43898498 | Prevalence of undiagnosed eye disease in high-risk diabetic individuals |
| Q90314602 | Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21 |
| Q90084589 | Prevalence, incidence and future projection of diabetic eye disease in Europe: a systematic review and meta-analysis |
| Q35708510 | Preventing visual loss from chronic eye disease in primary care: scientific review |
| Q95569284 | Prevention and Management of Diabetes-Related Eye Disease |
| Q58004690 | Prevention of Thyroid Eye Disease and Final Conclusions |
| Q73152150 | Prevention of allergic eye disease by treatment with IL-1 receptor antagonist |
| Q39808277 | Prevention of diabetic eye disease: the commonest cause of blindness in individuals younger than 65 years |
| Q44275559 | Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis |
| Q39549140 | Prevention, detection, and treatment of diabetic eye disease: an overview and demonstration project |
| Q83225195 | Primary cilia deficiency in neural crest cells models anterior segment dysgenesis in mouse |
| Q90390767 | Prioritising downgaze alignment in the management of vertical strabismus for thyroid eye disease: principles and outcomes |
| Q47884603 | Pro-inflammatory cytokines associated with clinical severity of dry eye disease of patients with depression |
| Q72308335 | Problems posed during the management of ocular complications of diabetes |
| Q81199009 | Program helps relieve distress of age-related eye disease |
| Q69051491 | Progressive dysthyroid orbital infiltration an indication for urgent treatment in dysthyroid eye disease |
| Q51766470 | Projection of Eye Disease Burden in Singapore. |
| Q92527902 | Prospective Application of Activity-Based Proteomic Profiling in Vision Research-Potential Unique Insights into Ocular Protease Biology and Pathology |
| Q98774007 | Prospective Correlation of Risk of Obstructive Sleep Apnea With Severe Clinical Features of Thyroid Eye Disease |
| Q39744155 | Prospective Study of Eye Disease in Timor-Leste: The East Timor Eye Program |
| Q101119593 | Prospective evaluation of a new intense pulsed light, thermaeye plus, in the treatment of dry eye disease due to meibomian gland dysfunction |
| Q33650494 | Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction |
| Q94472657 | Prospective randomized study to evaluate the efficacy and tolerability of Ectoin® containing Eye Spray (EES09) and comparison to the liposomal Eye Spray Tears Again® (TA) in the treatment of dry eye disease |
| Q91289772 | Prospective, Multicenter, Cross-Sectional Survey on Dry Eye Disease in Japan |
| Q92261434 | Prostaglandin analogue drops for the treatment of soft tissue expansion and exophthalmos in patients with inactive thyroid eye disease |
| Q45785300 | Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins |
| Q96303873 | Protective effect of high-affinity liposomes encapsulating astaxanthin against corneal disorder in the in vivo rat dry eye disease model |
| Q37682939 | Proteomic analysis of tears following acupuncture treatment for menopausal dry eye disease by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry |
| Q30481543 | Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial |
| Q90179008 | Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor |
| Q93193716 | Provocation of the ocular surface to investigate the evaporative pathophysiology of dry eye disease |
| Q39711853 | Pseudoexfoliation in southern India: the Andhra Pradesh Eye Disease Study |
| Q41284221 | Pseudohallucinations in diabetic eye disease: a natural Rorschach test? |
| Q69767861 | Pseudotumorous chorioretinitis in adolescents. Clinical case report: apropos of a case of ocular toxocariasis and review of the literature |
| Q80195052 | Psoriasis and the eye: prevalence of eye disease in Singaporean Asian patients with psoriasis |
| Q35142930 | Psychiatric aspects of eye disease in the elderly. |
| Q73293657 | Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections. Herpetic Eye Disease Study Group |
| Q64055506 | Pulse Pressure and Diabetic Eye Disease |
| Q90371205 | Quality of Life in Thyroid Eye Disease: A Systematic Review |
| Q90248939 | Quality of life and patient satisfaction after submandibular gland transplantation in patients with severe dry eye disease |
| Q37849042 | Quality of life in thyroid eye disease: impact of quality of care |
| Q90350929 | Quantification of optic nerve length and tortuosity in thyroid eye disease |
| Q47253862 | Quantification of surfactant proteins in tears of patients suffering from dry eye disease compared to healthy subjects |
| Q80336527 | Questions & some answers on Graves' eye disease |
| Q84888491 | RADIUM THERAPY IN EYE DISEASE |
| Q35172880 | RNA toxicity and missplicing in the common eye disease fuchs endothelial corneal dystrophy. |
| Q64942305 | ROLE OF LOCAL PUBLIC HEALTH ORGANS IN EYE DISEASE CONTROL |
| Q91536429 | Racial and Ethnic Differences in the Association Between Diabetes Mellitus and Dry Eye Disease |
| Q38577101 | Radioactive Iodine Therapy and Thyroid Eye Disease From an Ophthalmologist's Perspective. |
| Q98905289 | Radiographic analysis of fatty infiltration of the extraocular muscles in thyroid eye disease |
| Q56091412 | Radiologic Parameters of Orbital Bone Remodeling in Thyroid Eye Disease |
| Q88714979 | Radiotherapy for Active Thyroid Eye Disease |
| Q34629319 | Radiotherapy in thyroid eye disease: the effect on the field of binocular single vision |
| Q90983824 | Randomized, Controlled, Double-Masked, Multicenter, Pilot Study Evaluating Safety and Efficacy of Intranasal Neurostimulation for Dry Eye Disease |
| Q36569538 | Randomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease |
| Q83353719 | Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease |
| Q33830753 | Ranibizumab versus bevacizumab for ophthalmic diseases related to neovascularisation: a meta-analysis of randomised controlled trials |
| Q97551429 | Rates of Eye Care and Diabetic Eye Disease Among Insured Patients with Newly-diagnosed Type 2 Diabetes |
| Q103837179 | Rationale and Methodology of The PopulatION HEalth and Eye Disease PRofile in Elderly Singaporeans Study [PIONEER] |
| Q93375597 | Rationale for 24-hour management of dry eye disease: A review |
| Q84939744 | Rationale for radiotherapy in thyroid eye disease |
| Q87023694 | Re: "Orbital Fat Decompression for Thyroid Eye Disease: Retrospective Case Review and Criteria for Optimal Case Selection" |
| Q87456389 | Re: "Reactivation of thyroid eye disease following extraocular muscle surgery" |
| Q80370740 | Re: "congenitally enlarged extraocular muscles: can congenital thyroid eye disease exist in a euthyroid infant?" |
| Q53451855 | Re: "thyroid eye disease presenting after cosmetic botulinum toxin injections". |
| Q86229346 | Re: Awh et al.: Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study (Ophthalmology 2015;122:162-9) |
| Q96619276 | Re: Goldberg et al.: A phase 3, randomized, double-masked study of OTX-101 ophthalmic solution 0.09% in the treatment of dry eye disease (Ophthalmology. 2019;126:1230-1237) |
| Q44997883 | Re: Repka: a close look at pediatric eye disease (Ophthalmology 2014;121:617-8). |
| Q89843034 | Re: Van Asten et al.: No CFH/ARMS2 interaction with omega-3 fatty acids, low vs high zinc, or β-carotene versus Lutein and Zeaxanthin on progression of age-related macular degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease |
| Q98186593 | Re: Varin et al.: Age-related eye disease and cognitive function: the search for mediators (Ophthalmology. 2020;127:660-666) |
| Q68450336 | Reactivation of latent infection and induction of recurrent herpetic eye disease in mice |
| Q86297347 | Reactivation of thyroid eye disease following extraocular muscle surgery |
| Q58713024 | Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease |
| Q93377446 | Real-world experience at a Scottish university teaching hospital regarding the tolerability and persistence with topical Ciclosporin 0.1% (Ikervis) treatment in patients with dry eye disease |
| Q64066727 | Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice |
| Q52019903 | Recall bias in a prospective cohort study of acute time-varying exposures: example from the herpetic eye disease study. |
| Q93018809 | Recent advances of exosomes in immune-mediated eye diseases |
| Q71134472 | Recent concepts in eye disease |
| Q24564205 | Recent developments in thyroid eye disease |
| Q75954601 | Recent developments in treatment of eye disease |
| Q37581630 | Recent developments on dry eye disease treatment compounds |
| Q87894332 | Rectus Muscle Resection for Vertical Strabismus in Thyroid Eye Disease |
| Q43237702 | Recurrent orbital myositis with radiological feature mimicking thyroid eye disease in a patient with Crohn's disease |
| Q35506809 | Recurrent proptosis and thyroid eye disease |
| Q37278493 | Red blood cell fatty acid analysis for determining compliance with omega3 supplements in dry eye disease trials |
| Q35579883 | Reduced Corneal Endothelial Cell Density in Patients With Dry Eye Disease |
| Q88151824 | Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease |
| Q100991529 | Reduced Global-Brain Functional Connectivity of the Cerebello-Thalamo-Cortical Network in Patients With Dry Eye Disease |
| Q87385286 | Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease |
| Q84858018 | Reducing vision loss in chronic eye disease |
| Q73570541 | Reflections on sex-related risk of eye disease |
| Q35761570 | Refractive change in thyroid eye disease (a neglected clinical sign) |
| Q39521715 | Refractive errors in an urban population in Southern India: the Andhra Pradesh Eye Disease Study. |
| Q103834419 | Refractory dry eye disease associated with Meige's syndrome induced by long-term use of an atypical antipsychotic |
| Q47984525 | Regression of severe Behcet's eye disease with infliximab therapy; .first two cases treated in Pakistan |
| Q37760696 | Regulation of the inflammatory component in chronic dry eye disease by the eye-associated lymphoid tissue (EALT). |
| Q50034049 | Relation Between Dietary Essential Fatty Acid Intake and Dry Eye Disease and Meibomian Gland Dysfunction in Postmenopausal Women. |
| Q74638513 | Relation between thyroid eye disease and type of treatment of Graves' hyperthyroidism |
| Q53292158 | Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: the Aravind Comprehensive Eye Survey. |
| Q91473182 | Reliability and validity of the Japanese version of the Ocular Surface Disease Index for dry eye disease |
| Q51852266 | Reliability of estimating ductions in thyroid eye disease: an International Thyroid Eye Disease Society multicenter study. |
| Q71042117 | Renal and eye disease |
| Q36835236 | Repeatability and Reproducibility of Noninvasive Keratograph 5M Measurements in Patients with Dry Eye Disease |
| Q94603993 | Reply re: "Association of Risk of Obstructive Sleep Apnea With Thyroid Eye Disease: Compressive Optic Neuropathy" |
| Q87456392 | Reply re: "Reactivation of thyroid eye disease following extraocular muscle surgery" |
| Q49680176 | Reply to Comment on: 'Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine'. |
| Q51796037 | Report of the TFOS/ARVO Symposium on global treatments for dry eye disease: an unmet need. |
| Q73675184 | Report on the campaign against ocular diseases in Tunis |
| Q72431510 | Reproducibility of a food frequency questionnaire for use in ocular research. Eye Disease Case-Control Study Group |
| Q78635214 | Researches into the regional distribution of eye disease |
| Q42339162 | Resolution of pinguecula-related dry eye disease after argon laser photocoagulation |
| Q57048591 | Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model |
| Q96030375 | Restoration of regulatory T cell function in dry eye disease by antagonizing substance P/neurokinin-1 receptor |
| Q55670977 | Restriction enzyme analysis of the apolipoprotein A-I gene in fish eye disease and Tangier disease |
| Q44482225 | Results of combined anti-recurrence treatment of herpetic eye disease |
| Q99569895 | Resveratrol Rescues Human Corneal Epithelial Cells Cultured in Hyperosmolar Conditions: Potential for Dry Eye Disease Treatment |
| Q26750615 | Resveratrol and Ophthalmic Diseases |
| Q35762819 | Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease |
| Q38203969 | Rethinking dry eye disease: a perspective on clinical implications |
| Q104693691 | Reticular Pseudodrusen Characteristics and Associations in the Carotenoids in Age-Related Eye Disease Study 2 (CAREDS2) |
| Q91926372 | Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies |
| Q40123386 | Retinal Vein Occlusion in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Disease Study |
| Q102073420 | Retinal vascularity, nerve fiber, and ganglion cell layer thickness in thyroid eye disease on optical coherence tomography angiography |
| Q64899282 | Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients. |
| Q61811294 | Review of Biomarkers in Ocular Matrices: Challenges and Opportunities |
| Q88431488 | Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults |
| Q35203760 | Review of findings of the Andhra Pradesh Eye Disease Study: policy implications for eye-care services |
| Q91653026 | Review of thyroid eye disease in euthyroid state with periocular mucinosis |
| Q36727726 | Review: Epigenetic mechanisms in ocular disease |
| Q27005563 | Review: magnetic resonance imaging techniques in ophthalmology |
| Q90501872 | Risk Factors for Severe Dry Eye Disease: Crowdsourced Research Using DryEyeRhythm |
| Q24545563 | Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3 |
| Q34084938 | Risk factors associated with age-related nuclear and cortical cataract : a case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5. |
| Q35523653 | Risk factors associated with childhood strabismus: the multi-ethnic pediatric eye disease and Baltimore pediatric eye disease studies |
| Q35228091 | Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32. |
| Q39737259 | Risk factors for age-related macular degeneration: findings from the Andhra Pradesh eye disease study in South India |
| Q35269567 | Risk factors for astigmatism in preschool children: the multi-ethnic pediatric eye disease and Baltimore pediatric eye disease studies |
| Q72893110 | Risk factors for branch retinal vein occlusion. The Eye Disease Case-control Study Group |
| Q71054248 | Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group |
| Q35523233 | Risk factors for decreased visual acuity in preschool children: the multi-ethnic pediatric eye disease and Baltimore pediatric eye disease studies |
| Q74566516 | Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study |
| Q37324691 | Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group |
| Q72849986 | Risk factors for idiopathic macular holes. The Eye Disease Case-Control Study Group |
| Q70686470 | Risk factors for idiopathic rhegmatogenous retinal detachment. The Eye Disease Case-Control Study Group |
| Q67803483 | Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group |
| Q60937794 | Risk factors for ocular surface damage in Mexican patients with dry eye disease: a population-based study |
| Q24554181 | Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19 |
| Q34491990 | Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25. |
| Q83768592 | Rituximab for thyroid eye disease |
| Q28081573 | Rituximab in the Treatment of Thyroid Eye Disease: A Review |
| Q84746794 | Rituximab in the treatment of thyroid eye disease: science fiction? |
| Q33818008 | Rituximab was used to treat recurrent IgG4-related hypophysitis with ophthalmopathy as the initial presentation: A case report and literature review |
| Q93016877 | Robotics and ophthalmology: Are we there yet? |
| Q92465220 | Role of advanced technology in the detection of sight-threatening eye disease in a UK community setting |
| Q38151227 | Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting |
| Q93609637 | Role of orbital radiotherapy in thyroid eye disease is controversial |
| Q90403125 | Role of tear film biomarkers in the diagnosis and management of dry eye disease |
| Q47822465 | Role of the eye muscles in thyroid eye disease: identification of the principal autoantigens. |
| Q106642523 | Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration |
| Q100639898 | Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study |
| Q103759531 | Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease |
| Q90972349 | Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease |
| Q98622520 | Safety of KPI-121 Ophthalmic Suspension 0.25% in Patients With Dry Eye Disease: A Pooled Analysis of 4 Multicenter, Randomized, Vehicle-Controlled Studies |
| Q36877000 | Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study |
| Q56940606 | Save your sight. Eye disease and HIV |
| Q94600594 | Scientia Professor Fiona Stapleton: leading academic and world-renowned epidemiologist of contact lens-related eye disease |
| Q59184135 | Screening and Managing Eye Disease in 2010: An Asian Perspective |
| Q33740180 | Screening for Diabetic Eye Disease among Samoan Adults: A Pilot Study. |
| Q73097675 | Screening for diabetic eye disease by optometrists using slit lamps |
| Q61782692 | Screening for dry eye disease using infrared ocular thermography |
| Q74594278 | Screening for eye disease |
| Q84992518 | Screening for eye disease in the elderly: is it worth it? |
| Q36728480 | Screening for eye disease in type 2 diabetes mellitus |
| Q47152094 | Screening for eye disease: Our role, responsibility and opportunity of research. |
| Q50438290 | Screening of dry eye disease in visual display terminal workers during occupational health examinations: The Moriguchi study. |
| Q40036027 | Self-Reported Type 2 Diabetes and Diabetes-Related Eye Disease in Jews and Arabs in Israel |
| Q39120932 | Self-care tools to treat depressive symptoms in patients with age-related eye disease: a randomized controlled clinical trial |
| Q51454973 | Self-reported dry eye disease across refractive modalities. |
| Q39550145 | Self-reported eye disease in elderly South Asian subjects from an inner city cluster in Bradford: a small-scale study to investigate knowledge and awareness of ocular disease |
| Q97558794 | Semi-fluorinated Alkane Eye Drops Reduce Signs and Symptoms of Evaporative Dry Eye Disease After Cataract Surgery |
| Q45952791 | Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease. |
| Q36905296 | Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool diabetic eye study |
| Q43586885 | Sensitivity and specificity of tests to detect eye disease in an older population |
| Q33409569 | Sensitivity of death certificate data for monitoring diabetes mortality--diabetic eye disease follow-up study, 1985-1990. |
| Q78810926 | Separation of the choroid following bulbar operations in an eye disease clinic in Poznan |
| Q58606862 | Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy |
| Q90372577 | Serum Vitamin D Deficiency Is an Independent Risk Factor for Thyroid Eye Disease |
| Q80767500 | Serum concentrations of interleukin (IL-)1alpha, 1beta, 6 and tumor necrosis factor (TNF-) alpha in patients with thyroid eye disease (TED) |
| Q42524978 | Serum levels of tumor necrosis factor-alpha, soluble intercellular adhesion molecule-1, soluble vascular cell adhesion molecule-1, and soluble interleukin-1 receptor antagonist in patients with thyroid eye disease undergoing treatment with somatosta |
| Q37361951 | Serum total IgG and IgG4 levels in thyroid eye disease |
| Q46730649 | Severe Pediatric Thyroid Eye Disease: Surgical Case Series |
| Q73266843 | Severe thyroid eye disease associated with primary hypothyroidism and thyroid-associated dermopathy |
| Q45771632 | Severity of experimentally reactivated herpetic eye disease is related to the neurovirulence of the latent virus. |
| Q95932675 | Severity of thyroid eye disease and type-2 diabetes mellitus: Is there a correlation? |
| Q88716938 | Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial |
| Q103018874 | Sex and age differences in symptoms and signs of dry eye disease in a Norwegian cohort of patients |
| Q38598996 | Sex differences in the effect of aging on dry eye disease |
| Q89948348 | Shining a light on thyroid eye disease |
| Q40567245 | Shopping for doctors: Thyroid eye disease patients are never satisfied. |
| Q91833183 | Short-Term Effects of Ground-Level Ozone in Patients With Dry Eye Disease: A Prospective Clinical Study |
| Q86411240 | Should we test for genotype in deciding on age-related eye disease study supplementation? |
| Q70069010 | Sickle cell eye disease |
| Q100632445 | Sight-Threatening Thyroid Eye Disease: Role of Diabetes Mellitus and Interaction with Other Risk Factors |
| Q34237548 | Sight-threatening diabetic eye disease: an update and review of the literature |
| Q81752092 | Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease |
| Q71154635 | Significance of auto-antibody determination, using Steffen's antiglobulin consumption tests in endogenic eye diseases |
| Q95652969 | Simplified Classification of Tear Film Break-Up Patterns and Their Clinicopathological Correlations in Patients With Dry Eye Disease |
| Q39722899 | Simulation of diabetic eye disease to compare screening policies |
| Q64979865 | Simulation of eye disease in virtual reality. |
| Q47548759 | Simultaneous Aesthetic Eyelid Surgery and Orbital Decompression for Rehabilitation of Thyroid Eye Disease: The One-Stage Approach |
| Q37404304 | Single Nucleotide Polymorphisms in the BDNF, VDR, and DNASE 1 Genes in Dry Eye Disease Patients: A Case-Control Study |
| Q84301352 | Sinus opacification associated with exacerbation of thyroid eye disease |
| Q78737587 | Sinusitis and eye disease |
| Q40265421 | Six-Year Incidence and Baseline Risk Factors for Pseudoexfoliation in a South Indian Population: The Chennai Eye Disease Incidence Study. |
| Q38791988 | Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study. |
| Q40140339 | Six-year incidence of angle-closure disease in a South Indian population: the Chennai Eye Disease Incidence Study |
| Q40306752 | Six-year incidence of visually significant age-related cataract: the Chennai eye disease incidence study. |
| Q36634380 | Sleep and mood disorders in dry eye disease and allied irritating ocular diseases. |
| Q93036611 | Sleep outcomes associated with dry eye disease: a systematic review and meta-analysis |
| Q36951627 | Small proline-rich protein 1B (SPRR1B) is a biomarker for squamous metaplasia in dry eye disease |
| Q36812082 | Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye disease |
| Q30826797 | Smartphone use is a risk factor for pediatric dry eye disease according to region and age: a case control study |
| Q48082167 | Smartphones, video display terminals, and dry eye disease in children |
| Q39703915 | Smoking and its association with cataract: results of the Andhra Pradesh eye disease study from India |
| Q44673700 | Snowflake vitreoretinal degeneration: follow-up of the original family |
| Q95571402 | Sodium hyaluronate eye drops in the treatment of dry eye disease: an open label, uncontrolled, multi-centre trial |
| Q49712817 | Soft Tissue Metrics in Thyroid Eye Disease: An International Thyroid Eye Disease Society Reliability Study. |
| Q71956083 | Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease |
| Q74484191 | Somatostatin receptor scintigraphy before and after treatment with somatostatin analogues in patients with thyroid eye disease |
| Q69032631 | Some aspects of Australia aboriginal eye disease |
| Q42185190 | Some aspects of eye disease in the Transkei |
| Q34633851 | Some notes on publications of Professor Arnold Sorsby and on Aland eye disease (Forsius-Eriksson syndrome) |
| Q34070100 | Spatial epidemiology of dry eye disease: findings from South Korea |
| Q59282077 | Specific attentional impairments and complex visual hallucinations in eye disease |
| Q73444127 | Spectral sensitivity in patients with dysthyroid eye disease |
| Q92642581 | Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 4. Glaucoma in people with type 2 diabetes mellitus |
| Q46111832 | Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus |
| Q63247321 | Splicing Factor Polymorphisms, the Control of VEGF Isoforms and Association with Angiogenic Eye Disease |
| Q95298630 | Spontaneous Orbital Wall Decompression in Thyroid Eye Disease: A Rare Feature |
| Q95833411 | Spontaneous orbital decompression in thyroid eye disease: new measurement methods and its influential factors |
| Q84416190 | Spontaneous orbital floor fracture in thyroid eye disease |
| Q85888634 | Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of age-related eye disease study report no. 26 |
| Q76429457 | Staining technique for anterior segment eye disease |
| Q39230626 | State of blood coagulation in vascular eye disease |
| Q26865154 | Stem cell treatment of degenerative eye disease |
| Q85193855 | Steroids in thyroid eye disease |
| Q26740005 | Stimuli-Responsive Polymeric Systems for Controlled Protein and Peptide Delivery: Future Implications for Ocular Delivery |
| Q99609068 | Strategies in Surgical Decompression for Thyroid Eye Disease |
| Q36838494 | Structural Functional Associations of the Orbit in Thyroid Eye Disease: Kalman Filters to Track Extraocular Rectal Muscles |
| Q79740749 | Structural differences between wild-type and fish eye disease mutant of lecithin:cholesterol acyltransferase |
| Q36545495 | Structure of eye disease in the Peoples' Republic of the Congo (according to data from the Brazzaville Eye Hospital in 1969) |
| Q64383073 | Studies of adenovirus-induced eye disease in the rabbit model |
| Q71721697 | Studies on high density lipoproteins in fish eye disease |
| Q81926875 | Studies probe diet's role in eye disease |
| Q95314883 | Study on the potential effective ingredients of Xiaosheng prescription for dry eye disease |
| Q46965301 | Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series |
| Q92325103 | Subcutaneous Tocilizumab for Thyroid Eye Disease: Simplified Dosing and Delivery |
| Q57299523 | Subjective versus objective dry eye disease in patients with moderate-severe thyroid eye disease |
| Q34522738 | Summary results and recommendations from the age-related eye disease study |
| Q92175539 | Superior oblique enlargement in thyroid eye disease |
| Q96957939 | Supraorbital Neuralgia Associated With Thyroid Eye Disease |
| Q39868626 | Surgical management of dysthyroid eye disease: a review |
| Q49033910 | Surgical management of vertical ocular misalignment in thyroid eye disease using an adjustable suture technique. |
| Q24234593 | Surgical orbital decompression for thyroid eye disease |
| Q24242058 | Surgical orbital decompression for thyroid eye disease |
| Q70976572 | Surgical problems in dysthyroid eye disease |
| Q67978877 | Surgical treatment of eyelid retraction associated with thyroid eye disease |
| Q90536593 | Surgical treatment of strabismus in thyroid eye disease: characteristics, dose-response, and outcomes |
| Q74638521 | Surgical treatment of thyroid eye disease |
| Q31114704 | Surveillance Tools Emerging From Search Engines and Social Media Data for Determining Eye Disease Patterns |
| Q67266023 | Survey of conjunctival flora in dogs with clinical signs of external eye disease |
| Q92986359 | Survey of practice patterns for the management of ophthalmic genetic disorders among AAPOS members: report by the AAPOS Genetic Eye Disease Task Force |
| Q101051525 | Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial |
| Q35070541 | Symptom burden of patients with dry eye disease: a four domain analysis |
| Q36197724 | Symptoms of Dry Eye Disease and Personality Traits |
| Q44556384 | Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomised pilot study |
| Q62417799 | Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease |
| Q47133516 | Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome |
| Q36732736 | Systematic screening for diabetic eye disease in insulin dependent diabetes |
| Q73900813 | Systematic screening for diabetic eye disease is cost effective |
| Q93644008 | Systematic screening for diabetic eye disease is cost effective |
| Q92959074 | Systemic Determinants of Peripapillary Vessel Density in Healthy African Americans: The African American Eye Disease Study |
| Q92081741 | Systemic risk factors of dry eye disease subtypes: A New Zealand cross-sectional study |
| Q34687332 | Systemic therapies for inflammatory eye disease: past, present and future |
| Q38172090 | Systemic treatments for noninfectious vitreous inflammation |
| Q33484488 | Sándor Petöfi, his eyes, eye disease and death |
| Q37686712 | T Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Contributes to Dry Eye Disease Pathogenesis by Promoting CD11b+ Myeloid Cell Maturation and Migration |
| Q37374838 | T helper cytokines in dry eye disease |
| Q38238831 | T helper subsets in allergic eye disease |
| Q74075312 | T-cell cytokines in chronic allergic eye disease |
| Q63387336 | T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study |
| Q39846820 | THE INCIDENCE OF EYE DISEASE IN THE AUSTRALIAN IMPERIAL FORCES, MIDDLE EAST. |
| Q78295243 | THE TREATMENT OF EYE DISEASE UNDER EXCEPTIONAL CIRCUMSTANCES |
| Q84921905 | TREATMENT OF EYE DISEASE BY TUBERCULIN |
| Q94199228 | TREATMENT OF EYE DISEASE BY TUBERCULIN |
| Q55416342 | TREATMENT OF EYE DISEASE BY TUBERCULIN. |
| Q47138569 | TRI Microspheres prevent key signs of dry eye disease in a murine, inflammatory model. |
| Q102333173 | TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease |
| Q90770967 | TSHR Signaling Stimulates Proliferation Through PI3K/Akt and Induction of miR-146a and miR-155 in Thyroid Eye Disease Orbital Fibroblasts |
| Q90285262 | Targeting connexin hemichannels to control the inflammasome: the correlation between connexin43 and NLRP3 expression in chronic eye disease |
| Q92421175 | Tear Film Extensional Viscosity Is a Novel Potential Biomarker of Dry Eye Disease |
| Q41181275 | Tear Film Steroid Profiling in Dry Eye Disease by Liquid Chromatography Tandem Mass Spectrometry. |
| Q91295647 | Tear Production Levels and Dry Eye Disease Severity in a Large Norwegian Cohort |
| Q59337066 | Tear Proteins Calcium binding protein A4 (S100A4) and Prolactin Induced Protein (PIP) are Potential Biomarkers for Thyroid Eye Disease |
| Q64249310 | Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease |
| Q104748882 | Tear Proteomics Study of Dry Eye Disease: Which Eye Do You Adopt as the Representative Eye for the Study? |
| Q33869200 | Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease |
| Q36257052 | Tear film osmolarity and dry eye disease: a review of the literature |
| Q48222071 | Tear film osmolarity measurements in dry eye disease using electrical impedance technology |
| Q37386334 | Tear fluid extracellular DNA: diagnostic and therapeutic implications in dry eye disease |
| Q92578725 | Tear inflammatory cytokines and ocular surface changes in patients with active thyroid eye disease treated with high-dose intravenous glucocorticoids |
| Q43099149 | Tear osmolarity as a biomarker for dry eye disease severity |
| Q83395082 | Tear osmolarity in the diagnosis and management of dry eye disease |
| Q81899031 | Tears hold clues to eye disease |
| Q91338431 | Temporal Fat Pad Volume in Patients With Thyroid Eye Disease |
| Q39280720 | Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36. |
| Q51210154 | Ten-year incidence rates of age-related cataract in the Age-Related Eye Disease Study (AREDS): AREDS report no. 33. |
| Q83422539 | Tenon recession: a novel adjunct to improve outcome in the treatment of large-angle strabismus in thyroid eye disease |
| Q94660037 | Teprotumumab for Active Thyroid Eye Disease |
| Q104057899 | Teprotumumab for Optic Neuropathy in Thyroid Eye Disease |
| Q90605597 | Teprotumumab for Thyroid Eye Disease |
| Q102320345 | Teprotumumab for non-inflammatory thyroid eye disease (TED): evidence for increased IGF-1R expression |
| Q92873427 | Teprotumumab for the Treatment of Active Thyroid Eye Disease |
| Q97686436 | Teprotumumab for the treatment of thyroid eye disease |
| Q101563424 | Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease |
| Q90695307 | Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis |
| Q47868108 | Testability of refraction, stereopsis, and other ocular measures in preschool children: the Sydney Paediatric Eye Disease Study |
| Q36844395 | Testability of the Retinomax autorefractor and IOLMaster in preschool children: the Multi-ethnic Pediatric Eye Disease Study |
| Q53425391 | The African American Eye Disease Study: Design and Methods. |
| Q88039741 | The AgED Study. Age-related eye disease (AgED) in South Australian general practice: are we blind to early detection and intervention? |
| Q39092535 | The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration |
| Q34655539 | The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. |
| Q36360812 | The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) |
| Q34653094 | The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17 |
| Q43796210 | The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. |
| Q34651797 | The Age-Related Eye Disease Study: a clinical trial of zinc and antioxidants--Age-Related Eye Disease Study Report No. 2 |
| Q34590930 | The Association between Dry Eye Disease and Physical Activity as well as Sedentary Behavior: Results from the Osaka Study |
| Q102386671 | The Association between Tear Film Thickness as Measured with OCT and Symptoms and Signs of Dry Eye Disease: A Pooled Analysis of 6 Clinical Trials |
| Q92262996 | The Association of Aspirin Use with Age-Related Macular Degeneration Progression in the Age-Related Eye Disease Studies: Age-Related Eye Disease Study 2 Report No. 20 |
| Q35798037 | The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37 |
| Q36315753 | The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9 |
| Q36801014 | The British Asian community eye study: outline of results on the prevalence of eye disease in British Asians with origins from the Indian subcontinent |
| Q91521307 | The Case for a More Holistic Approach to Dry Eye Disease: Is It Time to Move beyond Antibiotics? |
| Q96118264 | The Development of Dry Eye Disease After Surgery-Indicated Chronic Rhinosinusitis: A Population-Based Cohort Study |
| Q92698972 | The Dry Eye Assessment and Management (DREAM) extension study - A randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease |
| Q71763927 | The EOG in unilateral eye disease: injuries |
| Q33838529 | The Effect of Dry Eye Disease on Scar Formation in Rabbit Glaucoma Filtration Surgery |
| Q58722677 | The Effect of Lutein on Eye and Extra-Eye Health |
| Q54696748 | The Effect of Topical Ocular Anesthetic Proparacaine on Conjunctival and Nasal Mucosal Flora in Dry Eye Disease Patients. |
| Q95270526 | The Efficacy and Safety of Qiming Granule for Dry Eye Disease: A Systematic Review and Meta-Analysis |
| Q93155581 | The Efficacy of 2% Topical Rebamipide on Conjunctival Squamous Metaplasia and Goblet Cell Density in Dry Eye Disease |
| Q95841005 | The Efficacy of Intense Pulsed Light Combined With Meibomian Gland Expression for the Treatment of Dry Eye Disease Due to Meibomian Gland Dysfunction: A Multicenter, Randomized Controlled Trial |
| Q93617719 | The Epidemiology of Eye Disease |
| Q93617629 | The Epidemology of Eye Disease Second Edition |
| Q48743888 | The Eye Book of Master Peter of Spain--a glimpse of diagnosis and treatment of eye disease in the Middle Ages. |
| Q55515186 | The Eye, Oxidative Damage and Polyunsaturated Fatty Acids. |
| Q101223105 | The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial |
| Q90572961 | The Herpetic Eye Disease Study: Topical Corticosteroid Trial for Herpes Simplex Stromal Keratitis: A Paradigm Shifting Clinical Trial |
| Q77172629 | The Human Genome Project and eye disease: clinical implications |
| Q90351231 | The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options |
| Q91185858 | The Important Role of the Chemokine Axis CCR7-CCL19 and CCR7-CCL21 in the Pathophysiology of the Immuno-inflammatory Response in Dry Eye Disease |
| Q89467743 | The Indian Health Service Primary Care-Based Teleophthalmology Program for Diabetic Eye Disease Surveillance and Management |
| Q91798266 | The Lacritin-Syndecan-1-Heparanase Axis in Dry Eye Disease |
| Q43752708 | The NEI VFQ-25 vision-related quality of life and prevalence of eye disease in a working population |
| Q33624678 | The Nakuru eye disease cohort study: methodology & rationale |
| Q42488956 | The Nambour Skin Cancer and Actinic Eye Disease Prevention Trial: design and baseline characteristics of participants |
| Q79296259 | The National Eye Health Education Program: increasing awareness of diabetic eye disease among American Indians and Alaska Natives |
| Q91870125 | The Negative Effects of Dry Eye Disease on Quality of Life and Visual Function |
| Q58347916 | The Ocular Genetics Program: multidisciplinary care of patients with ocular genetic eye disease |
| Q93343260 | The Ocular Surface Glycocalyx and its Alteration in Dry Eye Disease: A Review |
| Q47884949 | The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research |
| Q57254188 | The Pavagada Pediatric Eye Disease Study: Objectives, Methodology and Participant Characteristics |
| Q73383499 | The Pediatric Eye Disease Investigator Group |
| Q86735376 | The Portable Eye Examination Kit: Mobile phones can screen for eye disease in low-resource settings |
| Q101051568 | The Prevalence and Incidence of Dry Eye Disease Among Patients Using Continuous Positive Airway Pressure or Other Nasal Mask Therapy Devices to Treat Sleep Apnea |
| Q40142329 | The Prevalence of Age-Related Eye Disease in an Elderly Population |
| Q33555489 | The Prevalence of Depression and Depressive Symptoms among Eye Disease Patients: A Systematic Review and Meta-analysis |
| Q47952058 | The Psychosocial and Clinical Outcomes of Orbital Decompression Surgery for Thyroid Eye Disease and Predictors of Change in Quality of Life |
| Q60929923 | The Relationship of Dry Eye Disease with Depression and Anxiety: A Naturalistic Observational Study |
| Q96810373 | The Role Of Nano- Ophthalmology In Treating Dry Eye Disease |
| Q38849908 | The Role of Biological Agents and Immunomodulators in Treatment Strategies for Thyroid Eye Disease: An Evidence-based Review |
| Q35775758 | The Role of the Immune Response in the Pathogenesis of Thyroid Eye Disease: A Reassessment. |
| Q26765813 | The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults |
| Q72459779 | The STIR sequence MRI in the assessment of extraocular muscles in thyroid eye disease |
| Q42962924 | The Sinuses in Relation to Eye Disease: (Section of Laryngology and Section of Otology). |
| Q59699041 | The Wills eye manual: office and emergency room diagnosis and treatment of eye disease |
| Q36076822 | The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4. |
| Q34527527 | The age-related eye disease study (AREDS). |
| Q43965178 | The age-related eye disease study: the results of the clinical trial |
| Q98568462 | The applications of androgen in the treatment of dry eye disease: a systematic review of clinical studies |
| Q98196752 | The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-κB/NLRP3 signaling |
| Q35085765 | The association between dry eye disease and depression and anxiety in a large population-based study |
| Q33689141 | The association between nuclear receptors and ocular diseases |
| Q50900703 | The association of iris color with eye disease in diabetes. |
| Q28601496 | The association of sleep quality with dry eye disease: the Osaka study |
| Q33644688 | The burden of genetically determined eye disease |
| Q70142043 | The challenge of eye disease: the patient's perspective |
| Q97643528 | The closed eye harbours a unique microbiome in dry eye disease |
| Q71936746 | The continuing impact of treatment of eye disease on optometric practice in Missouri |
| Q34510429 | The core mechanism of dry eye disease is inflammation |
| Q81510853 | The cost of immunosuppressive therapies currently used in patients with thyroid eye disease |
| Q67575021 | The current management of herpetic eye disease |
| Q80347907 | The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) |
| Q88629268 | The development of dry eye disease during tenofovir and entecavir therapy in a patient with chronic hepatitis B |
| Q41313657 | The dimensions of the problem of eye disease among the elderly |
| Q55527700 | The dry eye disease activity log study. |
| Q34147677 | The economic burden of dry eye disease in the United States: a decision tree analysis |
| Q88097638 | The effect of antihypertensive therapy on dry eye disease |
| Q81154741 | The effect of autologous serum eye drops in the treatment of severe dry eye disease: a prospective randomized case-control study |
| Q45284543 | The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study |
| Q50524947 | The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy. |
| Q101127834 | The effect of eye disease, cataract surgery and hearing aid use on multisensory integration in ageing |
| Q34623556 | The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7. |
| Q86273524 | The effect of intensive education on concordance with the Age-Related Eye Disease Study (AREDS) recommendations in a tertiary referral practice |
| Q80283010 | The effect of long-term somatostatin analogue treatment on free and total insulin-like growth factor (IGF) -I, -II and IGF binding protein -1, -2 and -3 serum levels in euthyroid patients with active thyroid eye disease |
| Q51337996 | The effect of low vision rehabilitation in diabetic eye disease: a randomised controlled trial protocol. |
| Q90741414 | The effect of oral statin therapy on strabismus in patients with thyroid eye disease |
| Q84589522 | The effect of orbital decompression surgery on lid retraction in thyroid eye disease |
| Q69610662 | The effects of Graves' eye disease on levator muscle function |
| Q35676374 | The effects of PEP-1-FK506BP on dry eye disease in a rat model |
| Q90418082 | The efficacy and safety of qiming granule in dry eye disease: Protocol for systematic review and meta-analysis |
| Q50480678 | The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjögren's syndrome. |
| Q52589503 | The emerging role of fibrocytes in ocular disorders. |
| Q90574553 | The epidemiological characteristics of patients with thyroid eye disease in a referral center in northern Iran |
| Q80347909 | The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007) |
| Q36459984 | The epidemiology of eye disease: from glycemia to genetics: the Friedenwald Lecture |
| Q38258487 | The epidemiology of herpes simplex virus eye disease in Northern California |
| Q59689212 | The evaluation of dry eye mobile apps for screening of dry eye disease and educational tear event in Japan |
| Q71972591 | The eye and diabetes |
| Q36806038 | The eye and the heart |
| Q48290530 | The eye as a complement dysregulation hotspot. |
| Q52449729 | The eye disease leading to Blindness in Miklós Wesselényi |
| Q89250740 | The eye disease of Jean-Paul Sartre and its impact on his literary work |
| Q84895849 | The eye disease of Jefferson Davis (1808-1889) |
| Q30358354 | The eye disease of Jefferson Davis (1808-1889). |
| Q40892738 | The eye disease of Nietzsche |
| Q58582378 | The feasibility of finger prick autologous blood (FAB) as a novel treatment for severe dry eye disease (DED): protocol for a randomised controlled trial |
| Q79360302 | The features of dry eye disease in a Japanese elderly population |
| Q53684503 | The function and morphology of Meibomian glands in patients with thyroid eye disease: a preliminary study. |
| Q93196098 | The functions of IL-23 and IL-2 on driving autoimmune effector T-helper 17 cells into the memory pool in dry eye disease |
| Q41587391 | The genes of eye disease: the light beckons. |
| Q34511150 | The heritability of dry eye disease in a female twin cohort |
| Q68928777 | The herpetic Eye Disease Study |
| Q90586597 | The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease |
| Q44025895 | The impact of dry eye disease on visual performance while driving |
| Q93007707 | The impact of dry eye disease treatment on patient satisfaction and quality of life: A review |
| Q33808781 | The impact of the herpetic eye disease studies on the management of herpes simplex virus ocular infections |
| Q51729788 | The impact of thyroid eye disease upon patients' wellbeing: a qualitative analysis. |
| Q72789837 | The impact of treatment of eye disease on optometric practice in Missouri |
| Q77603672 | The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner-city district of North London: a quality of care study |
| Q80750228 | The incidence and clinical characteristics of the immune phase eye disease in treated cases of human leptospirosis |
| Q35598760 | The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic review |
| Q46885632 | The incidence of eye disease in dogs in a veterinary academic hospital: 1772 cases. |
| Q44300237 | The influence of benign essential blepharospasm on dry eye disease and ocular inflammation |
| Q35795205 | The influence of eye disease on pictorial art |
| Q83278155 | The inheritance of blindness: The contribution of eugenics to the reduction of eye disease |
| Q28280484 | The isolation and characterisation of a cDNA clone for human lecithin:cholesterol acyl transferase and its use to analyse the genes in patients with LCAT deficiency and fish eye disease |
| Q36678974 | The management of diabetic eye disease in the setting of cataract surgery |
| Q37884063 | The management of patients with thyroid eye disease after bilateral orbital 3 wall decompression |
| Q46404093 | The multi-ethnic pediatric eye disease study: design and methods |
| Q54626696 | The natural history of infantile esotropia during the first six months of life. Pediatric Eye Disease Investigator Group. |
| Q70297149 | The normalisation of blood glucose levels in patients with diabetic eye disease |
| Q36439938 | The pathophysiology of thyroid eye disease: implications for immunotherapy. |
| Q28083825 | The pathophysiology, diagnosis, and treatment of dry eye disease |
| Q43579038 | The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey |
| Q80945613 | The pediatric eye disease investigator group report may be too optimistic about efficacy of treatment |
| Q47629243 | The potential influence of Schirmer strip variables on dry eye disease characterisation, and on tear collection and analysis. |
| Q72418789 | The prevalence of eye disease in Leicester: a comparison of adults of Asian and European descent |
| Q57950964 | The prevalence of eye disease in elderly Bengalis in Tower Hamlets |
| Q35890529 | The prevalence of eye disease in nursing home and non-nursing home geriatric populations |
| Q97559530 | The prevalence of keratoconus in children with allergic eye disease in an Egyptian population |
| Q67349270 | The progression of sickle cell eye disease in Jamaica |
| Q42621926 | The relation of retinal microvascular characteristics to age-related eye disease: the Beaver Dam eye study |
| Q33895382 | The relationship between sex and symmetry in thyroid eye disease |
| Q90918494 | The relationship between thyroid eye disease and radioiodine treatment |
| Q40259710 | The reliability of anterior segment lesions as indicators of onchocercal eye disease in Guatemala. |
| Q35848378 | The role of central reading centers--current practices and future directions |
| Q37094617 | The role of complement in ocular pathology |
| Q39234554 | The role of flies in the transmission of eye disease in Egypt |
| Q92596861 | The role of inflammation in diabetic eye disease |
| Q37002600 | The role of lutein in eye-related disease |
| Q33608865 | The role of octreoscan in thyroid eye disease |
| Q34402169 | The role of optometrists in India: an integral part of an eye health team |
| Q35676411 | The role of thyroid eye disease and other factors in the overcorrection of hypotropia following unilateral adjustable suture recession of the inferior rectus (an American Ophthalmological Society thesis) |
| Q27013836 | The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review |
| Q49836067 | The scientific dry eye disease journey: From the beginning to the end of the beginning. |
| Q72271164 | The site of the autoantigen in dysthyroid eye disease: a significant negative |
| Q51547365 | The spectrum of eye disease in children with AIDS due to vertically transmitted HIV disease: clinical findings, virology and recommendations for surveillance. |
| Q38184669 | The spectrum of eye disease in hospitalized adults living with HIV, 1995-2010. |
| Q73674635 | The successful treatment of chronic eye disease by prolonged individualized administration of long-acting corticotropin |
| Q66980946 | The treatment of advanced diabetic eye disease |
| Q53836766 | The treatment of allergic eye disease: has sodium cromoglycate had its day? |
| Q61810601 | The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice |
| Q91591241 | The utility of a normal tear osmolarity test in patients presenting with dry eye disease like symptoms: A prospective analysis |
| Q92004595 | Therapeutic Challenges and Prognosis of Descemet's Membrane Endothelial Keratoplasty in Herpes Simplex Eye Disease |
| Q99548568 | Therapeutic Effects of Lactoferrin in Ocular Diseases: From Dry Eye Disease to Infections |
| Q38372075 | Therapeutic Efficacy of Nanocomplex of Poly(Ethylene Glycol) and Catechin for Dry Eye Disease in a Mouse Model |
| Q94683947 | Therapeutic benefits of blinking exercises in dry eye disease |
| Q57213056 | Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease |
| Q85304132 | There are people in Australia who have poor vision or eye disease that is avoidable. What more can we do? |
| Q89545046 | Thickness of Retro- and Sub-Orbicularis Oculi Fat in Thyroid Eye Disease: Comparison With Controls and Its Influential Factors |
| Q38543986 | Thrombospondin-1 as a Regulator of Corneal Inflammation and Lymphangiogenesis: Effects on Dry Eye Disease and Corneal Graft Immunology |
| Q73239445 | Thyroid Eye Disease |
| Q88014940 | Thyroid Eye Disease With Significant Levator Involvement and Ptosis: A Case Report |
| Q92983283 | Thyroid Eye Disease and Myasthenia Gravis |
| Q89885055 | Thyroid Eye Disease due to Immune Reconstitution Inflammatory Syndrome as a Consequence of Antiretroviral Therapy in the Setting of AIDS |
| Q92912364 | Thyroid Eye Disease in Hashimoto Ataxia |
| Q91789199 | Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm |
| Q38655641 | Thyroid Eye Disease: Optic Neuropathy and Orbital Decompression |
| Q68582277 | Thyroid eye disease |
| Q68635892 | Thyroid eye disease |
| Q69057968 | Thyroid eye disease |
| Q71928257 | Thyroid eye disease |
| Q72870703 | Thyroid eye disease |
| Q80927662 | Thyroid eye disease |
| Q83446693 | Thyroid eye disease |
| Q84575063 | Thyroid eye disease |
| Q84751831 | Thyroid eye disease |
| Q85133964 | Thyroid eye disease |
| Q86426993 | Thyroid eye disease |
| Q86525873 | Thyroid eye disease |
| Q93629753 | Thyroid eye disease |
| Q72603356 | Thyroid eye disease (TED)--a current understanding |
| Q44674925 | Thyroid eye disease and glaucoma |
| Q39885055 | Thyroid eye disease and its relationship to the long-acting thyroid stimulator |
| Q71851471 | Thyroid eye disease and normal computerized tomography |
| Q43093160 | Thyroid eye disease associated with athyria |
| Q38218334 | Thyroid eye disease for the primary care physician. |
| Q104491578 | Thyroid eye disease in New Zealand: interaction between ethnicity and smoking status |
| Q32061134 | Thyroid eye disease in children and adolescents--new therapeutic approaches |
| Q43477922 | Thyroid eye disease presenting after cataract surgery. |
| Q53519693 | Thyroid eye disease presenting after cosmetic botulinum toxin injections. |
| Q91774131 | Thyroid eye disease presenting with superior rectus/levator complex enlargement |
| Q97692339 | Thyroid eye disease survey: An anonymous web-based survey in the Indian subcontinent |
| Q93191237 | Thyroid eye disease with choroidal folds |
| Q48818966 | Thyroid eye disease: a Southeast Asian experience. |
| Q39937606 | Thyroid eye disease: a historical perspective |
| Q38971992 | Thyroid eye disease: a review |
| Q43008468 | Thyroid eye disease: an unusual presentation |
| Q92530028 | Thyroid eye disease: current and potential medical management |
| Q37805027 | Thyroid eye disease: honing your skills to improve outcomes |
| Q37639036 | Thyroid eye disease: pathogenesis and treatment |
| Q37962365 | Thyroid eye disease: review and case reports. |
| Q38211350 | Thyroid eye disease: therapy in the active phase |
| Q85899653 | Thyroid eye disease: therapy in the active phase: a comment |
| Q85899655 | Thyroid eye disease: therapy in the active phase: a comment: reply |
| Q37987063 | Thyroid eye disease: towards an evidence base for treatment in the 21st century |
| Q57128986 | Thyroid eye disease: what is new to know? |
| Q68310605 | Thyroid-associated eye disease |
| Q36500196 | Thyroid-associated eye disease: clinical management |
| Q36500180 | Thyroid-associated eye disease: pathophysiology |
| Q70195930 | Tobramycin in external eye disease: a double-masked study vs. gentamicin |
| Q93333216 | Tocilizumab for thyroid eye disease |
| Q94355143 | Tocilizumab for thyroid eye disease |
| Q48168317 | Tofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease: results from a phase 1/2 trial |
| Q57816711 | Tolerance Induction in Relation to the Eye |
| Q82591852 | Tonopen versus Goldmann applanation tonometry for detecting restrictive thyroid eye disease |
| Q90428223 | Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease |
| Q90870466 | Topical Quercetin and Resveratrol Protect the Ocular Surface in Experimental Dry Eye Disease |
| Q24563932 | Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease |
| Q74310551 | Topical antibiotics in eye disease |
| Q54002098 | Topical compound F in the treatment of anterior segment eye disease; a preliminary report. |
| Q73978099 | Topical cortisone in eye disease |
| Q75660396 | Topical cortisone in eye disease |
| Q75688737 | Topical cortisone in the treatment of anterior-segment eye disease |
| Q43087530 | Topical cyclosporine 0.05% for the prevention of dry eye disease progression |
| Q46179946 | Topical cyclosporine for severe dry eye disease in liver-transplanted Portuguese patients with familial amyloidotic polyneuropathy (ATTRV30M). |
| Q34206399 | Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial. |
| Q50025206 | Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program. |
| Q105789418 | Topotecan Episcleral Plaque for Treatment of Retinoblastoma |
| Q36922666 | Total cholesterol and lipoprotein composition are associated with dry eye disease in Korean women. |
| Q35176354 | Toward a better understanding of human eye disease insights from the zebrafish, Danio rerio. |
| Q54027033 | Trachoma and Other Eye Disease in a New Guinea Village |
| Q98883641 | Traditional Chinese medicine Xiaosheng Powder for dry eye disease: A protocol for systematic review and meta analysis |
| Q69058251 | Transantral orbital decompression in dysthyroid eye disease |
| Q55016513 | Transcriptome Analysis of Orbital Adipose Tissue in Active Thyroid Eye Disease Using Next Generation RNA Sequencing Technology. |
| Q47222550 | Translation and validation of the Portuguese version of a dry eye disease symptom questionnaire |
| Q91632324 | Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease |
| Q92258476 | Treatment Trends in Dry Eye Disease and Factors Associated with Ophthalmic Follow-up Discontinuation in Japan |
| Q47155411 | Treatment of Dry Eye Disease with Autologous Platelet-Rich Plasma: A Prospective, Interventional, Non-Randomized Study. |
| Q88878935 | Treatment of Geographic Atrophy with Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study |
| Q99372622 | Treatment of corticosteroid-resistant thyroid eye disease with subcutaneous tocilizumab |
| Q78137517 | Treatment of diabetic eye disease |
| Q37317581 | Treatment of dry eye disease by the non-ophthalmologist |
| Q38012490 | Treatment of severe inflammatory eye disease in patients of reproductive age and during pregnancy |
| Q45852178 | Treatment of severe thyroid eye disease: a survey of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS). |
| Q85032350 | Treatment of thyroid eye disease |
| Q74228903 | Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection |
| Q44915960 | Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study |
| Q30317472 | Trefoil factor family peptide 3 (TFF3) is upregulated under experimental conditions similar to dry eye disease and supports corneal wound healing effects in vitro |
| Q36505637 | Trends and topics in eye disease research in PubMed from 2010 to 2014. |
| Q102069803 | Trends in Treatment of Active, Moderate-to-Severe Thyroid Eye Disease in the United States |
| Q55518081 | Tribal Odisha Eye Disease Study (TOES # 2) Rayagada school screening program: efficacy of multistage screening of school teachers in detection of impaired vision and other ocular anomalies. |
| Q92767509 | Tribal Odisha Eye Disease Study Report # 6. Opportunistic screening of vitamin A deficiency through School Sight Program in tribal Odisha (India) |
| Q80664467 | Turmeric, haldi or haridra, in eye disease |
| Q37251005 | Turn-over orbital septal flap and levator recession for upper-eyelid retraction secondary to thyroid eye disease |
| Q72135005 | Twin studies in ophthalmology. Hereditary and environmental determinants of eye disease |
| Q85960528 | Twin study implicates genetic factors in dry eye disease |
| Q36906345 | Two Patients with Dry Eye Disease Followed Up Using an Expression Assay of Ocular Surface Mucin |
| Q49545554 | US's $2bn annual spend on dry eye disease "brings tears to your eyes," say critics. |
| Q83377615 | Ultrasonic bone removal versus high-speed burring for lateral orbital decompression: comparison of surgical outcomes for the treatment of thyroid eye disease |
| Q37995705 | Understanding dry eye disease: a managed care perspective |
| Q37210882 | Understanding the true burden of dry eye disease |
| Q39395740 | Undetected eye disease in a primary care clinic population |
| Q34747393 | Unilateral proptosis in thyroid eye disease with subsequent contralateral involvement: retrospective follow-up study |
| Q71736454 | Uniocular fields of fixation in thyroid eye disease |
| Q97559397 | Unique corneal tomography features of allergic eye disease identified by OCT imaging and artificial intelligence |
| Q61953700 | United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: report 4, real-world data on the impact of deprivation on the presentation of diabetic eye disease at hospital services |
| Q86693751 | Unmasking Bilateral Inferior Rectus Restriction in Thyroid Eye Disease: Using Degree of Cyclotropia |
| Q33819490 | Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease |
| Q54397482 | Unusual clinical presentations of new-onset herpetic eye disease after ocular surgery. |
| Q73105850 | Unusual family history of eye disease |
| Q47094242 | Update on retinal vascular caliber |
| Q91322421 | Update on the association between dry eye disease and meibomian gland dysfunction |
| Q91951738 | Update on the clinical assessment and management of thyroid eye disease |
| Q37406589 | Update on thyroid eye disease and management. |
| Q100424763 | Updated definition and classification of dry eye disease: Renewed proposals using the nominal group and Delphi techniques |
| Q39345787 | Updates in ophthalmic pathology |
| Q37462942 | Use of Cooking Fuels and Cataract in a Population-Based Study: The India Eye Disease Study |
| Q91008869 | Use of anti-vascular endothelial growth factor drugs for eye disease in Tuscany: Development and test of indicators of treatment intensity |
| Q100551871 | Using Medical Big Data to Develop Personalized Medicine for Dry Eye Disease |
| Q35311666 | Utilisation of eyecare services in an urban population in southern India: the Andhra Pradesh eye disease study |
| Q79839756 | Utility assessment and dry eye disease |
| Q90696025 | Utility of Tear Osmolarity Measurement in Diagnosis of Dry Eye Disease |
| Q69034964 | VI meeting of the International Society of Genetic Eye Disease and the III International Symposium on Retinoblastoma. May 1-3, 1986, Amsterdam, The Netherlands. Proceedings |
| Q61931345 | VISUAL HALLUCINATIONS IN DEMENTIA: PRELIMINARY FINDINGS FROM THE STUDY OF HALLUCINATIONS IN PARKINSON’S DISEASE, EYE DISEASE AND DEMENTIA (SHAPED) |
| Q30979930 | Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy |
| Q100513668 | Validation of a Novel Confocal Microscopy Imaging Protocol With Assessment of Reproducibility and Comparison of Nerve Metrics in Dry Eye Disease Compared With Controls |
| Q34248532 | Validity of self-reported eye disease and treatment in a population-based study: the Los Angeles Latino Eye Study |
| Q84568692 | Validity of self-reported eye disease and treatment: is that correct?! |
| Q41913821 | Validity of subjective assessment as screening tool for dry eye disease and its association with clinical tests |
| Q91927307 | Variability of Dry Eye Disease Following Removal of Lacrimal Glands in Rats |
| Q50712306 | Vernal eye disease in Northern Nigeria |
| Q38179488 | Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes |
| Q90385181 | Vertical rectus muscle recession versus combined vertical and horizontal rectus muscle recession in patients with thyroid eye disease and hypotropia |
| Q52688144 | Very long-chain tear film lipids produced by fatty acid elongase ELOVL1 prevent dry eye disease in mice. |
| Q34790989 | Veteran eye disease after eligibility reform: prevalence and characteristics |
| Q92305676 | Video interpretation and diagnosis of pediatric amblyopia and eye disease |
| Q104479893 | Visible Meibomian Gland Structure Increases After Vectored Thermal Pulsation Treatment in Dry Eye Disease Patients with Meibomian Gland Dysfunction |
| Q30872452 | Vision and vision-related outcome measures in multiple sclerosis |
| Q74796037 | Vision impairment, eye disease, and injurious motor vehicle crashes in the elderly |
| Q46835440 | Vision, eye disease, and art. |
| Q36605662 | Vision, eye disease, and art: 2015 Keeler Lecture |
| Q27030557 | Vision-related research priorities and how to finance them |
| Q56978743 | Visions of Eye Commensals: The Known and the Unknown About How the Microbiome Affects Eye Disease |
| Q92506860 | Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19 |
| Q40076543 | Visual Hallucinations in Eye Disease and Lewy Body Disease |
| Q33717538 | Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5. |
| Q57415647 | Visual acuity and its relationship to early growth, eye disease, and aging in North Hertfordshire |
| Q88897499 | Visual acuity and quality of life in dry eye disease: Proceedings of the OCEAN group meeting |
| Q24656042 | Visual acuity norms in pre-school children: the Multi-Ethnic Pediatric Eye Disease Study |
| Q34493282 | Visual acuity outcomes after cataract surgery in patients with age-related macular degeneration: age-related eye disease study report no. 27 |
| Q36093247 | Visual acuity testability and comparability in Australian preschool children: the Sydney Paediatric Eye Disease Study |
| Q36176725 | Visual acuity testability in African-American and Hispanic children: the multi-ethnic pediatric eye disease study |
| Q67824105 | Visual evoked potentials: the theoretical bases and principles for the practical use of the method in the eye disease clinic |
| Q91774223 | Visual field and orbital computed tomography correlation in dysthyroid optic neuropathy due to thyroid eye disease |
| Q50505523 | Visual function tests, eye disease and symptoms of visual disability: a population-based assessment. |
| Q71352524 | Visual hallucinations in eye disease |
| Q30432438 | Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease |
| Q97692354 | Visual morbidity in thyroid eye disease in Asian Indian patients |
| Q73689578 | Visual outcome with the array multifocal intraocular lens in patients with concurrent eye disease |
| Q70995981 | Vitamin A deficiency and associated eye disease |
| Q40781621 | Vitamin A-Deficiency Eye Disease Among Soldiers in the U.S. Civil War: Spectrum of Clinical Disease |
| Q50796566 | Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain. |
| Q90369194 | Vitamin D Enhances the Efficacy of Topical Artificial Tears in Patients With Dry Eye Disease |
| Q91333200 | Vitamin D and Selenium in a Thyroid Eye Disease Population in Texas |
| Q81522060 | Vitamin E and the age-related eye disease study supplementation for age-related macular degeneration |
| Q70266157 | Vitrectomy for diabetic eye disease |
| Q72016794 | Vitrectomy for severe diabetic eye disease |
| Q31039924 | Vitrectomy in the management of diabetic eye disease |
| Q37883492 | Vitreous cavity haemorrhage post-vitrectomy for diabetic eye disease: the effect of perioperative anticoagulation and antiplatelet agents |
| Q38051291 | Vitreous diagnosis in neoplastic diseases. |
| Q93343148 | What We Know About the Epidemiology of Dry Eye Disease in Japan |
| Q30597458 | What's on TV? Detecting age-related neurodegenerative eye disease using eye movement scanpaths |
| Q71914136 | When to use topical steroids in the treatment of eye disease |
| Q89783334 | Why Internists Should Care About Dry Eye Disease |
| Q39233800 | Why the NOSPECS classification of Graves' eye disease should be abandoned, with suggestions for the characterization of this disease |
| Q102997928 | Why the symptoms and objective signs of dry eye disease may not correlate |
| Q84049025 | Why using Avastin for eye disease is so difficult |
| Q83645366 | Work productivity loss in patients with dry eye disease: an online survey |
| Q82441523 | Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 49 Tunisian cases |
| Q82218185 | [A case of primary herpetic eye disease] |
| Q88765887 | [A case of the combination of myasthenia gravis and autoimmune eye disease with the symptoms of malignant exophthalmos] |
| Q84148117 | [Anti-inflammatory treatment in dry eye disease] |
| Q80476993 | [Botulinum toxin injection-treatment of upper lid retraction in thyroid eye disease] |
| Q71220942 | [Brigade method of work in an eye disease clinic] |
| Q95559744 | [Case of blind eye disease associated with central retinal artery occlusion] |
| Q87404739 | [Comparison of the OSDI and SPEED questionnaires for the evaluation of dry eye disease in clinical routine] |
| Q50890362 | [Compilation of Yan ke zheng zong yuan ji qi wei (Orthodox Ophthalmology: Revealing the Mystery of Eye Disease) and its academic achievements]. |
| Q50916626 | [Compilation of Yan ke zheng zong yuan ji qi wei (Orthodox Ophthalmology: Revealing the Mystery of Eye Disease) and its academic achievements]. |
| Q69395641 | [Compressive optic neuropathies in eye disease associated with Basedow's disease. Therapeutic problems] |
| Q70156627 | [Conservative therapy of diabetic eye disease] |
| Q52377529 | [Contemporary appreciation of a miraculous cure of Piotr Komorowski grave eye disease in the 17-th century]. |
| Q84485442 | [Controversial issues of differential diagnosis of optic nerve atrophy due to primary eye disease and symptomatic optic nerve atrophy] |
| Q72694304 | [Development and classification of neovascular glaucoma in diabetic eye disease: histopathological study] |
| Q50554224 | [Diabetic eye disease. Occurrence of diabetic eye disease and the resource consumption in early tracing and treatment of diabetics in Denmark with threatened sight] |
| Q33415518 | [Diabetic eye disease]. |
| Q85725384 | [Diagnosis, therapy and follow up of diabetic eye disease] |
| Q93066759 | [Diagnosis, treatment and monitoring of diabetic eye disease (Update 2019)] |
| Q81623623 | [Difficult to decide when an eye disease is a disability. Patient's assessment of the visual function a good support for the physician's assessment] |
| Q52552723 | [Dry eye disease as a complex dysregulation of the functional anatomy of the ocular surface. New concepts for understanding dry eye disease]. |
| Q82591185 | [Early evidence of eye disease in prehispanic ceramics] |
| Q68420729 | [Effect of Inacin capsule for eye disease] |
| Q73584272 | [Effect of cod-liver injection in eye disease; with regard to Filatov's tissue therapy] |
| Q79542951 | [Emphasizing on reconstruction of postoperative binocular vision in children with eye disease] |
| Q95533251 | [Emphasizing the prevention and anti-inflammation research of dry eye disease] |
| Q74476851 | [Evaluation of military fitness in cases of eye disease] |
| Q72288242 | [Experiment in eye disease in Toulouse nursery schools] |
| Q80867729 | [Eye disease and mode of delivery] |
| Q69395683 | [Eye disease associated with Basedow's disease and plasmapheresis] |
| Q79031518 | [Eye disease caused by spider-body or net toxin (swelling of eyelid and chemosis of bulboconjunctiva and hyposphagma)] |
| Q54113544 | [Eye disease in children aged 6 to 15 years: a hospital-based study in Yaounde]. |
| Q78810435 | [Eye disease in children.] |
| Q53814912 | [Eye disease in international adoption: Importance of the region of origin]. |
| Q52376385 | [Eye disease in painters--Camille Pissaro]. |
| Q45970463 | [Eye disease in pulmonary fibrosis] |
| Q52368724 | [Eye disease may affect painting throughout life. The Czech artist Josef Lada 17 December 1887--14 December 1957]. |
| Q79554479 | [Eye disease of welders.] |
| Q81814849 | [Fish eye disease revealing a partial LCAT deficiency] |
| Q72714579 | [Fish eye disease] |
| Q81154871 | [Fish eye disease] |
| Q73981615 | [Generalized muscular hypoplasia with lymphangiectatic edema; probable Bonnevie-Ullrich syndrome; association with eye disease of vaguely determined nature and nephropathy entailing hyperaminoaciduria] |
| Q95328823 | [If Artificial Tears Aren't Enough. The Importance of Inflammatory Processes in Dry Eye Disease. Practical Aspects of an Anti-Inflammatory Therapy of Dry Eye Disease] |
| Q95328783 | [Inflammation in Dry Eye Disease - A Topic with Many Faces] |
| Q95328817 | [Inflammation in Dry Eye Disease - Information on Diagnostic Testing and Therapy Using the Scientific Online Information Platform OSCB-Berlin.org] |
| Q95328776 | [Inflammatory Eye Disease - Uveitis Update] |
| Q84595458 | [Introduction and management of an eye disease screening unit for diabetic patients in primary care] |
| Q53371232 | [Investigation and strategy research of eye disease prevention resources in community health service centers in Shanghai]. |
| Q73584546 | [Irgapyrin-Geigy in the treatment of eye disease] |
| Q74722199 | [Lecithin-cholesterol acyltransferase deficiency and fish eye disease] |
| Q71850475 | [Lecithin: cholesterol acyltransferase (LCAT)--the genetic analysis of familial LCAT deficiency and fish eye disease] |
| Q54732573 | [Letter: Endocrine eye disease following external irradiation of thyroid gland] |
| Q75726166 | [Local applications of cortisone in the treatment of eye disease] |
| Q86024689 | [Morphological changes in autoimmune dacryoadenitis associated with thyroid eye disease] |
| Q80977463 | [Ocular manifestations of pregnancy and effect on eye disease] |
| Q82719504 | [Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?] |
| Q84627602 | [Pathological role of apelin in angiogenic eye disease] |
| Q73541246 | [Possibilities of diagnosis and treatment of eye disease by general practitioners] |
| Q73577688 | [Posterior segment involvement in HIV-related eye disease after commencement of highly-active antiretroviral therapy (HAART)] |
| Q51821123 | [Potentials of intraoperative navigation during balanced orbital bony decompression in thyroid eye disease (preliminary results)]. |
| Q75654848 | [Purified tuberculin and the leukocyte index in eye disease of suspected tuberculous etiology.] |
| Q87054711 | [Quantification of ocular dominance for better management of eye disease] |
| Q64053481 | [RARE DISEASES OF THE EYE CAUSED BY ASCARIASIS. (UNILATERAL EDEMA OF EYELIDS AND TOXICO-ALLERGIC SERO-FIBROUS IRIDOCYCLITIS)] |
| Q83909612 | [Relationship between birth month and ocular refraction noted during eye disease checkups for three-and-a-half-year-old children in Japan] |
| Q72257350 | [Results of eye disease treatment with somatotropin] |
| Q83588400 | [Risk factors of corneal damage in patients with Thyroid Eye Disease] |
| Q84067207 | [Screening questionnaire for documentation of medical history and diagnostic findings in dry eye disease] |
| Q53985238 | [Seasonal rhythm of infectious eye disease in North Africa] |
| Q90944214 | [Senile eye disease screening program in downtown Wenzhou: intraocular pressure] |
| Q71432858 | [Several atypical cases of anterior ischemic eye disease studied within the general framework of our cases] |
| Q89917015 | [Significance of New Methods of Examining the Tear Film in Dry Eye Disease: Tear Film Osmolarity and Matrix Metalloproteinases (MMP-9)] |
| Q48623425 | [Surgical rehabilitation of patients with thyroid eye disease: systematic approach]. |
| Q91700522 | [TOPICAL ANTI-INFLAMMATORY AGENTS FOR DRY EYE DISEASE] |
| Q72998026 | [Teeth and eye disease] |
| Q52418690 | [The eye disease of Francis of Assisi (author's transl)]. |
| Q52454018 | [The eye disease, blindness and recovery of Mihály Táncsics]. |
| Q74334110 | [The flap falls--early attestations for lat. cataracta as a description of an eye disease] |
| Q52407795 | [The patron saint of eye disease sufferers]. |
| Q74315696 | [The role of hyaluronic acid and hyaluronidase in eye disease] |
| Q69434845 | [The significance of interferon inductors in current antiviral therapy for herpetic eye disease] |
| Q73262785 | [The typical eye disease after Leptospira infection] |
| Q72254943 | [Thyroid-associated eye disease] |
| Q79267988 | [Treatment of burns of the eye in the eye disease clinic of the academy of medicine in Lodz during 1945-1959.] |
| Q70488218 | [Treatment of corneal injuries and eye disease with actihaemyl] |
| Q73759972 | [Treatment of scrofulous eye disease in children] |
| Q73541245 | [Tuberculous eye disease and liver biopsy] |
| Q73158166 | [Tyrosolvin as a new antibiotic for local application in eye disease] |
| Q64932758 | [Under what conditions are pulmonary tuberculosis and fluoride focal tuberculous eye disease mutually exclusive; a contribution to the chapter; allergy and tuberculosis]. |
| Q71339577 | [Use of an alternating magnetic field in treating herpetic eye disease] |
| Q70478219 | [Vitreous surgery for diabetic eye disease] |
| Q71077373 | [von Hippel-Lindau disease--an eye disease with fatal extraocular manifestations] |
| Q113855652 | iSyTE |
| Q90959914 | n-3 Fatty Acid Supplementation and Dry Eye Disease |
| Q88350776 | n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease |
| Q100431139 | sPLA2-IIa participates in ocular surface inflammation in humans with dry eye disease |
| Q37421203 | {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study |
| Q98709302 | БСЭ1/Глазные болезни |
| Q63437143 | Интеллектуальная ДСМ-система для диагностики заболеваний органа зрения |
| Q63437171 | Интеллектуальная система типа ДСМ для анализа клинических данных |
| Q24407232 | ЭСБЕ / Глазные болезни |